def14a
SCHEDULE 14A
INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Filed by the
Registrant þ
Filed by a Party other than the
Registrant o
Check the appropriate box:
o Preliminary
Proxy Statement
o Confidential,
for use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
þ Definitive
Proxy Statement
o Definitive
Additional Materials
o Soliciting
Material Pursuant to
Rule 14a-11(c)
or
Rule 14a-12
Ultralife Corporation
(Name of Registrant as Specified In
Its Charter)
Not Applicable
(Name of Person(s) Filing Proxy
Statement if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
þ
|
No fee required
|
|
o
|
Fee computed on table below per Exchange Act
Rules 14a-6(i)(4)
and 0-11
|
|
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act
Rule 0-11:
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
o
|
Fee paid previously with preliminary materials.
|
|
o
|
Check boxes if any part of the fee is offset as provided by
Exchange Act
Rule 0-11(a)(2)
and identifies the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
ULTRALIFE CORPORATION
2000 Technology Parkway
Newark, New York 14513
April 28,
2011
To Our Shareholders:
You are cordially invited to attend the Annual Meeting of
Shareholders of Ultralife Corporation on Tuesday, June 7,
2011 at 10:30 A.M. at our corporate offices, 2000
Technology Parkway, Newark, New York 14513.
This year, for the first time, we are providing our proxy
materials over the Internet. Accordingly, we are mailing to many
of our shareholders a Notice of Internet Availability of Proxy
Materials instead of a paper copy of our Proxy Statement and our
2010 Annual Report to Shareholders. The Notice of Internet
Availability of Proxy Materials contains instructions about how
to access those documents and vote online. The Notice of
Internet Availability of Proxy Materials also contains
instructions about how each of our shareholders can also receive
a paper copy of our proxy materials, including the Proxy
Statement, our 2010 Annual Report to Shareholders and a form of
proxy card or voting instruction card. By taking advantage of
this distribution process, we will not only conserve natural
resources, but we will also reduce our costs of printing and
distributing proxy materials.
We hope that you will be able to attend this years Annual
Meeting.
Very truly yours,
Michael D. Popielec
President and Chief Executive Officer
ULTRALIFE
CORPORATION
2000 Technology Parkway
Newark, New York 14513
NOTICE OF ANNUAL MEETING OF
SHAREHOLDERS
JUNE 7, 2011
Notice is hereby given that the 2011 Annual Meeting of
Shareholders of Ultralife Corporation will be held on Tuesday,
June 7, 2011 at 10:30 A.M. at our corporate offices,
2000 Technology Parkway, Newark, New York 14513 for the
following purposes:
1. to elect eight directors for a term of one year and
until their successors are duly elected and qualified;
2. to approve an advisory resolution on executive
compensation;
3. to conduct an advisory vote on the frequency of future
advisory votes on executive compensation;
4. to approve an amendment to our Amended and Restated 2004
Long-Term Incentive Plan, including an increase in the number of
authorized shares under the plan and an amendment to the annual
limitation set forth in the plan;
5. to ratify the selection of BDO USA, LLP as our
independent registered public accounting firm for the fiscal
year ending December 31, 2011; and
6. to transact such other business as may properly come
before the meeting and any adjournments thereof.
Only shareholders of record of our Common Stock, par value $.10
per share, at the close of business on April 12, 2011 are
entitled to receive notice of, and to vote at and attend our
Annual Meeting. Your vote is important. Whether or not you plan
to attend our Annual Meeting, we hope that you will vote as soon
as possible. If you received only a Notice of Internet
Availability of Proxy Materials by mail, you may vote your
shares at the Internet site address listed on your Notice of
Internet Availability. You may also request a paper copy of our
proxy materials by visiting the Internet site address listed on
your Notice of Internet Availability, by calling the toll-free
number or by sending an
e-mail to
the e-mail
address listed on your Notice of Internet Availability. If you
received a paper copy of the proxy materials by mail, you may
vote your shares by proxy by doing any one of the following:
vote at the Internet site address listed on your proxy or voting
instruction card; call the toll-free number listed on your proxy
or voting instruction card; or sign, date and return in the
pre-addressed envelope provided the enclosed proxy or voting
instruction card.
By Order of the Board of Directors
Bradford T. Whitmore
Chair of the Board of Directors
Dated: April 28, 2011
TABLE OF
CONTENTS
|
|
|
|
|
Title
|
|
Page
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
2
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
4
|
|
|
|
|
7
|
|
|
|
|
7
|
|
|
|
|
8
|
|
|
|
|
8
|
|
|
|
|
8
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
10
|
|
|
|
|
10
|
|
|
|
|
10
|
|
|
|
|
10
|
|
|
|
|
11
|
|
|
|
|
11
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
15
|
|
|
|
|
15
|
|
|
|
|
16
|
|
|
|
|
16
|
|
|
|
|
16
|
|
|
|
|
18
|
|
|
|
|
18
|
|
|
|
|
19
|
|
|
|
|
20
|
|
|
|
|
24
|
|
|
|
|
26
|
|
|
|
|
26
|
|
|
|
|
27
|
|
|
|
|
28
|
|
|
|
|
29
|
|
|
|
|
30
|
|
|
|
|
32
|
|
|
|
|
33
|
|
|
|
|
33
|
|
|
|
|
34
|
|
|
|
|
34
|
|
|
|
|
35
|
|
|
|
|
35
|
|
|
|
|
36
|
|
|
|
|
36
|
|
|
|
|
37
|
|
|
|
|
|
|
Title
|
|
Page
|
|
|
|
|
38
|
|
|
|
|
39
|
|
|
|
|
40
|
|
|
|
|
43
|
|
|
|
|
44
|
|
|
|
|
44
|
|
|
|
|
45
|
|
|
|
|
45
|
|
|
|
|
45
|
|
|
|
|
46
|
|
|
|
|
46
|
|
|
|
|
46
|
|
|
|
|
46
|
|
|
|
|
46
|
|
|
|
|
46
|
|
|
|
|
47
|
|
|
|
|
47
|
|
|
|
|
48
|
|
|
|
|
49
|
|
|
|
|
50
|
|
|
|
|
50
|
|
IMPORTANT
REGARDLESS OF WHETHER YOU PLAN TO ATTEND THE MEETING, WE
ENCOURAGE YOU TO VOTE IN ANY OF THE MANNERS DESCRIBED IN THIS
PROXY STATEMENT. WE ALSO ENCOURAGE BENEFICIAL OWNERS TO FOLLOW
THE INSTRUCTIONS PROVIDED BY YOUR BROKER REGARDING HOW TO
VOTE. YOUR BROKER CANNOT VOTE YOUR SHARES FOR DIRECTOR
NOMINEES OR FOR PROPOSALS 2, 3 AND 4 UNLESS YOU PROVIDE
YOUR BROKER WITH VOTING INSTRUCTIONS.
ULTRALIFE CORPORATION
2000 Technology Parkway
Newark, New York 14513
(315) 332-7100
PROXY STATEMENT
ANNUAL MEETING OF
SHAREHOLDERS
JUNE 7, 2011
We are furnishing this proxy statement to our shareholders in
connection with our Board of Directors solicitation of
proxies for use at our 2011 Annual Meeting of Shareholders,
which we refer to in this proxy statement as the Meeting, to be
held on Tuesday, June 7, 2011, at 10:30 A.M. and at
any adjournments thereof. The Meeting will be held at our
corporate offices, 2000 Technology Parkway, Newark, New York
14513.
In accordance with rules and regulations adopted by the
U.S. Securities & Exchange Commission
(SEC), instead of mailing a printed copy of our
proxy materials to each shareholder of record, we are now
furnishing proxy materials to our shareholders on the Internet.
If you received only a Notice of Internet Availability of Proxy
Materials by mail, you will not receive a printed copy of the
proxy materials unless you request a copy. Instead, the Notice
of Internet Availability will instruct you how to access and
review the proxy materials over the Internet. The Notice of
Internet Availability of Proxy Materials will also instruct you
as to how you may submit your proxy over the Internet. If you
received only a Notice of Internet Availability by mail and
would like to receive a printed copy of our proxy materials, you
should follow the instructions for requesting those materials
included in the Notice of Internet Availability.
The Notice of Internet Availability of Proxy Materials is first
being sent to our shareholders on or about April 28, 2011
and our proxy materials are also first being made available to
our shareholders on April 28, 2011.
You may vote by proxy or in person at the Meeting. If you
received only a Notice of Internet Availability by mail, you may
vote your shares on line by proxy at the Internet site address
listed on your Notice of Internet Availability. You may also
request a paper copy of our proxy materials by visiting the
Internet site address listed on your Notice of Internet
Availability, by calling the toll-free number or by sending an
e-mail to
the e-mail
address listed on your Notice of Internet Availability. If you
received a paper copy of the proxy materials by mail, you may
vote your shares by proxy by doing any one of the following:
vote at the Internet site address listed on your proxy or voting
instruction card; call the toll-free number listed on your proxy
or voting instruction card; or mail your signed and dated proxy
or voting instruction card to our tabulator in the
self-addressed envelope provided. Even if you plan to attend the
Meeting in person, we recommend that you vote by proxy prior to
the Meeting. You can always change your vote as described below.
When a proxy card is returned properly signed and dated, the
shares represented thereby will be voted in accordance with the
shareholders directions. If the proxy is signed, dated and
returned without choices having been specified, the shares will
be voted FOR the election of each director-nominee named
therein, FOR the other proposals
identified therein and in favor of a frequency of every three
years for future advisory votes on executive compensation.
You may receive more than one Notice of Internet Availability or
more than one paper copy of the proxy materials, including
multiple paper copies of this proxy statement and multiple proxy
or voting instruction cards, depending on how you hold your
shares. For example, if you hold your shares in more than one
brokerage account, you may receive a separate Notice of Internet
Availability, a separate
e-mail or a
separate voting instruction card for each brokerage account in
which you hold your shares. If you are a shareholder of record
and your shares are registered in more than one name, you may
receive more than one Notice of Internet Availability, more than
one e-mail
or more than one proxy card. To vote all of your shares by
proxy, you must vote at the Internet site address listed on your
Notice of Internet Availability, proxy or voting instruction
card; call the toll-free number listed on your proxy or voting
instruction card; or sign, date and return each proxy card and
voting instruction card that you receive.
If for any reason any of the nominees for election as directors
become unavailable for election, discretionary authority may be
exercised by the proxies to vote for substitute nominees
proposed by our Board of Directors. A shareholder has the right
to revoke a previously granted proxy at any time before it is
voted by filing with our Corporate Secretary a written notice of
revocation, or a duly executed later-dated proxy, or by
requesting return of the proxy at the Meeting and voting in
person.
We will bear the cost of soliciting proxies. In addition to the
solicitation of proxies by use of the mails, some of our
officers, directors and regular employees, without extra
remuneration, may solicit proxies personally or by telephone,
telefax or similar transmission. We may decide to retain the
services of a proxy solicitation firm if we believe it is
appropriate under the circumstances. We will reimburse record
holders for expenses in forwarding proxies and proxy soliciting
material to the beneficial owners of the shares held by them.
Only shareholders of record at the close of business on
April 12, 2011 are entitled to notice of, and to vote at,
the Meeting. As of April 12, 2011, there were
17,289,114 shares of our Common Stock, par value $.10 per
share, issued and outstanding, each entitled to one vote per
share at the Meeting.
Quorum
A majority of the outstanding shares of our Common Stock,
represented in person or by proxy at the Meeting, will
constitute a quorum for the transaction of all business. For
purposes of determining whether a quorum is present,
shareholders of record who are present at the Meeting in person
or by proxy are considered to be present at the Meeting.
Vote
Required
The table below shows the vote required at the Meeting to
approve each of the proposals described in this proxy statement,
assuming the presence of a quorum:
|
|
|
|
|
Proposal
|
|
Vote Required
|
|
1.
|
|
Election of directors
|
|
Plurality of the votes duly cast at the Meeting
|
2.
|
|
To approve an advisory resolution on executive compensation
|
|
Majority of the votes duly cast at the Meeting
|
3.
|
|
To conduct an advisory vote on the frequency of future advisory
votes on executive compensation
|
|
Majority of the votes duly cast at the Meeting
|
4.
|
|
To approve an amendment to our Amended and Restated 2004
Long-Term Incentive Plan, including an increase in the number of
authorized shares under the plan and an amendment to the annual
limitation set forth in the plan
|
|
Majority of the votes duly cast at the Meeting
|
5.
|
|
Ratification of the selection of BDO USA, LLP as our independent
registered public accounting firm for the fiscal year ending
December 31, 2011
|
|
Majority of the votes duly cast at the Meeting*
|
2
|
|
|
* |
|
The selection of BDO USA, LLP is being presented to our
shareholders for ratification. The Audit and Finance Committee
will consider the outcome of this vote when selecting our
independent registered public accounting firm for subsequent
fiscal years. |
Abstentions
Shares that abstain from voting on one or more proposals to be
acted on at the Meeting are considered to be present for the
purpose of determining whether a quorum exists. Abstentions will
have no effect on the election of directors; however,
abstentions will have the effect of voting against the other
proposals set forth in this proxy statement, because abstentions
are deemed to be present and entitled to vote but do not count
toward the affirmative vote required to approve the proposal.
Broker
Non-Votes
If you own your shares through a broker and do not provide your
broker with specific voting instructions, your broker will have
the discretion under the rules governing brokers who have record
ownership of shares that they hold in street name for their
clients to vote your shares on routine matters but not
otherwise. As a result of new rules applicable to director
elections after January 10, 2010, brokers may no longer
vote shares they hold as nominee in their discretion in the
election of directors or other non-routine matters. As a
result, your broker may exercise discretion to vote your shares
only with respect to the ratification of the selection of our
independent registered public accounting firm, because that is
considered a routine matter. If you want your broker-owned
shares to be counted in the election of directors and with
respect to Proposals 2, 3 and 4, you must provide
instructions to your broker on how to vote your shares.
A broker non-vote occurs when shares held by a broker are not
voted on a non-routine proposal because the broker has not
received voting instructions from the beneficial owner and the
broker lacks discretionary authority to vote the shares in the
absence of such instructions. Shares subject to broker non-votes
are considered to be present for the purpose of determining
whether a quorum exists and thus count towards satisfying the
quorum requirement but are not counted for purposes of
determining the number of shares entitled to vote on non-routine
matters. A broker non-vote will have no effect on the election
of directors or Proposals 2, 3 and 4 since they are not
counted for purposes of determining the number of shares
entitled to vote.
3
PROPOSAL 1
ELECTION
OF DIRECTORS
Our Board of Directors currently has eight directors, all of
whom have been nominated to serve for an additional one year
term. If elected, each director standing for election shall
serve until the next Annual Meeting of Shareholders and until
his or her successor shall have been elected and qualified. The
names of, and certain information with respect to, the persons
nominated for election as directors are presented below.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Present Principal Occupation, Employment History and
Expertise
|
|
Steven M. Anderson
|
|
|
54
|
|
|
Brigadier General (Ret.) Anderson has been a director since
April 13, 2010. General (Ret.) Anderson is currently Senior
Vice President of Relyant, LLC, a service-disabled veteran-owned
small business and global provider of solutions to complex
projects. Prior to joining Relyant, LLC in February 2011,
General (Ret.) Anderson served as Chief Operating Officer for
Synovision Solutions LLC, a service-disabled veteran-owned small
business specializing in unique applications of emerging
technology, many central to innovative energy solutions. General
(Ret.) Anderson, a career military officer who retired from
active duty in November 2009, served for five years as a general
officer in the US Army, including 15 months as the senior
US and coalition logistician in Iraq in support of Operation
Iraqi Freedom. From 2004 to 2006, General (Ret.) Anderson served
as the senior US logistician in Korea (Deputy C-4 for the United
Nations Command/Combined Forces Command and J4, United States
Forces Korea) and spearheaded the development of Camp Humphreys,
the new combined and US headquarters facility in Central Korea.
He served in various command positions including Commander,
Division Support Command, 2nd Infantry Division, Korea
(2000-02), and Commander,
725th
Main Support Battalion,
25th
Infantry Division (Light), Schofield Barracks, Hawaii
(1995-97). In his final military assignment, he served for two
years on the Army Staff in the Pentagon as the Director,
Operations and Logistics Readiness, Office of the Army Deputy
Chief of Staff, G4 (logistics). General (Ret.) Anderson is a
1978 graduate of the US Military Academy at West Point and
earned a Masters of Science degree in Operations Research and
Systems Analysis Engineering at the Naval Postgraduate School in
1987. General (Ret.) Anderson has been nominated for re-election
to our Board of Directors because of his familiarity with the US
military.
|
Patricia C. Barron
|
|
|
68
|
|
|
Ms. Barron has been a director since December 2000 and served as
Chair of the Board of Directors from June 2007 to August 2009.
Ms. Barron serves as lead director of Quaker Chemical
Corporation, and as a director of Teleflex Incorporated and
United Services Automobile Association, an insurance mutual
corporation. She also serves on a number of non-profit
organizations, with a focus on education and health. Ms. Barron
had a 28-year career in business. She was an Associate at
McKinsey and Company and then moved to Xerox Corporation where
she became a corporate officer and held the positions of Vice
President of Business Operation Support, President of
Engineering Systems and President of Office Document Products.
Most recently, she has been a Clinical Associate Professor at
the Leonard N. Stern School of Business of New York University,
where she focused on issues of corporate governance and
leadership. Ms. Barron has been nominated for
re-election
to our Board of Directors because of her longstanding business
career and expertise in corporate governance.
|
4
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Present Principal Occupation, Employment History and
Expertise
|
|
James A. Croce
|
|
|
48
|
|
|
Mr. Croce has been a director since June 8, 2010. Mr. Croce is
currently the President and Chief Executive Officer of the
Nevada Institute for Renewable Energy Commercialization (NIREC),
serving in that position since mid-2009. Prior to accepting his
position at NIREC, from 2008 to 2009, Mr. Croce was President of
Lipten Energy Services, an engineering and energy project
development firm, whose primary focus was the development and
execution of strategic growth initiatives in the alternative
energy space, including power generation, biomass and
waste-to-energy projects. From 2003 to 2008, Mr. Croce was
President and Chief Executive Officer of NextEnergy, one of the
nations leading clean energy technology commercialization
catalysts. From 2001 to 2003, Mr. Croce was Vice President of
Business Development at DTE Energy Technologies, a developer of
distributed power generation technologies and energy products
including fuel cells, internal combustion engines, turbines and
energy information systems. From 1998 to 2001, he was Executive
Director, Business Marketing and Sales at Michigan Consolidated
Gas Company (MichCon), an integrated natural gas transportation
and storage business where he was responsible for sales and
marketing programs for the companys commercial and
industrial customers. Prior to that, from 1996 to 1998, he was
General Manager at MichCon Pipeline Company, where he launched
and managed new energy delivery services. Mr. Croce is
co-founder of the Michigan Sustainable Energy Coalition, a
renewable energy policy advocacy group, and has served on the
board of directors of numerous nonprofit agencies. Mr. Croce
has been nominated for re-election to our Board of Directors
because of his expertise in the renewable energy industry.
|
Michael D. Popielec
|
|
|
49
|
|
|
Mr. Popielec was appointed as our President and Chief Executive
Officer and as a director effective December 30, 2010. Mr.
Popielec has 25 years experience in growing domestic and
international industrial businesses. Prior to joining us, Mr.
Popielec was Group President, Applied Technologies in 2008 and
2009 and Group President, Diversified Components from 2005 to
2007 at Carlisle Companies, Inc., a $2.5 billion diversified
global manufacturer. Prior to that, from 2003 to 2005, he held
various positions, most recently Chief Operating Officer,
Americas, for Danka Business Systems, PLC. From 1985 to 2002,
Mr. Popielec held positions of increasing responsibility at
General Electric Company, most recently as a GE corporate
officer and President and Chief Executive Officer of GE Power
Controls, the European arm of GE Industrial Systems. Mr.
Popielec has a B.S. in Mechanical Engineering from Michigan
State University. Mr. Popielec has been nominated for election
to our Board of Directors because of his operations expertise
and his experience in growing domestic and international
industrial businesses.
|
5
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Present Principal Occupation, Employment History and
Expertise
|
|
Thomas L. Saeli
|
|
|
54
|
|
|
Mr. Saeli has been a director since March 5, 2010. Mr. Saeli is
currently the Chief Executive Officer of JRB Enterprises, Inc.,
a manufacturer of commercial and industrial roofing systems,
having been appointed to that position in March 2011. Prior to
that, Mr. Saeli was a business consultant to international
corporate clients on matters involving business development
strategies, consolidations, acquisitions and operations. He
previously served as Chief Executive Officer and a member of the
Board of Directors of Noble International, Ltd., an auto
supplier of engineered laser-welded steel blanks and roll-formed
products, from March 2006 to April 13, 2009 when he resigned
those positions. Noble International, Ltd. filed for voluntary
relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S.
Bankruptcy Court, Eastern District of Michigan on April 15,
2009. From 1998 through 2006, Mr. Saeli served as Vice
President of Corporate Development for Lear Corporation, an
automotive supplier of seating, electronics and interior
products, where he also served as Vice President of Mergers and
Acquisitions. Mr. Saeli also serves on the Boards of Directors
of Advance Capital Management, a mutual fund, and Oakwood
Hospital in Dearborn, Michigan. Mr. Saeli has been nominated for
re-election to our Board of Directors because of his familiarity
with the auto industry and his manufacturing, corporate
development and finance experience. Mr. Saeli also qualifies as
an audit committee financial expert.
|
Robert W. Shaw II
|
|
|
54
|
|
|
Mr. Shaw has been a director since June 8, 2010. Mr. Shaw is
currently the President of Hornblower Yachts, Inc., the largest
dining and excursion boat operator in the United States, with
over 50 vessels serving California and New York with
the Hornblower, Alcatraz and Statue Cruises brands. From 2007 to
2010, he was President of R.M. Thornton, Inc., a mechanical
contracting company specializing in the Federal government and
healthcare markets. Prior to that, from 1995 to 2006, Mr. Shaw
was Chief Executive Officer and Managing Partner at Odyssey
Cruises/Premier Yachts, Inc., a leading U.S. dining and
excursion boat operator, where he successfully led the company
through a sale process to private equity firm ICV Capital
Partners. From 1989 to 1995, he served in Sodexho, S.A., one of
the worlds largest contract services providers, as both
President and Chief Executive Officer of Spirit Cruises, Inc.,
and Division President of The Seiler Corporation. Mr. Shaw
served in the US Marine Corps from 1978 to 1982 as an infantry
Captain. Mr. Shaw has consulted or served on a number of boards
of advisors of various non-public organizations and he has been
nominated for re-election to our Board of Directors because of
his management expertise and experience as an executive officer.
|
6
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Present Principal Occupation, Employment History and
Expertise
|
|
Ranjit C. Singh
|
|
|
58
|
|
|
Mr. Singh has been a director since August 2000, and served as
Chair of the Board of Directors from December 2001 to June
2007. Mr. Singh is currently Chief Executive Officer of CSR
Consulting Group, which provides business and technology
consulting services. He previously served as President and
Chief Executive Officer of Aptara, Inc. (formerly known as Tech
Books), a content outsourcing services company, from February
2003 until July 2008. From February 2002 to February 2003, Mr.
Singh served as President and Chief Executive Officer of
Reliacast Inc., a video streaming software and services company.
Prior to that, he was President and Chief Operating Officer of
ContentGuard, which develops and markets digital property rights
software. Before joining ContentGuard earlier in 2000, Mr.
Singh worked for Xerox as a corporate Senior Vice President in
various assignments related to software businesses. Mr. Singh
joined Xerox in 1997, having come from Citibank where he was
Vice President of Global Distributed Computing. Prior to that,
he was a principal at two start-up companies and also held
executive positions at Data General and Digital Equipment
Corporation. Since January 2005, Mr. Singh has served on the
Board of Directors of Authentidate Holding Corp. Mr. Singh has
been nominated for re-election to our Board of Directors because
of his experience in the service industry and with
technology-based organizations.
|
Bradford T. Whitmore
|
|
|
53
|
|
|
Mr. Whitmore has been a director since June 2007 and Chair of
the Board of Directors since March 2010. Since 1985, he has
been the Managing Partner of Grace Brothers, Ltd., an investment
firm which holds approximately 26.1% of the outstanding shares
of our Common Stock. Mr. Whitmore and Grace Brothers, Ltd.
collectively hold slightly less than 30% of the outstanding
shares of our Common Stock. Within the past five years, Mr.
Whitmore has served as a director of several non-public
companies related to ownership of Grace Brothers,
Ltd./affiliates investments as well as not-for-profit
organizations. Mr. Whitmore has been nominated for re-election
to our Board of Directors because of his corporate development
expertise.
|
Our Board of Directors has approved the above-named nominees for
directors. Our Board of Directors recommends a vote FOR
all of these nominees.
CORPORATE
GOVERNANCE
General
Pursuant to the General Corporation Law of the State of
Delaware, the state under which we were organized, and our
By-laws, our business, property and affairs are managed by or
under the direction of our Board of Directors. Members of our
Board of Directors are kept informed of company business through
discussions with our President and Chief Executive Officer and
other corporate officers, by reviewing materials provided to
them and by participating in meetings of the Board and its
committees.
Our Board of Directors has determined that all of our directors
(other than Michael D. Popielec, who serves as our President and
Chief Executive Officer) are independent for
purposes of the listing standards of the Nasdaq Stock Market.
Our Board of Directors has also determined that the Chair of the
Board of Directors should be an independent director. We believe
that the segregation of the roles of Board Chair and President
and Chief Executive Officer ensures better overall governance of
our company and provides meaningful checks and balances
regarding our overall performance. This structure allows our
President and Chief Executive Officer to focus on our business
while the Board Chair leads our Board of Directors in
establishing corporate policy and complying with heightened
regulatory scrutiny.
Our Board of Directors has four standing committees: an Audit
and Finance Committee, a Governance Committee, a Compensation
and Management Committee, and a Strategy and Corporate
Development Committee (formerly the Mergers and Acquisitions
Committee). During 2010, our Board of Directors held 12 meetings
and the
7
committees of our Board of Directors held a total of 33
meetings, two of which were non-mandatory, uncompensated status
meetings of the Audit and Finance Committee. During 2010,
General (Ret.) Daniel W. Christman served as our Board Chair
until his retirement effective March 24, 2010. Upon General
(Ret.) Christmans retirement from our Board of Directors,
our Board elected Bradford T. Whitmore as Board Chair. As Board
Chair, Mr. Whitmore served as a non-voting ex-officio
member of all of our Board committees. Each director attended at
least 75% of the aggregate of: (1) the total number of
meetings of the Board; and (2) the total number of meetings
held by all committees of the Board on which he or she served.
Our Board of Directors has adopted a charter for each of the
four standing committees that addresses the composition and
function of each committee and has also adopted Corporate
Governance Principles that address the composition and function
of the Board of Directors. These charters and Corporate
Governance Principles are available on our website at
http://investor.ultralifecorp.com
under the subheading Corporate Governance. Pursuant
to our Corporate Governance Principles, it is our policy that
directors retire from service at the Annual Meeting following a
directors 70th birthday.
Our Board of Directors has determined that all of the directors
who serve on these committees are independent for
purposes of the listing standards of the Nasdaq Stock Market,
and that the members of the Audit and Finance Committee are also
independent for purposes of Section 10A(m)(3)
of the Securities Exchange Act of 1934, as amended, which we
refer to in this proxy statement as the Exchange Act. Our Board
of Directors based these determinations primarily on a review of
the responses of the directors to questions regarding
employment, compensation history, affiliations and family and
other relationships, and on
follow-up
discussions.
Committees
of the Board of Directors
Audit
and Finance Committee
The current members of the Audit and Finance Committee are
Thomas L. Saeli (Chair), Patricia C. Barron and Robert W. Shaw
II. This committee selects our independent registered public
accounting firm and has oversight responsibility for reviewing
the scope and results of the independent registered public
accounting firms annual examination of our financial
statements and the quality and integrity of those financial
statements. Further, the committee reviews the qualifications
and independence of the independent registered public accounting
firm, and meets with our financial management, including our
Internal Audit Manager, and the independent registered public
accounting firm to review matters relating to internal
accounting controls, our accounting practices and procedures and
other matters relating to our financial condition. The Audit and
Finance Committee met 15 times during 2010, with two of those
meetings being non-mandatory, uncompensated status meetings.
Our Board of Directors has determined that each of the members
of the Audit and Finance Committee is financially
literate in accordance with the listing standards of the
Nasdaq Stock Market. In addition, our Board of Directors has
determined that Mr. Saeli qualifies as an audit
committee financial expert as defined in
Item 407(d)(5) of
Regulation S-K.
Governance
Committee
The current members of the Governance Committee are Patricia C.
Barron (Chair), Steven M. Anderson and James A. Croce. This
committee reviews the performance and compensation of our
directors, makes recommendations to our Board of Directors for
membership and committee assignments and for the compensation of
our directors, and manages the annual evaluation of the
performance of our President and Chief Executive Officer. The
Governance Committee met six times during 2010.
The Governance Committee identifies potential nominees for
directors based on its own research for appropriate candidates
as well as on recommendations received by directors or from
shareholders as described below. On occasion, the Governance
Committee will retain an executive search firm to assist in the
identification of potential director nominees. The committee
will also evaluate information provided by the National
Association of Corporate Directors about prospective Board
candidates. The evaluation process and the factors considered in
undertaking that evaluation are set forth under the caption
Shareholder Recommendations for Director
Nominations on page 9.
8
The Governance Committee also has overall responsibility for
assessing and managing our exposure to various risks.
Compensation
and Management Committee
The current members of the Compensation and Management Committee
are Ranjit C. Singh (Chair), Steven M. Anderson and James A.
Croce. The Compensation and Management Committee has general
responsibility for determining the compensation of officers
elected by our Board of Directors, granting stock options and
restricted stock awards and otherwise administering our equity
compensation plans, and approving and administering any other
compensation plans or agreements. Our Restated 2004 Long-Term
Incentive Plan, which we refer to in this proxy statement as the
Restated LTIP, is administered by the Compensation and
Management Committee. The Compensation and Management Committee
met seven times during 2010.
Strategy
and Corporate Development Committee
The current members of the Strategy and Corporate Development
Committee are Robert W. Shaw II (Chair), Thomas L. Saeli
and Ranjit C. Singh. The Strategy and Corporate Development
Committee is responsible for working with management to develop
corporate strategy and for identifying and evaluating
acquisition opportunities. The Strategy and Corporate
Development Committee met five times during 2010.
Shareholder
Recommendations for Director Nominations
As noted above, the Governance Committee considers and
establishes procedures regarding recommendations for nomination
to our Board of Directors, including nominations submitted by
shareholders. Such recommendations, if any, should be sent to
Corporate Secretary, Ultralife Corporation, 2000 Technology
Parkway, Newark, New York 14513. Any recommendations
submitted to the Corporate Secretary should be in writing and
should include any supporting material the shareholder considers
appropriate in support of that recommendation, but must include
the information that would be required under the rules of the
SEC in a proxy statement soliciting proxies for the election of
such candidate and a signed consent of the candidate to serve as
a director, if elected. The Governance Committee evaluates all
potential candidates in the same manner, regardless of the
source of the recommendation.
Based on the information provided to the Governance Committee,
it will make an initial determination whether to conduct a full
evaluation of a candidate. The Governance Committee considers
the composition and size of the existing Board of Directors,
along with other factors, in making its determination to conduct
a full evaluation of a candidate. As part of the full evaluation
process, the Governance Committee may conduct interviews, obtain
additional background information and conduct reference checks
of candidates. The Governance Committee may also ask the
candidate to meet with management and other members of our Board
of Directors. In evaluating a candidate, our Board of Directors,
with the assistance of the Governance Committee, takes into
account a variety of factors as described in our Corporate
Governance Principles, including the particular experience,
attributes and skills that would qualify the candidate to serve
as a director. The criteria for selection to our Board of
Directors include character and leadership skills, general
business acumen and executive experience; knowledge of strategy,
finance, relations between business and government, internal
business all to ensure an active Board of Directors
whose members work well together and possess the collective
knowledge and expertise required. Our Governance Committee
reviews the qualifications of any candidate with those of its
current directors to augment and complement the skill sets of
our current Board members. We believe that it is important for
our Board of Directors to be comprised of individuals with
diverse backgrounds, skills and experiences. Although we do not
have a formal diversity policy and identify qualified potential
candidates without regard to any particular classification, we
believe that the breadth of experience and qualifications of our
Board members promotes Board diversity.
Annual
Meeting Attendance
Our policy is that all of the directors, absent special
circumstances, should attend our Annual Meeting of Shareholders.
A regular meeting of the Board of Directors is typically
scheduled in conjunction with the Annual Meeting of
Shareholders. All directors attended last years Annual
Meeting of Shareholders.
9
Executive
Sessions
Our Corporate Governance Principles require our Board of
Directors to meet in executive session regularly by requiring
our independent directors to have at least four
regularly-scheduled meetings per year without management
present. Our Board of Directors met in executive session 15
times during 2010. In addition, our standing committees meet in
executive session on a regular basis.
Communicating
with the Board of Directors
Shareholders interested in communicating directly with our Board
of Directors as a group or individually may do so in writing to
our Corporate Secretary, Ultralife Corporation, 2000 Technology
Parkway, Newark, New York 14513. The Corporate Secretary will
review all such correspondence and forward to our Board of
Directors a summary of that correspondence and copies of any
correspondence that, in his opinion, deals with the functions of
the Board of Directors or that he otherwise determines requires
their attention. Directors may at any time review a log of all
correspondence received by us that is addressed to members of
the Board of Directors and request copies of any such
correspondence. Any concerns relating to accounting, internal
controls or auditing matters will be brought to the attention of
the Audit and Finance Committee and handled in accordance with
the procedures established by the Audit and Finance Committee
with respect to such matters.
Code of
Ethics
We have a Code of Ethics applicable to all employees, including
our Principal Executive Officer and our Principal Financial
Officer (who is also our Principal Accounting Officer), and, to
the extent it applies to their activities, all members of our
Board of Directors. Our Code of Ethics incorporates the elements
of a code of ethics specified in Item 406 of
Regulation S-K
and also complies with the Nasdaq Stock Market requirements for
a code of conduct. Shareholders can find a link to this Code of
Ethics on our website at
http://investor.ultralifecorp.com
under the subheading Corporate Governance. We intend
to post amendments to or waivers (whether expressed or implied)
from the Code of Ethics (to the extent applicable to our
Principal Executive Officer or Principal Financial Officer) at
the same location on our website as the Code of Ethics.
Our Code of Ethics emphasizes our commitment to conducting
business in a legal and ethical manner and encourages prompt and
confidential reporting of any suspected violations of law or the
Code of Ethics. As part of our Code of Ethics, directors and
employees are expected to make business decisions and to take
actions based upon the best interests of our company and not
based upon personal relationships or benefits. Any potential
conflict of interest, and any transaction or relationship
involving our officers or directors that could give rise to a
conflict of interest, must be reviewed and resolved by our
Governance Committee.
We have adopted written policies and procedures for the review
and approval or ratification of any related party
transaction, defined by us as any transaction, or proposed
transaction, in excess of $120,000 between us and any of our
executive officers, directors or director nominees. The policy
provides that each related party transaction must be reviewed by
our Audit and Finance Committee. The committee reviews the
relevant facts and circumstances of the transaction, including
if the transaction is on terms comparable to those that could be
obtained in arms-length dealings with an unrelated third party
and the extent of the related partys interest in the
transaction, taking into account the conflicts of interest and
corporate opportunity provisions of our Code of Ethics, and
either recommends that the Board of Directors approve or
disapprove the related party transaction. We will disclose all
required related party transactions in our filings with the SEC.
To our knowledge, no reportable transaction existed during 2010,
and there are currently no such proposed transactions.
Risk
Management
Our management team is responsible for assessing and managing
our exposure to various risks. We have an enterprise risk
management process to identify, assess and manage the most
significant risks facing our company. Our Governance Committee
has general responsibility to review managements risk
management process, including the policies and guidelines used
by management to identify, assess and manage our exposure to
risk. Our Audit and Finance Committee has oversight
responsibility for financial risks. Our management reviews these
10
financial risks with our Audit and Finance Committee regularly
and reviews the risk management process, as it affects financial
risks, with our Audit and Finance Committee on an on-going basis.
Our Compensation and Management Committee evaluates the extent
to which our compensation policies expose us to risk that could
threaten the value of our company.
In 2010,
|
|
|
|
|
all bonus plans were reviewed with Human Resources, Finance and
our Chief Executive Officer, and officer bonus plans required
Compensation and Management Committee approval;
|
|
|
|
the metrics of those bonus plans were reviewed to make sure they
were financial in nature and were stretch in nature;
|
|
|
|
all commission plans were developed by the Business Unit Vice
Presidents and Human Resources followed by Finance and Chief
Executive Officer review;
|
|
|
|
all stock option or equity requests are approved by Human
Resources, our Chief Executive Officer and the Business Unit
leader followed by Compensation and Management Committee
approval and, in the case of awards for more than
10,000 shares, Board of Directors approval; and
|
|
|
|
additional guidelines were adopted so that effective
January 1, 2011 the Compensation and Management Committee
is notified and in some cases must approve certain compensation
actions for key non-officer employees.
|
The Compensation and Management Committee has reviewed our
incentive compensation arrangements to determine whether the
risks related to the design and operation of our compensation
plans and programs, if present, were reasonably likely to have a
material adverse effect on our company. We have concluded that
such arrangements do not encourage excessive risk taking and are
not reasonably likely to have a material adverse effect on our
company.
DIRECTOR
COMPENSATION
We use a combination of cash compensation and stock-based
incentive compensation to attract and retain qualified
candidates to serve on our Board of Directors. Our practice is
to resurvey our peer group companies every two to three years to
ascertain whether our overall director compensation is
appropriate and balanced. If we perceive that there has been a
major change in our company or the market, we may conduct a more
frequent survey. In setting director compensation, we consider
the amount of time that directors spend fulfilling their duties
to us, the skill-level required by members of our Board of
Directors, and, based on an independent review by our external
compensation consultant and other publicly available director
compensation data, the compensation paid to directors in similar
sized organizations in our industry. Our program remains
designed to deliver annual director compensation at
approximately the median of companies in similar industries and
of similar size.
Director
Cash Compensation
Through June 30, 2010, each non-employee director received
a $3,000 quarterly retainer, and the Board Chair received a
$5,000 quarterly retainer. Each non-employee director also
received $1,000 for each board meeting attended whether a
regularly scheduled meeting or a specially called meeting, and
regardless of whether attendance was in person or by telephone.
Each non-employee director also received $750 for each meeting
of the four standing committee meetings attended as a committee
member, whether in person or by telephone. The Chair of the
Audit and Finance Committee received a $2,500 quarterly
retainer, the Chair of the Compensation and Management Committee
received a $2,000 quarterly retainer and the Chairs of the
Governance and the Strategy and Corporate Development Committees
received a $1,250 quarterly retainer.
At its June 8, 2010 meeting, our Board of Directors
modified our cash compensation for directors by terminating the
payment of cash meeting fees to each director for each Board and
committee meeting attended. Instead, effective July 1,
2010, each non-employee director receives an annual cash
retainer of $20,000, except for the Board Chair, who receives an
annual cash retainer of $28,000. In addition, each director who
is a member
11
of a Board committee receives an additional cash retainer for
such committee service as summarized in the table below.
|
|
|
|
|
|
|
|
|
|
|
Annual Retainer for
|
|
Annual Retainer for
|
|
|
Committee Members
|
|
Committee Chair
|
|
Audit and Finance Committee
|
|
$
|
6,750
|
|
|
$
|
16,750
|
|
Compensation and Management Committee
|
|
$
|
5,250
|
|
|
$
|
13,250
|
|
Governance Committee
|
|
$
|
4,500
|
|
|
$
|
9,500
|
|
Strategy and Corporate Development Committee
|
|
$
|
3,750
|
|
|
$
|
8,750
|
|
Annual retainers for both committee members and committee chairs
are paid quarterly in cash. For Board and committee service
during 2010, we paid our directors an aggregate $264,964.
Directors
Stock-Based Incentive Compensation
Our Board of Directors did not modify our equity compensation
program for directors, which continues to provide each director
with an annual award of shares of our Common Stock without any
restrictions. The aggregate value of the award for each
non-employee director is $40,000 and the aggregate value of the
award for the Board Chair is $66,000. Our directors are elected
annually in June of each year. Accordingly, these grants of
Common Stock to our current directors were scheduled for four
equal installments on August 15, 2010, November 15,
2010, February 15, 2011 and May 15, 2011. In order to
receive an installment of Common Stock, a director must be a
current member of our Board of Directors on the scheduled
installment payment date. To determine the number of shares of
Common Stock to award based on this valuation, the value of each
quarterly award, which is $10,000 for each director other than
the Board Chair and $16,500 for the Board Chair, is divided by
the volume weighted average price (VWAP) of the
Common Stock on the grant date of the award. On August 15,
2010, each incumbent non-employee director received
2,172 shares of Common Stock and the Board Chair received
an additional 1,362 shares of Common Stock. On
November 15, 2010, each incumbent non-employee director
received 1,544 shares of Common Stock and the Board chair
received an additional 1,003 shares of Common Stock. On
February 15, 2011, each incumbent non-employee director
received 2,529 shares of Common Stock and the Board Chair
received an additional 1,643 shares.
Our directors also have stock ownership guidelines which require
them to hold 2,000 shares. Directors have two years to
achieve the required ownership. Furthermore, until the required
stock ownership guidelines are met, directors are required to
hold at least 50% of all vested after-tax shares and 50% of
shares received on exercise of stock options. Currently, all of
our non-employee directors meet the share ownership guidelines.
Director
Compensation for 2010
The table below summarizes the compensation paid by us to our
non-employee directors for their service during the fiscal year
ended December 31, 2010.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
Stock Awards
|
|
Total
|
Name (1)
|
|
Paid in Cash ($)
|
|
($)(2)(3)
|
|
($)
|
|
Carole Lewis Anderson
|
|
|
20,696
|
|
|
|
20,003
|
|
|
|
40,699
|
|
Steven M. Anderson
|
|
|
19,483
|
|
|
|
30,005
|
|
|
|
49,488
|
|
Patricia C. Barron
|
|
|
36,448
|
|
|
|
40,006
|
|
|
|
76,454
|
|
Anthony J. Cavanna
|
|
|
15,494
|
|
|
|
20,003
|
|
|
|
35,497
|
|
Paula H.J. Cholmondeley
|
|
|
22,080
|
|
|
|
20,003
|
|
|
|
42,083
|
|
Daniel W. Christman
|
|
|
6,648
|
|
|
|
16,498
|
|
|
|
23,146
|
|
James A. Croce
|
|
|
16,635
|
|
|
|
20,003
|
|
|
|
36,638
|
|
Thomas L. Saeli
|
|
|
32,014
|
|
|
|
30,005
|
|
|
|
62,019
|
|
Robert W. Shaw II
|
|
|
19,833
|
|
|
|
20,003
|
|
|
|
39,836
|
|
Ranjit C. Singh
|
|
|
40,752
|
|
|
|
40,006
|
|
|
|
80,758
|
|
Bradford T. Whitmore
|
|
|
34,881
|
|
|
|
59,504
|
|
|
|
94,385
|
|
12
|
|
|
(1) |
|
John D. Kavazanjian was ineligible to receive compensation for
his service as a director because he was also an employee,
serving as our President and Chief Executive Officer through
December 30, 2010. Michael D. Popielec is ineligible to
receive compensation for his service as a director because he is
also an employee, serving as our President and Chief Executive
Officer. Carole Lewis Anderson, Anthony J. Cavanna and Paula
H.J. Cholmondeley ceased serving as directors on June 8,
2010, and Daniel W. Christman ceased serving as a director on
March 24, 2010. Thomas L. Saeli did not become a director
until March 5, 2010. Steven M. Anderson did not become a
director until April 13, 2010. James A. Croce and Robert W.
Shaw II did not become directors until June 8, 2010. |
|
(2) |
|
The amounts set forth in this column reflect the aggregate grant
date fair value of stock awards granted during 2010. The
Financial Accounting Standards Boards Accounting Standards
Codification Topic 718 (ASC 718) (formerly,
Statement of Financial Accounting Standards No. 123(R),
Share-Based Payment), requires us to recognize compensation
expense for stock options and other stock-related awards granted
to our employees and directors based on the estimated fair value
of the equity awards at the time of grant. The compensation
expense for such awards is expensed at the time of grant. There
was no stock option expense in 2010 for directors options
since no stock options were granted to directors during 2010.
The assumptions used to determine the valuation of the awards
are discussed in Note 7 to our audited consolidated
financial statements included in our Annual Report on
Form 10-K
for the year ended December 31, 2010. The number of shares
granted in 2010 and the grant date fair value of those grants
determined in accordance with ASC 718 are set forth below. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grant Date
|
Name
|
|
Grant Date
|
|
Shares (#)
|
|
Fair Value ($)
|
|
Carole Lewis Anderson
|
|
|
2/15/10
|
|
|
|
2,529
|
|
|
|
10,001
|
|
|
|
|
5/15/10
|
|
|
|
2,142
|
|
|
|
10,002
|
|
Steven M. Anderson
|
|
|
5/15/10
|
|
|
|
2,142
|
|
|
|
10,002
|
|
|
|
|
8/15/10
|
|
|
|
2,172
|
|
|
|
10,001
|
|
|
|
|
11/15/10
|
|
|
|
1,544
|
|
|
|
10,002
|
|
Patricia C. Barron
|
|
|
2/15/10
|
|
|
|
2,529
|
|
|
|
10,001
|
|
|
|
|
5/15/10
|
|
|
|
2,142
|
|
|
|
10,002
|
|
|
|
|
8/15/10
|
|
|
|
2,172
|
|
|
|
10,001
|
|
|
|
|
11/15/10
|
|
|
|
1,544
|
|
|
|
10,002
|
|
Anthony J. Cavanna
|
|
|
2/15/10
|
|
|
|
2,529
|
|
|
|
10,001
|
|
|
|
|
5/15/10
|
|
|
|
2,142
|
|
|
|
10,002
|
|
Paula H.J. Cholmondeley
|
|
|
2/15/10
|
|
|
|
2,529
|
|
|
|
10,001
|
|
|
|
|
5/15/10
|
|
|
|
2,142
|
|
|
|
10,002
|
|
Daniel W. Christman
|
|
|
2/15/10
|
|
|
|
4,172
|
|
|
|
16,498
|
|
James A. Croce
|
|
|
8/15/10
|
|
|
|
2,172
|
|
|
|
10,001
|
|
|
|
|
11/15/10
|
|
|
|
1,544
|
|
|
|
10,002
|
|
Thomas L. Saeli
|
|
|
5/15/10
|
|
|
|
2,142
|
|
|
|
10,002
|
|
|
|
|
8/15/10
|
|
|
|
2,172
|
|
|
|
10,001
|
|
|
|
|
11/15/10
|
|
|
|
1,544
|
|
|
|
10,002
|
|
Robert W. Shaw II
|
|
|
8/15/10
|
|
|
|
2,172
|
|
|
|
10,001
|
|
|
|
|
11/15/10
|
|
|
|
1,544
|
|
|
|
10,002
|
|
Ranjit C. Singh
|
|
|
2/15/10
|
|
|
|
2,529
|
|
|
|
10,001
|
|
|
|
|
5/15/10
|
|
|
|
2,142
|
|
|
|
10,002
|
|
|
|
|
8/15/10
|
|
|
|
2,172
|
|
|
|
10,001
|
|
|
|
|
11/15/10
|
|
|
|
1,544
|
|
|
|
10,002
|
|
Bradford T. Whitmore
|
|
|
2/15/10
|
|
|
|
2,529
|
|
|
|
10,001
|
|
|
|
|
5/15/10
|
|
|
|
3,534
|
|
|
|
16,502
|
|
|
|
|
8/15/10
|
|
|
|
3,584
|
|
|
|
16,502
|
|
|
|
|
11/15/10
|
|
|
|
2,547
|
|
|
|
16,499
|
|
13
|
|
|
(3) |
|
The aggregate number of director stock options outstanding at
December 31, 2010 were as follows: |
|
|
|
|
|
Name
|
|
Stock Options
|
|
Steven M. Anderson
|
|
|
|
|
Patricia C. Barron
|
|
|
25,500
|
|
James A. Croce
|
|
|
|
|
Thomas L. Saeli
|
|
|
|
|
Robert W. Shaw II
|
|
|
|
|
Ranjit C. Singh
|
|
|
48,500
|
|
Bradford T. Whitmore
|
|
|
|
|
14
PROPOSAL 2
ADVISORY
RESOLUTION ON EXECUTIVE COMPENSATION
As required by the recently enacted Dodd-Frank Wall Street
Reform and Consumer Protection Act, which is referred to in this
proxy statement as Dodd-Frank, we are asking our shareholders to
approve an advisory resolution on our executive compensation as
reported in this proxy statement. As described in the
Compensation Discussion and Analysis on pages 16 through 27
of this proxy statement, our Compensation and Management
Committee has structured our executive compensation program to
achieve the following objectives: pay for performance; align the
interests of our executive officers with those of our
shareholders; and attract, retain and motivate talented
individuals. Our compensation programs are designed to reward
our Named Executive Officers, as defined on page 16, for the
achievement of both short-term and long-term strategies and
operational goals while promoting enhanced shareholder return.
At the same time, our compensation programs are designed to
avoid encouraging unnecessary or excessive risk-taking by our
Named Executive Officers.
We direct our shareholders to our Compensation Discussion and
Analysis on pages 16 through 27 of this proxy statement
which sets forth the principles of our executive compensation
programs and the policies and procedures that implement those
policies. We encourage our shareholders to read this information
carefully, as well as the Summary Compensation Table and other
related compensation tables and narratives which follow the
Compensation Discussion and Analysis.
The vote on this advisory resolution is not intended to address
any specific component of our executive compensation. It is
meant to address the overall compensation of our Named Executive
Officers as described in this proxy statement.
In accordance with recently-adopted
Rule 14a-21(a)
of the Exchange Act and as a matter of good corporate
governance, we are asking our shareholders to approve the
following advisory resolution at the Meeting:
Resolved,
that the shareholders of Ultralife Corporation (the
Company) approve, on an advisory basis, the
compensation of the Companys Named Executive Officers
disclosed in the Compensation Discussion and Analysis, the
Summary Compensation Table and the related compensation tables,
notes and narrative in the proxy statement for the
Companys 2011 Annual Meeting of Shareholders.
This advisory resolution, commonly referred to as a
Say-on-Pay
resolution is non-binding on our company and our Board of
Directors. Although it is non-binding, the Board of Directors
and the Compensation and Management Committee will review and
consider the voting results when making future decisions
regarding our executive compensation program and policies.
Our Board of Directors recommends a vote FOR the approval
of the advisory resolution on executive compensation.
PROPOSAL 3
ADVISORY
VOTE ON THE FREQUENCY OF FUTURE
ADVISORY VOTES ON EXECUTIVE COMPENSATION
As also required by Dodd-Frank and pursuant to recently adopted
Rule 14a-21(b)
of the Exchange Act, we are asking our shareholders to vote on
an advisory basis on whether future advisory votes on executive
compensation of the nature reflected in Proposal 2 above
should occur every year, every two years or every three years.
After careful consideration and dialogue with our shareholders,
various proxy advisory organizations and various institutional
shareholder representative organizations, our Board of Directors
has determined that holding an advisory vote on executive
compensation every three years is the most appropriate policy
for us at this time, and recommends that shareholders vote for
future advisory votes on executive compensation to occur every
three years. Our executive compensation programs are designed to
promote a long-term connection between pay and performance. Our
Board of Directors believes that providing our shareholders with
the ability to vote for advisory votes on executive compensation
every three years will give them the best opportunity to
evaluate in context how our
15
executive compensation programs are working. Our Board of
Directors also recognizes that we are required to make, and our
shareholders expect to see, annual executive compensation
disclosures. As the
Say-on-Pay
advisory vote is something new to us this year, holding a
three-year advisory vote on executive compensation will provide
us with appropriate feedback on our compensation disclosures
without overemphasizing short-term analysis of programs that
have significant long-term components. It should be noted,
however, that because the advisory
Say-on-Pay
vote occurs after compensation for the current year has already
been initiated and because the different elements of our
executive compensation program are, in some instances, long-term
in nature and are coordinated with our short-term incentives, it
may well not be appropriate or advisable to alter our executive
compensation programs as a result of any years
Say-on-Pay
advisory vote by the time of the following years Annual
Meeting of Shareholders.
This advisory vote on the frequency of future
Say-on-Pay
votes is non-binding on our company and our Board of Directors.
Shareholders will be able to specify one of four choices for
this proposal on the proxy card or voting instruction card: one
year, two years, three years or abstain. Shareholders are
cautioned that they are not voting to approve or disapprove the
recommendation of our Board of Directors. Although the vote is
non-binding, the Board of Directors and our Compensation and
Management Committee will carefully review the voting results.
Notwithstanding the recommendation of the Board of Directors and
the outcome of the shareholder advisory vote, the Board of
Directors may in the future decide to conduct advisory votes on
a more or less frequent basis and may vary its practice based on
factors not known to the Board of Directors at this time.
The Board of Directors recommends that shareholders vote to
conduct future advisory votes on executive compensation on a
three-year basis.
Compensation
Discussion and Analysis
Introduction
This Compensation Discussion and Analysis, which we refer to as
CD&A, provides information about the compensation programs
for our President and Chief Executive Officer, our former
President and Chief Executive Officer, our Chief Financial
Officer and Treasurer, our next two most highly compensated
executive officers employed at the end of 2010, our former
Executive Vice President of Business Operations and our former
Vice President, Corporate Communications Officer, to whom we
refer collectively as our Named Executive Officers.
This CD&A includes our compensation philosophy and the
objectives of our executive compensation programs, descriptions
of each of the elements of our executive compensation programs
and the basis for the compensation decisions we made during
2010. Our Named Executive Officers for 2010 are:
|
|
|
|
|
Michael D. Popielec, President and Chief Executive Officer
(effective as of December 30, 2010)
|
|
|
|
John D. Kavazanjian, former President and Chief Executive
Officer (ceased to be our President and Chief Executive Officer
as of December 30, 2010; retired effective as of
February 7, 2011)
|
|
|
|
Philip A. Fain, Chief Financial Officer and Treasurer
|
|
|
|
Peter F. Comerford, Vice President of Administration, Secretary
and General Counsel
|
|
|
|
Patrick R. Hanna, Jr., Vice President, Corporate Compliance
Officer
|
|
|
|
James E. Evans, former Executive Vice President of Business
Operations (resigned effective as of April 30, 2010)
|
|
|
|
Julius M. Cirin, former Vice President, Corporate Communications
Officer (died December 30, 2010)
|
Executive
Summary
Our compensation philosophy is designed by our Compensation and
Management Committee, referred to in this CD&A as the
Committee, to align the interests of our Named Executive
Officers with those of our shareholders by rewarding performance
that enhances the long-term objective of increasing shareholder
value. Our executive compensation programs are designed to
motivate our Named Executive Officers to achieve strong
financial,
16
operational and strategic performance and to provide a link
between the amounts earned by our Named Executive Officers and
the creation of shareholder value.
Despite a difficult economic environment, we substantially
improved our operating performance during the last completed
fiscal year. As described in Managements Discussion
and Analysis of Financial Condition and Results of
Operations in our Annual Report on
Form 10-K,
our fiscal 2010 financial results were strong relative to our
fiscal 2009 results. The following table highlights the
year-over-year
comparison of the key financial metric that we used in
evaluating our performance for the purpose of making
compensation decisions in 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Measure
|
|
Fiscal Year 2009
|
|
Fiscal Year 2010
|
|
Dollar Change
|
|
Operating Profit (Loss)
|
|
$
|
(7,362,000
|
)
|
|
$
|
7,878,500
|
|
|
$
|
15,240,500
|
|
We use operating profit for purposes of determining achievement
under our annual Short-Term Incentive Plan, referred to in this
proxy statement as the STIP. Operating profit is a non-GAAP
measure that is calculated by modifying operating income (as
defined under GAAP) to exclude incentive compensation expenses
and asset impairment charges associated with our Energy Services
business.
Our fiscal 2010 financial performance, along with the individual
performance of our Named Executive Officers, served as key
factors in making compensation decisions for 2010, including the
following:
|
|
|
|
|
In December 2010, based on company and individual performance
and also in consideration as to where the base salaries of our
Named Executive Officers fell in comparison with our peer group,
the Committee approved base salary increases to
Messrs. Fain and Comerford of 4.2% and 10.0%, respectively.
Such increases were effective February 14, 2011.
|
|
|
|
Our STIP is aligned directly to an annual corporate financial
target in line with our
pay-for-performance
philosophy. For 2010, operating profit was the key metric for
our Named Executive Officers annual cash incentive awards
under the STIP. Our performance with respect to this metric was
substantially improved in 2010 as compared to 2009, but was
slightly below our 2010 target. As such, our 2010 performance
resulted in the payment of annual cash incentive awards under
the STIP that were slightly below the target levels for our
Named Executive Officers.
|
|
|
|
Long-term equity incentive compensation continues to make up a
significant portion of the compensation for each of our Named
Executive Officers. During 2010, long-term equity incentive
compensation was granted solely in the form of stock options, as
the Committee believed that stock options presented the best
incentive to our Named Executive Officers to act in a manner
designed to improve our market value by rewarding them only if
our market value increases over the term of the stock option.
|
|
|
|
As discussed in greater detail below under the subheading
New Chief Executive Officer Compensation Package,
Mr. Popielec became our President and Chief Executive
Officer effective December 30, 2010.
Mr. Popielecs compensation package includes a
significant equity component designed to incentivize him to
effectively manage our growth strategy and improve our market
value.
|
Our executive compensation programs contain other key components
and features that are designed to reinforce our
pay-for-performance
philosophy. For example:
|
|
|
|
|
We do not reimburse or
gross-up
our Named Executive Officers for any of the taxes associated
with any of the compensation and benefits we provide to them.
|
|
|
|
We maintain double-triggered agreements with certain
of our Named Executive Officers under which payment is triggered
only by certain terminations of employment subsequent to a
change in control of our company.
|
We encourage you to read this CD&A for a detailed
discussion and analysis of our executive compensation programs,
including information about the 2010 compensation of our Named
Executive Officers.
17
Compensation
Philosophy and Objectives
Our compensation philosophy is designed to align the interests
of our Named Executive Officers with those of our shareholders
by rewarding performance that enhances the long-term objective
of increasing shareholder value. The Committee establishes
specific annual, long-term and strategic goals and rewards Named
Executive Officers for performance that meets or exceeds those
goals. In addition, we expect our Named Executive Officers to
work to these objectives while maintaining the highest ethical
standards.
We design our executive compensation programs to attract, retain
and motivate talented individuals, and to motivate them to
achieve strong financial, operational and strategic performance.
In particular:
|
|
|
|
|
Our goal is to have our compensation package reflect the value
of the job in the marketplace. To attract and retain a skilled
work force, we must remain competitive with the pay of other
employers who compete with us for talent.
|
|
|
|
Our executive compensation programs are designed to support our
pay-for-performance
philosophy by aligning compensation with executing long-term
business strategies and achieving near-term financial targets.
We base compensation decisions on a combination of the level of
job responsibility, individual performance and our company
performance. Generally, as an individuals level of
responsibility increases, so does the amount of compensation
that is at risk and dependent on achievement of such
goals.
|
|
|
|
We develop and administer our compensation programs to foster
the long-term focus required for success in our industry, but we
also work to achieve an appropriate balance between short-term
and long-term compensation in order to adequately motivate our
employees.
|
To this end, the Committee reviews our executive compensation
program annually to assess if we are able to attract and retain
talented executives, and to ensure that the total compensation
paid to our executives, including our Named Executive Officers,
is fair, reasonable, competitive and, where appropriate,
performance-based. The Committee also ensures that our total
compensation is linked to our ability to meet our annual
financial and non-financial goals, and longer term, to drive
strong levels of shareholder return.
Setting
Executive Compensation
The following table identifies the various individuals and
groups who participated in the compensation-setting process for
2010, as well as their responsibilities in connection with such
participation.
|
|
|
Participant
|
|
Responsibilities
|
|
Compensation and Management Committee
|
|
Responsible for establishing,
implementing and monitoring adherence to our compensation
philosophy and objectives for our Named Executive Officers
|
|
|
The Compensation and Management
Committee Chair, the Audit and Finance Committee Chair and the
Chair of our Board of Directors, working with a retained search
firm specializing in the placement of chief executive officers,
performed the initial screening of candidates to become our
President and Chief Executive Officer, and recommended to the
Board that Mr. Popielec be offered the position.
|
|
|
Reviewed the performance of our
President and Chief Executive Officer and our other Named
Executive Officers
|
|
|
Reviewed the peer group composition and
compensation program evaluation prepared for the Committee in
2008 by DolmatConnell & Partners, an independent executive
compensation consulting firm (due to general economic conditions
and the stability of our performance, the Committee did not
engage DolmatConnell, or any other compensation consultant, in
2010)
|
18
|
|
|
Participant
|
|
Responsibilities
|
|
|
|
Reviewed the peer group data compiled by
Human Resources and obtained through Equilar, an independent
executive compensation data provider
|
|
|
Reviewed our President and Chief
Executive Officers recommendations regarding the
compensation levels of our other Named Executive Officers
|
|
|
Approved the compensation levels and
STIP payouts for our other Named Executive Officers (except for
long-term equity incentive awards of more than
10,000 shares which require full Board approval)
|
|
|
Made recommendations to the Board
regarding the compensation levels and STIP payout for our
President and Chief Executive Officer
|
|
|
Approved financial metrics to be used
for the STIP for 2011
|
President and Chief Executive Officer
|
|
Reviewed the performance of our other
Named Executive Officers
|
|
|
Made recommendations to the Committee
regarding the compensation levels and STIP payouts for our other
Named Executive Officers with input from our Vice President of
Corporate Human Resources
|
|
|
Made recommendations to the Committee
for financial metrics to be used for the STIP for 2011
|
Competitive
Market Data
The Committee believes that the compensation of our Named
Executive Officers should be generally consistent with pay
practices at comparable companies, in order to attract and
retain top management talent. Each year, the Committee reviews
the executive compensation practices of a group of public
companies in our industry that it determines to be our peers
based on their revenue and market capitalization. The data for
2010 basically utilized the same peer group that was established
by DolmatConnell for 2009 to include companies of similar size
within our industry. The peer group we used for establishing our
2010 executive compensation programs for our Named Executive
Officers was comprised of the following companies:
|
|
|
Advanced Energy Industries, Inc.
|
|
LaBarge, Inc.
|
Aero Vironmento, Inc.
|
|
Motorcar Parts of America, Inc.
|
AZZ, Inc.
|
|
Performed Line Products Co.
|
Bel Fuse, Inc.
|
|
Quantum Fuel Systems Technologies Worldwide, Inc.
|
C&D Technologies, Inc.
|
|
SL Industries Inc.
|
Electro Scientific Industries Inc.
|
|
Spectrum Control, Inc.
|
EMCORE Corp.
|
|
Vicor Corp.
|
Greatbatch, Inc.
|
|
|
Peer group data for our 2010 executive compensation programs was
obtained through Equilar, which is an executive compensation
data provider that provides benchmark data on publicly held
companies on executive compensation, equity grants and
compensation practices. If peer group data is not available on a
specific Named Executive Officers position, we use a
composite of published executive compensation surveys.
The Committee uses the peer group executive compensation data as
a market check only. While the target compensation
levels for our Named Executive Officers are not set to
correspond to a specific level of market competitiveness, the
Committees general approach has been to align compensation
with the 50th percentile of our peer group. In addition, the
Committee exercises significant discretion and judgment in
determining individual
19
compensation target levels and actual amounts paid based on its
overall understanding of the labor market for executive
leadership, our specific needs and each Named Executive
Officers individual circumstances.
Executive
Compensation Components
The 2010 total compensation package for our Named Executive
Officers consisted of the following primary components:
|
|
|
|
|
|
|
Compensation
|
|
|
|
|
|
Performance
|
Element
|
|
Form of Compensation
|
|
Purpose
|
|
Metrics
|
|
Base salary
|
|
Cash
|
|
Provide compensation that is not at-risk to
compensate our Named Executive Officers for services rendered
during the fiscal year
|
|
None
|
Annual incentive compensation
|
|
Cash
|
|
Motivate our Named Executive Officers to attain vital short-term
business goals and objectives as reflected in our annual
operating plan
|
|
Operating Profit
|
Long-term incentive compensation
|
|
Equity
|
|
Incent our Named Executive Officers to focus on company growth,
align their compensation with our business strategy and create
value for our shareholders
|
|
None
|
Health and welfare plans
|
|
Eligibility to receive health and other welfare benefits paid
for by our company, including life insurance, short- and
long-term disability insurance and a comprehensive medical and
dental plan (we pay the monthly premiums for our Named Executive
Officers)
|
|
Provide a competitive employee benefits program
|
|
None
|
Retirement benefits
|
|
Eligibility to participate in our 401(k) plan (available to all
employees)
|
|
Provide an incentive for long-term retention of our Named
Executive Officers
|
|
None
|
Limited perquisites and other personal benefits
|
|
A $7,500 flexible benefits allowance for the President and Chief
Executive Officer, a $5,000 allowance for benefits such as
supplemental long-term disability and company-paid executive
physicals and tax preparation services
|
|
Provide a competitive compensation package, facilitate strong,
focused performance and better enable us to attract and retain
superior employees for key positions
|
|
None
|
Base
Salary
The President and Chief Executive Officer reviews the
performance of the other Named Executive Officers and then
recommends base salary adjustments, if any, to the Committee. In
turn, the Committee independently reviews, adjusts where
appropriate and approves the base salary adjustments, if any,
based upon the subjective discretion of the Committee. In its
executive session, the Committee reviews and recommends to the
full Board of Directors any
20
base salary adjustment for the President and Chief Executive
Officer. If changes to base salaries are recommended and
approved, the changes in the base salary are effective during
the 1st quarter of the following calendar year.
The Committee typically reviews base salary levels from peer
group companies and other published executive compensation
surveys (if required) on an annual basis. The Committee has
endeavored to better align executive salaries with the market,
moving them toward approximately the 50th percentile of our peer
group, since base salaries for our executive officers have been
significantly below market norms for comparable companies. In
addition to looking at the peer group and other published
executive compensation surveys, salaries for executives are
determined based upon the following factors:
|
|
|
|
|
Individual performance
|
|
|
|
Company performance
|
|
|
|
Job responsibilities, including any significant change in
responsibilities
|
|
|
|
Experience
|
|
|
|
Internal pay equity
|
|
|
|
Retention
|
Due to overall company performance during fiscal year 2009 and
the difficulty of the global economic crisis and recession, none
of our Named Executive Officers received a base salary increase
that was effective during 2010. In December 2010, the President
and Chief Executive Officer recommended to the Committee that
base salary increases be given to Messrs. Fain and
Comerford in February 2011. The merit increases were approved by
the Committee based on company and individual performance and
also in consideration of the fact that both were positioned well
below the 50th percentile of our peer group as established at
the end of 2008. Mr. Fains salary increased from
$240,000 to $250,000 and Mr. Comerfords salary was
changed from $210,000 to $231,000. Following their respective
increases in base salary, Messrs. Fain and Comerfords
base salaries still remain below the 50th percentile of our peer
group.
Short-Term
Incentive Plan
Typically, we establish a short-term incentive plan each fiscal
year, which provides the Named Executive Officers an opportunity
to receive an annual cash payment in addition to their base
salaries. The short-term incentive plan is designed to place
at risk a significant portion of the annual total
cash compensation of the Named Executive Officers by linking the
amount of compensation that can be achieved under the plan with
our financial performance. We believe that the STIP is a key
component of maintaining a competitive executive compensation
program because it motivates our Named Executive Officers to
achieve our short-term financial and strategic objectives while
making progress towards our longer term growth.
Setting
Threshold, Target and Maximum STIP Levels
Initially, based on the recommendation from the President and
Chief Executive Officer, the Committee establishes threshold,
target and maximum bonus levels for each Named Executive
Officer, which is expressed as a percentage of his base salary.
The percentages are determined by the position of the Named
Executive Officers within the organization and based upon the
review of peer data and other published executive compensation
surveys if peer data is not available. The threshold level is
the minimum level of performance required before any amount
would be earned under the STIP. The Committee also establishes a
maximum bonus level under the STIP. For 2010, that maximum bonus
level was two times the target bonus level.
Generally, the Committee sets the target bonus level such that,
assuming achievement of the corporate financial metric(s), the
combined base salary and annual STIP opportunity for our Named
Executive Officers will be at or near the 50th percentile for
comparable executives at the companies in our peer group or from
published executive
21
compensation surveys if peer group data is not available. For
the 2010 STIP, the threshold, target and maximum levels under
the STIP were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
|
(as a % of
|
|
(as a % of
|
|
(as a % of
|
Name
|
|
Base Salary)
|
|
Base Salary)
|
|
Base Salary)
|
|
John D. Kavazanjian
|
|
|
0
|
%
|
|
|
60
|
%
|
|
|
120
|
%
|
Philip A. Fain
|
|
|
0
|
%
|
|
|
45
|
%
|
|
|
90
|
%
|
Peter F. Comerford
|
|
|
0
|
%
|
|
|
30
|
%
|
|
|
60
|
%
|
Patrick R. Hanna, Jr.
|
|
|
0
|
%
|
|
|
30
|
%
|
|
|
60
|
%
|
James E. Evans*
|
|
|
0
|
%
|
|
|
30
|
%
|
|
|
60
|
%
|
Julius M. Cirin **
|
|
|
0
|
%
|
|
|
30
|
%
|
|
|
60
|
%
|
|
|
|
* |
|
Mr. Evans resigned effective as of April 30, 2010, and
forfeited his 2010 STIP payments in connection with such
termination. |
|
** |
|
The actual amount for Mr. Cirin would have been based on
full-year participation. Mr. Cirin went out on disability
in June 2010 and died on December 30, 2010. Therefore, any
STIP payment due for 2010 would be prorated. |
Establishing
the STIP Performance Metrics
Normally, at the December Committee meeting, based on the
recommendation from the President and Chief Executive Officer,
the Committee identifies financial metrics that will be used for
the STIP for the following calendar year. The metrics are
normally finalized in January after the annual operating plan
has been approved.
For purposes of setting 2010 executive compensation, the
Committee, based on recommendations from our President and Chief
Executive Officer, changed its approach to the STIP for certain
Named Executive Officers. In prior years, the STIP for certain
Named Executive Officers was based on a combination of
individual goals and the achievement of our approved operating
plan, and for the President and Chief Executive Officer and the
Chief Financial Officer and Treasurer, the STIP was based solely
on achievement of the operating plan. In setting 2010 executive
compensation, the recommendation was made by the President and
Chief Executive Officer and approved by the Committee that all
Named Executive Officers would have their STIP based on our
operating plan financial goals only. The threshold, target and
maximum performance levels under the 2010 STIP were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Measure
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Operating Profit
|
|
$
|
4,589,000
|
|
|
$
|
7,909,667
|
|
|
$
|
15,695,095
|
|
If our operating profits were not above $4,589,000, then no cash
bonus would be paid to any of the Named Executive Officers for
2010 performance. Compensation would only begin to be earned
under the STIP if our operating profits exceeded $4,589,000.
Fifteen percent of every dollar of operating profit that we
achieved in excess of $4,589,000 would go into a bonus pool for
potential distribution to the participants on a pro-rata basis
based on their specific percentage of participation. Once the
target operating profit of $7,909,667 was reached, STIP
participants would be eligible to receive their target bonus
payout. Once the target bonus payout has been met, then the
bonus pool would be funded by 7% of each dollar in additional
operating profit for potential distribution to participants on a
pro-rata basis. At an operating profit of $15,695,095, the Named
Executive Officers could receive their maximum STIP bonus of two
times their target bonus amount.
Since the targeted cash bonus for most of the companies in our
peer group is based on the achievement of the approved operating
plan for those companies, the Committee believes that the
approach adopted for 2010 is a more conservative approach
appropriate to the way that our operating plan was constructed,
in line with our current position and designed to reward
performance that exceeds our operating plan targets. It also has
the effect of getting all of our Named Executive Officers
focused on the same common company-wide goals. The Committee
also added an additional performance metric that if a bonus was
earned for 2010, we must be profitable each quarter or the bonus
pool would be reduced by 10%.
22
STIP
Payments
While the decisions to make STIP payouts as well as the amounts
earned under the STIP are made at the sole discretion of the
Committee, in making such determinations, the Committee relies
on the recommendations from our President and Chief Executive
Officer for all other Named Executive Officers. The Committee
makes recommendations to the full Board for the STIP payout (if
any) for the President and Chief Executive Officer. In December
2010, the Committee recommended to the Board of Directors that
the $14,000,000 non-cash impairment associated with the Energy
Services business be excluded from the STIP financial results
calculations. This was approved by the Board of Directors. Based
on our overall 2010 financial results of an operating profit of
$7,878,500, STIP payments were made to the eligible Named
Executive Officers for 2010. We were profitable for each quarter
in 2010, and, therefore, the amounts earned under the STIP were
not reduced by 10%. The chart below shows the STIP payment made
for the Named Executive Officers for 2010 performance.
|
|
|
|
|
|
|
2010 STIP
|
Name
|
|
Payout ($)
|
|
John D. Kavazanjian
|
|
|
251,312
|
|
Philip A. Fain
|
|
|
107,705
|
|
Peter F. Comerford
|
|
|
62,828
|
|
Patrick R. Hanna, Jr.
|
|
|
56,844
|
|
James E. Evans*
|
|
|
0
|
|
Julius M. Cirin **
|
|
|
28,422
|
|
|
|
|
* |
|
Mr. Evans resigned effective as of April 30, 2010, and
forfeited his 2010 STIP payments in connection with such
termination. |
|
** |
|
Mr. Cirin earned a partial bonus under the STIP through the
date he went out on disability. Mr. Cirin died on
December 30, 2010. |
Long-Term
Incentive Compensation
We use equity awards to motivate our Named Executive Officers to
increase the long-term value of our Common Stock and align the
interests of our Named Executive Officers with those of our
shareholders. Long-term equity incentive awards are intended to
further our success by ensuring that sustainable value creation
is a key factor in our Named Executive Officers management
of the business and to help retain executives over time.
Long-term equity incentive compensation may consist of awards of
stock options, performance-vested restricted shares and
time-vested restricted shares that vest over a multi-year
period. This design approach helps align the interests of our
Named Executive Officers with those of our shareholders in
seeing long-term increases in the value of equity instruments.
We use stock options as one of our long-term incentives because,
in addition to providing our executive officers with the
opportunity to develop a stock ownership stake in our company,
they result in compensation only to the extent that the market
price of our Common Stock increases over the term of the stock
option.
The size and form of these equity awards is determined by the
Committee with recommendations from the President and Chief
Executive Officer for the other Named Executive Officers. If the
equity awards recommended for the Named Executive Officers
exceed 10,000 shares, the awards will be recommended for
approval by the Committee and must be approved by the full Board
of Directors. The Committee also recommends to the full Board
any equity awards for the President and Chief Executive Officer.
Generally, the Committee bases the overall long-term incentive
compensation around the mid-point (50th percentile) of those
companies in our peer group. As with other compensation
components, however, the Committee can modify this target either
upward or downward based on the Committees subjective
evaluation of the long-term value of the individual Named
Executive Officer to us.
In recognition of our current market capitalization and to
better align management with the goals of our shareholders, the
Committee decided for 2010 not to provide additional equity
compensation in the form of either time-based stock awards or
performance-based stock awards for the Named Executive Officers
or the other
23
executives. Instead, the Committee approved only stock options,
as more fully described below, in the belief that when granted
with an exercise price at or above the current market price,
stock options represent the best incentive to our Named
Executive Officers to act in a manner designed to improve our
market value and to reward our Named Executive Officers only if
the market value increases over the term of the stock option.
The Committee determines the value of long-term equity incentive
compensation to be granted to each Named Executive Officer based
on factors including the individuals level of
responsibility with our company and the results of the
Committees annual evaluation of the individuals
performance, and then utilizes the peer group compensation data
as a check on the competitiveness of the level of compensation.
Typically, equity awards are granted in the regularly scheduled
December Committee meeting. As was previously disclosed in our
proxy statement for our 2010 Annual Meeting of Shareholders, as
a component of the 2010 executive compensation program, in
December 2009 the Committee granted options to purchase shares
of our Common Stock under our Restated LTIP to certain of our
executive officers. The options that were granted have a
seven-year term, vest over a three-year period in equal
installments and have an exercise price of $3.9085 per share.
Mr. Kavazanjian received an option to purchase
23,500 shares; Mr. Fain and Mr. Evans each
received an option to purchase 33,000 shares;
Mr. Comerford received an option to purchase
24,000 shares; and Mr. Cirin and Mr. Hanna each
received an option to purchase 12,000 shares.
In addition, on January 13, 2010, the Committee recommended
to the Board of Directors, and it was approved by the Board,
that Mr. Kavazanjian receive an additional seven-year
option under our Restated LTIP, which vests over a three-year
period in equal installments, for 26,500 shares at an
exercise price of $4.7761 per share.
In December 2010, as a component of the 2011 executive
compensation program, the Committee granted options to purchase
shares of our Common Stock under our Restated LTIP to certain
Named Executive Officers. The options that were granted have a
seven-year term, vest over a three-year period in equal
installments and have an exercise price of $6.9061 per share.
Mr. Fain received an option to purchase 25,000 shares;
Mr. Comerford received an option to purchase
20,000 shares; and Mr. Hanna received an option to
purchase 10,000 shares.
Retirement
Benefits
We provide to all active employees a tax-qualified 401(k) plan
that provides for both employer and employee contributions.
Employees may defer annually to the plan up to the IRS limits.
We provide a company match of 50% of an employees
deferrals, up to a maximum of 4% of the employees annual
salary.
Perquisites
and Other Personal Benefits
We provide our Named Executive Officers with perquisites and
other personal benefits that we and the Committee believe are
reasonable and consistent with our overall compensation program
to better enable us to attract and retain superior employees for
key positions. The Committee periodically reviews the levels of
perquisites and other personal benefits provided to our Named
Executive Officers.
The aggregate incremental costs of the personal benefits
provided to our Named Executive are included in the All
Other Compensation column of the 2010 Summary Compensation
Table.
New
Chief Executive Officer Compensation Package
Mr. Popielec became our President and Chief Executive
Officer effective December 30, 2010. Most recently,
Mr. Popielec was employed by Carlisle Companies, Inc. of
Charlotte, North Carolina, as its Group President, Applied
Technologies, in 2008 and 2009 and as its Group President,
Diversified Components, from 2005 to 2007. Prior to that, from
2003 to 2005, Mr. Popielec held various positions at Danka
Business Systems, PLC and for 17 years prior to Danka, he
held various positions at General Electric Company, including
President and Chief Executive Officer of GE Power Controls,
Industrial Systems in Europe from 2000 to 2002. After his tenure
at Carlisle Companies, Inc., Mr. Popielec was engaged in
special projects and consulting to both public and private
companies. Mr. Popielec received his B.S. in Mechanical
Engineering from Michigan State University in 1985.
The search committee of the Board of Directors, working with a
retained search firm specializing in the placement of chief
executive officers, conducted an extensive search that included
interviews of a large number of
24
qualified individuals and after careful consideration selected
Mr. Popielec as our new President and Chief Executive
Officer given his extensive sales and marketing background and
his 25 years in growing domestic and international
industrial businesses.
The compensation package offered Mr. Popielec reflects
competitive market data provided by Equilar and the search firm
retained in connection with the chief executive officer search.
Based on this data, the search committee of the Board of
Directors determined that the total compensation target was
within the range provided to chief executives in companies of
comparable size and operations to Ultralife Corporation. This
was also confirmed by reviewing the peer company data from the
Equilar executive compensation database.
Mr. Popielecs compensation structure includes a
significant equity component designed to incentivize him to
effectively manage our companys growth strategy. The Board
of Directors and the Committee believe that the success or
failure of these initiatives will be reflected in our share
price and Mr. Popielecs reward will be commensurate
with the results experienced by the shareholders.
Annual
Cash Compensation
We have set Mr. Popielecs base annual salary at
$450,000. Mr. Popielec is also eligible to receive an
annual cash bonus outside of the STIP if we exceed certain
performance metrics to be agreed upon no later than January 31
of the year for which the bonus applies. For 2011, and each year
thereafter, Mr. Popielecs annual cash bonus target
shall not be less than 75% of his 2011 Base Salary.
Long-Term
Equity Incentive Compensation
Long-term equity incentive compensation is a significant
component of Mr. Popielecs compensation package.
Under his employment agreement, Mr. Popielec received the
following options to purchase shares of our Common Stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Exercise
|
|
|
|
Date of Grant
|
|
Shares
|
|
|
Price
|
|
|
Vesting Schedule
|
|
December 30, 2010
|
|
|
50,000
|
|
|
$
|
6.4218
|
|
|
Twenty five percent of the shares will vest on each of the four
anniversaries of the date of grant.
|
January 3, 2011
|
|
|
50,000
|
|
|
$
|
6.5820
|
|
|
Twenty five percent of the shares will vest on each of December
30, 2011, December 30, 2012, December 30, 2013 and December 30,
2014.
|
In addition, Mr. Popielec received three additional stock
options, each of which is conditioned upon shareholder approval
of an amendment to our Restated LTIP at the Meeting. The stock
options detailed below are subject to shareholder approval to
increase the number of shares available under the Restated LTIP
and to increase the limitation on the maximum options issuable
to an employee in a given year. If such approval is not
obtained, such options shall be null and void. As detailed
below, most of these stock options were granted with an exercise
price substantially above the grant date fair market value of
our Common Stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Exercise
|
|
|
Date of Grant
|
|
Shares
|
|
Price
|
|
Vesting Schedule
|
|
December 30, 2010
|
|
|
250,000
|
|
|
$
|
6.4218
|
|
|
Twenty five percent of the shares will vest on each of the four
anniversaries of the date of grant.
|
December 30, 2010
|
|
|
200,000
|
|
|
$
|
10.00
|
|
|
Vesting begins on the date the stock first reaches a closing
price equal to the exercise price for 15 trading days in a 30
trading-day period, with such vesting in equal amounts over the
four anniversary dates of that date.
|
December 30, 2010
|
|
|
200,000
|
|
|
$
|
15.00
|
|
|
Vesting begins on the date the stock first reaches a closing
price equal to the exercise price for 15 trading days in a 30
trading-day period, with such vesting in equal amounts over the
four anniversary dates of that date.
|
25
Relocation
Benefits
Under his employment agreement, Mr. Popielec is also
entitled to the following relocation benefits:
|
|
|
|
|
Rent and commuting transportation to the Rochester, New York
area for up to nine months during 2011, as needed, for a total
actual expense not to exceed $50,000.
|
|
|
|
Payment of all actual reasonable relocation and moving expenses
incurred in 2011, including expenses incurred by
Mr. Popielec and his spouse for travel to the Rochester,
New York area to locate living accommodations, packing and
transporting of household items to the new household and meals,
lodging and travel in connection with the move to the new
household, in an aggregate amount not to exceed $60,000.
|
|
|
|
Payment of all actual reasonable current house sale/closing
costs, including deed preparation, tax stamps, reasonable
attorneys fees, real estate transfer taxes and real estate
commissions incurred in 2011 and 2012.
|
Mr. Popielec will also be entitled to receive the
retirement, fringe and other personal benefits generally
provided to our senior executives, in accordance with the terms
of such arrangements.
Severance
and Change in Control Arrangements
We have employment agreements with Messrs. Popielec and
Comerford that contain change in control and severance
provisions. These potential benefits provide these Named
Executive Officers with important protections that we believe
are necessary to attract and retain executive talent while, at
the same time, requiring certain terminations following a change
in control before any severance compensation is paid. In
addition, Messrs. Fain and Hanna, as well as several
members of our senior management team, are currently covered by
a short-term severance and
change-in-control
benefit. This special benefit was put in place by the Board of
Directors to alleviate any concerns that key management
employees might have with their future employment opportunities
with us following the retirement of Mr. Kavazanjian, and
the search for a new President and Chief Executive Officer. This
special benefits package is not intended to be a permanent
benefit, was initially put in place for a period of one year and
will be reviewed by the Committee on an annual basis.
The severance provisions of the employment agreements and the
short-term severance and
change-in-control
benefit are intended to address competitive concerns by
providing the Named Executive Officers with compensation that
may alleviate the uncertainty of having to leave for another
employer or foregoing other opportunities. The change in control
provisions are intended to allow us to rely upon the Named
Executive Officers continued employment and objective advice,
without concern that a Named Executive Officer might be
distracted by the personal uncertainties and risks created by an
actual or proposed change in control. The terms of these
arrangements are summarized below under the headings
Employment Arrangements and Potential Payments
upon Termination or Change in Control.
On May 24, 2010, we entered into an addendum to the
employment agreement with Mr. Kavazanjian. This addendum
gave either Mr. Kavazanjian or us the right to terminate
his employment agreement by giving the other party written
notice. Pursuant to the terms of this addendum,
Mr. Kavazanjian notified us of his decision to retire
effective February 7, 2011. Mr. Kavazanjian ceased
being our President and Chief Executive Officer on
December 30, 2010, when Mr. Popielec assumed the
position. Upon his retirement, Mr. Kavazanjian was entitled
to certain benefits discussed more fully below on page 37 under
the section Potential Payments upon Termination and/or a
Change in Control.
Stock
Ownership and Retention Guidelines for 2010
In order to better align the interests of executive officers and
shareholders, several years ago the Committee implemented stock
ownership and retention guidelines for executive officers. The
stock ownership requirements for executive officers are as
follows:
|
|
|
President and Chief Executive Officer
|
|
1.00 times salary
|
Chief Financial Officer
|
|
0.50 times salary
|
Other Executive Officers
|
|
0.33 times salary
|
26
For 2010, the Committee established the presumed share price at
$9.59 per share, which was based on the volume weighted average
price of our Common Stock for the two-year period ended
December 31, 2009. Each year the Committee will establish a
new presumed share price for the following year based on the
volume weighted average price of our Common Stock for the
preceding two-year period. Executive officers have three years
to achieve the required holdings. Additionally, there are
shareholding requirements which require that until the share
ownership guidelines are met, executive officers must hold at
least 50% of all vested restricted share grants (on an after tax
basis) and 50% of shares received on exercise of stock options.
For 2010, our Named Executive Officers, with the exception of
Mr. Popielec, who became our President and Chief Executive
Officer on December 30, 2010, have either met or are on
target to meet their applicable stock ownership guidelines. The
Committee is currently reviewing the Named Executive Officer
Stock Ownership Guidelines for 2011 to ensure that best
practices are being used.
Deductibility
of Executive Compensation
As part of its role, the Committee reviews and considers the
deductibility of executive compensation under
Section 162(m) of the Code which provides that we may not
deduct compensation of more than $1,000,000 that is paid to
certain individuals. We believe that compensation paid under the
executive compensation plans is fully deductible for federal
income tax purposes. However, in certain situations, the
Committee may approve compensation that will not meet these
requirements in order to ensure competitive levels of total
compensation for our executive officers.
Accounting
for Stock-Based Compensation
Beginning on January 1, 2006, we began accounting for
stock-based payments, including stock options and restricted
stock awards, in accordance with the requirements of
SFAS 123(R), now referred to as ASC 718.
COMPENSATION
AND MANAGEMENT COMMITTEE REPORT
The Compensation and Management Committee has reviewed and
discussed the Compensation Discussion and Analysis required by
Item 402(b) of
Regulation S-K
with management and, based on such review and discussions, the
Compensation and Management Committee recommended to the Board
that the Compensation Discussion and Analysis be included in
this proxy statement.
The Compensation and Management Committee:
Ranjit C. Singh, Chair
Steven M. Anderson
James A. Croce
27
2010
SUMMARY COMPENSATION TABLE
The following table sets forth information concerning the
compensation awarded to, paid to or earned by the Named
Executive Officers for all services in all capacities to us and
our subsidiaries during 2008, 2009 and 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
Option
|
|
Incentive Plan
|
|
All Other
|
|
|
|
|
|
|
Salary
|
|
Bonus
|
|
Awards
|
|
Awards
|
|
Compensation
|
|
Compensation
|
|
Total
|
Name and Principal Position
|
|
Year
|
|
($)
|
|
($)
|
|
($)(1)
|
|
($)(2)
|
|
($)
|
|
($)(3)
|
|
($)
|
|
Michael D. Popielec (4)
|
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
193,831
|
|
|
|
|
|
|
|
|
|
|
|
193,831
|
|
President and Chief
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John D. Kavazanjian
|
|
|
2010
|
|
|
|
437,437
|
|
|
|
|
|
|
|
|
|
|
|
70,343
|
|
|
|
251,312
|
|
|
|
17,363
|
|
|
|
776,455
|
|
Former President and
|
|
|
2009
|
|
|
|
419,360
|
|
|
|
|
|
|
|
53,999
|
|
|
|
148,237
|
|
|
|
|
|
|
|
15,597
|
|
|
|
637,193
|
|
Chief Executive Officer
|
|
|
2008
|
|
|
|
349,302
|
|
|
|
43,750
|
|
|
|
|
|
|
|
126,813
|
|
|
|
|
|
|
|
17,036
|
|
|
|
536,901
|
|
Philip A. Fain
|
|
|
2010
|
|
|
|
250,927
|
|
|
|
|
|
|
|
|
|
|
|
97,499
|
|
|
|
107,705
|
|
|
|
12,090
|
|
|
|
468,221
|
|
Chief Financial Officer
|
|
|
2009
|
|
|
|
240,538
|
|
|
|
|
|
|
|
22,501
|
|
|
|
109,956
|
|
|
|
|
|
|
|
9,189
|
|
|
|
382,184
|
|
and Treasurer
|
|
|
2008
|
|
|
|
186,660
|
|
|
|
20,000
|
|
|
|
85,612
|
|
|
|
265,510
|
|
|
|
|
|
|
|
88,408
|
(5)
|
|
|
646,190
|
|
Peter F. Comerford (6)
|
|
|
2010
|
|
|
|
210,453
|
|
|
|
|
|
|
|
|
|
|
|
77,999
|
|
|
|
62,828
|
|
|
|
9,994
|
|
|
|
361,274
|
|
Vice President of
|
|
|
2009
|
|
|
|
210,066
|
|
|
|
|
|
|
|
13,505
|
|
|
|
69,345
|
|
|
|
|
|
|
|
11,529
|
|
|
|
304,445
|
|
Administration, Secretary and General Counsel
|
|
|
2008
|
|
|
|
194,411
|
|
|
|
12,000
|
|
|
|
|
|
|
|
33,817
|
|
|
|
|
|
|
|
9,670
|
|
|
|
249,898
|
|
Patrick R. Hanna, Jr. (7)
|
|
|
2010
|
|
|
|
192,429
|
|
|
|
|
|
|
|
|
|
|
|
38,999
|
|
|
|
56,844
|
|
|
|
10,479
|
|
|
|
298,751
|
|
Vice President, Corporate
|
|
|
2009
|
|
|
|
190,655
|
|
|
|
|
|
|
|
10,797
|
|
|
|
42,460
|
|
|
|
|
|
|
|
9,883
|
|
|
|
253,795
|
|
Compliance Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James E. Evans (8)
|
|
|
2010
|
|
|
|
100,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79,093
|
(9)
|
|
|
8,409
|
|
|
|
188,229
|
|
Former Executive Vice
|
|
|
2009
|
|
|
|
231,095
|
|
|
|
|
|
|
|
|
|
|
|
63,217
|
|
|
|
165,924
|
(9)
|
|
|
9,785
|
|
|
|
470,021
|
|
President of Business Operations
|
|
|
2008
|
|
|
|
203,280
|
|
|
|
10,000
|
|
|
|
|
|
|
|
33,817
|
|
|
|
228,222
|
(9)
|
|
|
12,887
|
|
|
|
488,206
|
|
Julius M. Cirin (7)(10)
|
|
|
2010
|
|
|
|
160,923
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,422
|
|
|
|
8,131
|
|
|
|
197,476
|
|
Former Vice President,
|
|
|
2009
|
|
|
|
190,347
|
|
|
|
|
|
|
|
10,797
|
|
|
|
42,460
|
|
|
|
|
|
|
|
11,306
|
|
|
|
254,910
|
|
Corporate Communications Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The amount in the Stock Awards column is the grant date fair
value of restricted share awards granted pursuant to our
shareholder-approved Restated LTIP calculated in accordance with
ASC 718. See Note 7 to our audited consolidated
financial statements included in our Annual Reports on
Form 10-K
for the fiscal years ended December 31, 2008 and 2009 for
the assumptions we used in valuing and expensing these
restricted share awards in accordance with ASC 718. |
|
(2) |
|
The amounts reported in the Option Awards column represent the
grant date fair value of stock option awards granted pursuant to
our shareholder-approved Restated LTIP calculated in accordance
with ASC 718. See Note 7 to our audited financial
statements included in our Annual Reports on
Form 10-K
for the fiscal years ended December 31, 2008, 2009 and 2010
for the assumptions we used in valuing and expensing these stock
options in accordance with ASC 718. |
|
(3) |
|
All Other Compensation for 2010 consists of the following: |
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
401(k) Plan
|
|
|
|
|
|
|
|
|
|
Employer
|
|
|
Other
|
|
|
|
|
|
|
Match
|
|
|
Benefits (a)
|
|
|
Total
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Michael D. Popielec
|
|
|
|
|
|
|
|
|
|
|
|
|
John D. Kavazanjian
|
|
|
8,864
|
|
|
|
8,499
|
|
|
|
17,363
|
|
Philip A. Fain
|
|
|
4,961
|
|
|
|
7,129
|
|
|
|
12,090
|
|
Peter F. Comerford
|
|
|
4,109
|
|
|
|
5,885
|
|
|
|
9,994
|
|
Patrick R. Hanna, Jr.
|
|
|
4,089
|
|
|
|
6,390
|
|
|
|
10,479
|
|
James E. Evans
|
|
|
2,085
|
|
|
|
6,324
|
|
|
|
8,409
|
|
Julius M. Cirin
|
|
|
2,232
|
|
|
|
5,899
|
|
|
|
8,131
|
|
|
|
|
(a) |
|
The Other Benefits column of the above table
includes premiums paid for group medical and dental coverage,
physical rehabilitation, life insurance, long-term care
insurance and tax preparation. |
|
|
|
(4) |
|
Mr. Popielec became our President and Chief Executive
Officer effective December 30, 2010. |
|
(5) |
|
Prior to Mr. Fains employment with us, he was a
partner with CXO on the Go, LLC, a management consulting firm,
which we retained in connection with our acquisition activity.
Disclosed in this column is $79,944 in consulting fees that we
paid to CXO on the Go, LLC for services rendered by
Mr. Fain and others during 2008. |
|
(6) |
|
Mr. Comerford was not a Named Executive Officer for 2008
and became a Named Executive Officer once again in 2009. |
|
(7) |
|
Messrs. Hanna and Cirin each became a Named Executive
Officer in 2009. |
|
(8) |
|
Mr. Evans resigned as our Executive Vice President of
Business Operations effective April 30, 2010. |
|
(9) |
|
Mr. Evans received sales commission incentive compensation
based on a specified percentage of all of our qualifying defense
and government sales in 2008. His sales commissions for 2009 and
2010 were based on a specified percentage of all of our sales. |
|
(10) |
|
Mr. Cirin went out on disability in June 2010 and died on
December 30, 2010. |
2010
GRANTS OF PLAN-BASED AWARDS
The following table sets forth information concerning grants of
plan-based awards to the Named Executive Officers during 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
|
Exercise
|
|
|
|
|
|
Fair
|
|
|
|
|
|
|
|
|
|
|
Estimated Possible
|
|
|
Awards:
|
|
|
or
|
|
|
Closing
|
|
|
Value
|
|
|
|
|
|
|
|
|
|
|
Payouts Under
|
|
|
Number of
|
|
|
Base
|
|
|
Market
|
|
|
of Stock
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive
|
|
|
Securities
|
|
|
Price of
|
|
|
Price on
|
|
|
and
|
|
|
|
|
|
|
|
|
|
|
Plan Awards(1)
|
|
|
Underlying
|
|
|
Option
|
|
|
Grant
|
|
|
Option
|
|
|
|
Type of
|
|
|
|
Grant
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Options
|
|
|
Awards
|
|
|
Date
|
|
|
Awards
|
|
Name
|
|
Award
|
|
Plan
|
|
Date
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(#)
|
|
|
($/Sh) (2)
|
|
|
($/Sh)
|
|
|
($)
|
|
|
Michael D. Popielec (3)
|
|
Option
|
|
LTIP
|
|
|
12/30/10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
6.42
|
|
|
|
6.51
|
|
|
|
193,831
|
|
John D. Kavazanjian
|
|
Cash Incentive
|
|
STIP
|
|
|
|
|
|
|
|
|
|
|
270,000
|
|
|
|
540,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
LTIP
|
|
|
01/13/10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26,500
|
|
|
|
4.78
|
|
|
|
4.77
|
|
|
|
70,343
|
|
Philip A. Fain
|
|
Cash Incentive
|
|
STIP
|
|
|
|
|
|
|
|
|
|
|
108,000
|
|
|
|
216,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
LTIP
|
|
|
12/03/10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
6.91
|
|
|
|
6.92
|
|
|
|
97,499
|
|
Peter F. Comerford
|
|
Cash Incentive
|
|
STIP
|
|
|
|
|
|
|
|
|
|
|
63,000
|
|
|
|
126,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
LTIP
|
|
|
12/03/10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
6.91
|
|
|
|
6.92
|
|
|
|
77,999
|
|
Patrick R. Hanna, Jr.
|
|
Cash Incentive
|
|
STIP
|
|
|
|
|
|
|
|
|
|
|
57,000
|
|
|
|
114,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
LTIP
|
|
|
12/03/10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
6.91
|
|
|
|
6.92
|
|
|
|
38,999
|
|
James E. Evans
|
|
Commissions
|
|
|
|
|
|
|
|
|
|
|
|
|
79,093
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Incentive
|
|
STIP
|
|
|
|
|
|
|
|
|
|
|
69,000
|
|
|
|
138,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Julius M. Cirin
|
|
Cash Incentive
|
|
STIP
|
|
|
|
|
|
|
|
|
|
|
57,000
|
|
|
|
114,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29
|
|
|
(1) |
|
Other than for Mr. Evans, amounts represent the potential
threshold, target and maximum bonus under the STIP described in
the CD&A under the heading Short-Term Incentive
Plan. Under the terms of the STIP, the maximum award
amount is payable as an overachievement award. |
|
(2) |
|
The exercise price of stock options granted on January 13,
2010, December 3, 2010 and December 30, 2010 is equal
to the volume weighted average sales price of our Common Stock,
as determined in accordance with the trading rules of the NASDAQ
Global Market, on the respective date of grant. |
|
(3) |
|
Mr. Popielec also received additional stock options that
are conditioned upon shareholder approval of an amendment to our
Restated LTIP at the Meeting. Such stock options are null and
void if such shareholder approval is not obtained. These
conditional stock options are more specifically described on
pages 38 and 39 of this proxy statement under
Proposal 4. |
|
(4) |
|
Mr. Evans participated in a sales commission incentive
compensation program, whereby he was entitled to receive a
specified percentage of all of our sales. He received
0.1 percent of all sales up to our budgeted number and
0.125 percent of all sales above our budgeted number. There
was no threshold award amount nor was there a maximum amount
that Mr. Evans could earn under the sales commission
incentive compensation program. |
OUTSTANDING
EQUITY AWARDS AT DECEMBER 31, 2010
The following table sets forth information concerning the number
of shares underlying exercisable and non-exercisable options
outstanding at December 31, 2010 and unvested restricted
stock awards outstanding at December 31, 2010 for our Named
Executive Officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
Number of
|
|
Number of
|
|
|
|
|
|
Number of
|
|
Value of
|
|
|
Securities
|
|
Securities
|
|
|
|
|
|
Shares or
|
|
Shares or
|
|
|
Underlying
|
|
Underlying
|
|
|
|
|
|
Units of
|
|
Units of
|
|
|
Unexercised
|
|
Unexercised
|
|
Option
|
|
|
|
Stock That
|
|
Stock That
|
|
|
Options
|
|
Options
|
|
Exercise
|
|
Option
|
|
Have Not
|
|
Have Not
|
|
|
(#)
|
|
(#)
|
|
Price
|
|
Expiration
|
|
Vested
|
|
Vested
|
Name
|
|
Exercisable
|
|
Unexercisable
|
|
($)
|
|
Date
|
|
(#)
|
|
($)(1)
|
|
Michael D. Popielec
|
|
|
|
|
|
|
50,000
|
(2)
|
|
$
|
6.4218
|
|
|
|
12/30/2017
|
|
|
|
|
|
|
|
|
|
John D. Kavazanjian
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
(3)
|
|
$
|
6,610
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,177
|
(4)
|
|
|
21,000
|
|
|
|
|
50,000
|
|
|
|
0
|
|
|
|
15.0500
|
|
|
|
12/07/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
0
|
|
|
|
12.9600
|
|
|
|
12/09/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
48,000
|
|
|
|
0
|
|
|
|
12.9600
|
|
|
|
06/08/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
0
|
|
|
|
10.5500
|
|
|
|
12/21/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
22,500
|
|
|
|
0
|
|
|
|
13.4338
|
|
|
|
12/07/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
5,872
|
|
|
|
11,742
|
(5)
|
|
|
12.1848
|
|
|
|
01/14/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
7,834
|
|
|
|
15,666
|
(6)
|
|
|
3.9085
|
|
|
|
12/04/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
26,500
|
(7)
|
|
|
4.7761
|
|
|
|
01/13/2017
|
|
|
|
|
|
|
|
|
|
Philip A. Fain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
600
|
(8)
|
|
|
3,966
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,324
|
(9)
|
|
|
8,752
|
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
11.4217
|
|
|
|
09/07/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
33,333
|
|
|
|
16,667
|
(10)
|
|
|
12.7385
|
|
|
|
03/07/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
2,659
|
|
|
|
5,317
|
(11)
|
|
|
12.1848
|
|
|
|
01/14/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
11,000
|
|
|
|
22,000
|
(12)
|
|
|
3.9085
|
|
|
|
12/04/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
25,000
|
(13)
|
|
|
6.9061
|
|
|
|
12/03/2017
|
|
|
|
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
Number of
|
|
Number of
|
|
|
|
|
|
Number of
|
|
Value of
|
|
|
Securities
|
|
Securities
|
|
|
|
|
|
Shares or
|
|
Shares or
|
|
|
Underlying
|
|
Underlying
|
|
|
|
|
|
Units of
|
|
Units of
|
|
|
Unexercised
|
|
Unexercised
|
|
Option
|
|
|
|
Stock That
|
|
Stock That
|
|
|
Options
|
|
Options
|
|
Exercise
|
|
Option
|
|
Have Not
|
|
Have Not
|
|
|
(#)
|
|
(#)
|
|
Price
|
|
Expiration
|
|
Vested
|
|
Vested
|
Name
|
|
Exercisable
|
|
Unexercisable
|
|
($)
|
|
Date
|
|
(#)
|
|
($)(1)
|
|
Peter F. Comerford
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400
|
(14)
|
|
|
2,644
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
794
|
(9)
|
|
|
5,248
|
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
21.2800
|
|
|
|
03/31/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
19.3600
|
|
|
|
06/30/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
10.1700
|
|
|
|
09/30/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
0
|
|
|
|
15.0500
|
|
|
|
12/07/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
19.4500
|
|
|
|
12/31/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
17.1200
|
|
|
|
03/31/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
16.1500
|
|
|
|
06/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
12.9200
|
|
|
|
09/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
21,000
|
|
|
|
0
|
|
|
|
12.9600
|
|
|
|
12/09/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
12.0000
|
|
|
|
12/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
12.8500
|
|
|
|
03/31/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
|
0
|
|
|
|
10.5500
|
|
|
|
12/21/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
6,000
|
|
|
|
0
|
|
|
|
13.4338
|
|
|
|
12/07/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
1,330
|
|
|
|
2,658
|
(11)
|
|
|
12.1848
|
|
|
|
01/14/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
8,000
|
|
|
|
16,000
|
(12)
|
|
|
3.9085
|
|
|
|
12/04/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
20,000
|
(15)
|
|
|
6.9061
|
|
|
|
12/03/2017
|
|
|
|
|
|
|
|
|
|
Patrick R. Hanna, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400
|
(14)
|
|
|
2,644
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
635
|
(9)
|
|
|
4,197
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
21.2800
|
|
|
|
03/31/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
19.3600
|
|
|
|
06/30/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
10.1700
|
|
|
|
09/30/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
15.0500
|
|
|
|
12/07/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
19.4500
|
|
|
|
12/31/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
17.1200
|
|
|
|
03/31/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
16.1500
|
|
|
|
06/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
12.9200
|
|
|
|
09/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
11,500
|
|
|
|
0
|
|
|
|
12.9600
|
|
|
|
12/09/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
12.0000
|
|
|
|
12/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
12.8500
|
|
|
|
03/31/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
|
0
|
|
|
|
10.5500
|
|
|
|
12/21/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
6,000
|
|
|
|
0
|
|
|
|
13.4338
|
|
|
|
12/07/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
1,108
|
|
|
|
2,215
|
(11)
|
|
|
12.1848
|
|
|
|
01/14/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
4,000
|
|
|
|
8,000
|
(12)
|
|
|
3.9085
|
|
|
|
12/04/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
10,000
|
(15)
|
|
|
6.9061
|
|
|
|
12/03/2017
|
|
|
|
|
|
|
|
|
|
James E. Evans (16)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Julius M. Cirin
|
|
|
500
|
|
|
|
0
|
|
|
|
21.2800
|
|
|
|
03/31/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
19.3600
|
|
|
|
06/30/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
10.1700
|
|
|
|
09/30/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
15.0500
|
|
|
|
12/07/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
19.4500
|
|
|
|
12/31/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
17.1200
|
|
|
|
03/31/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
16.1500
|
|
|
|
06/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
12.9200
|
|
|
|
09/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
15,500
|
|
|
|
0
|
|
|
|
12.9600
|
|
|
|
12/09/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
12.0000
|
|
|
|
12/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
0
|
|
|
|
12.8500
|
|
|
|
03/31/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
|
0
|
|
|
|
10.5500
|
|
|
|
12/21/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
6,000
|
|
|
|
0
|
|
|
|
13.4338
|
|
|
|
12/07/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
1,108
|
|
|
|
0
|
|
|
|
12.1848
|
|
|
|
01/14/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
4,000
|
|
|
|
0
|
|
|
|
3.9085
|
|
|
|
12/04/2016
|
|
|
|
|
|
|
|
|
|
31
|
|
|
(1) |
|
The amounts set forth in this column equal the number of
time-based restricted stock awards indicated multiplied by the
closing price of our Common Stock on December 31, 2010
($6.61). |
|
(2) |
|
This stock option will vest in equal installments of
12,500 shares on each of December 30, 2011, 2012, 2013
and 2014. |
|
(3) |
|
The remaining 1,000 shares subject to this restricted stock
award were forfeited upon Mr. Kavazanjians retirement
on February 7, 2011. |
|
(4) |
|
1,589 shares subject to this restricted stock award vested
on January 14, 2011. The remaining 1,588 shares were
forfeited upon Mr. Kavazanjians retirement on
February 7, 2011. |
|
(5) |
|
This stock option vested on January 14, 2011 with respect
to 5,871 shares and will vest on January 14, 2012 with
respect to 5,871 shares. |
|
(6) |
|
This stock option will vest on December 4, 2011 with
respect to 7,833 shares and on December 4, 2012 with
respect to 7,833 shares. |
|
(7) |
|
This stock option vested on January 13, 2011 with respect
to 8,834 shares and will vest with respect to
8,333 shares on each of January 13, 2012 and 2013. |
|
(8) |
|
The remaining 600 shares subject to this restricted stock
award vested on March 7, 2011. |
|
(9) |
|
These restricted stock awards vest in equal installments on each
of January 14, 2011 and 2012. |
|
(10) |
|
This stock option vested on March 7, 2011 with respect to
16,667 shares. |
|
(11) |
|
This stock option vested on January 14, 2011 with respect
to 2,659 shares for Mr. Fain, 1,329 shares for
Mr. Comerford, and 1,108 shares for Mr. Hanna,
and will vest on January 14, 2012 with respect to the
balance of shares subject to each option. |
|
(12) |
|
This stock option will vest in equal installments on
December 4, 2011 and December 4, 2012. |
|
(13) |
|
This consists of two stock option grants: one for
9,541 shares which will vest with respect to
4,771 shares on December 3, 2011 and with respect to
4,770 shares on December 3, 2012 and another for
15,459 shares which will vest with respect to
3,563 shares on each of December 3, 2011 and
December 3, 2012 and with respect to 8,333 shares on
December 3, 2013. |
|
(14) |
|
These restricted stock awards vested on March 1, 2011. |
|
(15) |
|
This stock option will vest in equal installments on
December 3, 2011, December 3, 2012 and
December 3, 2013. |
|
(16) |
|
Upon his resignation, Mr. Evans forfeited all of his
unvested stock options and restricted stock awards. |
2010
OPTION EXERCISES AND STOCK VESTED
The following table sets forth information concerning the number
of shares of our Common Stock acquired and the value realized on
vesting of restricted stock awards during 2010 by the Named
Executive Officers. None of our Named Executive Officers
exercised any stock options during 2010.
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
|
Number of Shares
|
|
Value Realized
|
|
|
Acquired on Vesting
|
|
on Vesting
|
|
|
(#)
|
|
($)(1)
|
|
Michael D. Popielec
|
|
|
|
|
|
|
|
|
John D. Kavazanjian
|
|
|
2,589
|
|
|
|
12,345
|
|
Philip A. Fain
|
|
|
1,262
|
|
|
|
5,889
|
|
Peter F. Comerford
|
|
|
798
|
|
|
|
3,700
|
|
Patrick R. Hanna, Jr.
|
|
|
718
|
|
|
|
3,282
|
|
James E. Evans
|
|
|
3,300
|
|
|
|
13,365
|
|
Julius M. Cirin
|
|
|
718
|
|
|
|
3,282
|
|
32
|
|
|
(1) |
|
The value realized on the vesting of stock awards is based on
the closing price of our Common Stock on the vesting date
multiplied by the number of shares acquired. |
2010
PENSION BENEFITS TABLE
We do not have any qualified or nonqualified defined benefit
plans.
2010
NONQUALIFIED DEFERRED COMPENSATION TABLE
We do not have any nonqualified defined contribution or other
nonqualified deferred compensation plans.
33
EMPLOYMENT
ARRANGEMENTS
Mr. Popielec
On December 6, 2010, we entered into an employment
agreement with Mr. Popielec which provides that, effective
December 30, 2010, Mr. Popielec became our President
and Chief Executive Officer, succeeding Mr. Kavazanjian. In
connection with his appointment as our President and Chief
Executive Officer, we set Mr. Popielecs annual base
salary at $450,000. Mr. Popielec is also eligible to
receive an annual cash bonus outside our short-term cash bonus
incentive plan if we exceed certain quantitative and qualitative
performance metrics to be agreed upon no later than January 31
of the year for which the bonus applies. Satisfaction of 80% to
99% of the bonus plan metrics will result in bonus ranges from
20% to 100% of Mr. Popielecs target bonus.
Satisfaction of 100% to 125% of the bonus plan metrics will
result in bonus ranges from 100% to 140% of
Mr. Popielecs target bonus. In no event will the
bonus exceed 140% of Mr. Popielecs target bonus. For
2011 and each year thereafter, Mr. Popielecs target
bonus shall not be less than 75% of his 2011 base salary.
Mr. Popielec is also a participant in our Restated LTIP.
Pursuant to the terms of his employment agreement,
Mr. Popielec was granted options to purchase shares of our
Common Stock as more specifically described on pages 38 and
39 of this proxy statement under Proposal 4. As mentioned
therein, three of the options granted on December 30, 2010
are conditional and are subject to shareholder approval to
increase the number of shares available under our Restated LTIP
to accommodate those options and to also increase the current
limitation on maximum options issuable to an employee in a given
year. If such approval is not obtained, those options shall be
null and void.
We have also agreed that Mr. Popielec shall be entitled to
the following relocation benefits: (i) rent in and commute
transportation to the Rochester, New York area for up to nine
months, as needed, during 2011 for a total actual expense not to
exceed $50,000; (ii) payment of all actual reasonable
relocation and moving expenses, including expenses incurred by
Mr. Popielec and his spouse for travel to the Rochester,
New York area to locate living accommodations, packing and
transporting of household items to the new household and meals,
lodging and travel in connection with the move to the new
household, incurred in 2011 in an aggregate amount not to exceed
$60,000; and (iii) payment of all actual reasonable current
house sale/closing costs, including deed preparation, tax
stamps, reasonable attorneys fees, real estate transfer
taxes and real estate commissions incurred in 2011 and 2012.
Mr. Popielec is also entitled to receive the retirement
benefits and fringe and other personal benefits described in
this proxy statement under the sections entitled
Retirement Benefits and Perquisites and Other
Personal Benefits.
The employment agreement provides that Mr. Popielecs
employment is at will. Mr. Popielec is entitled
to certain severance benefits if we terminate his employment
without Business Reasons or a Constructive Termination occurs
(as those terms are defined in the employment agreement),
including (i) salary continuation for a period of
18 months following the termination date, provided,
however, that such
18-month
period shall be reduced to 12 months if the termination
date is on or after June 30, 2012, (ii) a pro rata
amount (calculated on a per diem basis) of the full-year bonus
which Mr. Popielec would have earned for the calendar year
in which the termination of employment occurs,
(iii) acceleration of vesting of all outstanding stock
options and other equity arrangements, subject to the provision,
however, that the acceleration shall not cover more than
18 months from the termination date, (iv) continuation
of health benefits for Mr. Popielec, his spouse and any
dependent children for a period of 12 months after the
termination date followed by 18 months of executive-paid
COBRA eligibility. In addition, if we terminate the employment
of Mr. Popielec within 12 months of the date of a
Change in Control, without Business Reasons or a Constructive
Termination occurs (as those terms are defined in the Employment
Agreement), then Mr. Popielec shall be entitled to receive
(i) salary, any unpaid bonus from the prior year plus an
amount equal to 18 months of his salary as then in effect,
payable immediately upon the termination date, (ii) one and
one-half times his target bonus for the calendar year in which
the termination date occurs, (iii) acceleration in full of
vesting of all outstanding stock options, all such options to
remain exercisable for 18 months following the termination
date, or through the original expiration date of the stock
options, if earlier, (iv) continuation of health benefits
for Mr. Popielec, his spouse and any dependent children for
a period of 24 months after the termination date. To the
extent the vesting
and/or
accelerated payment of outstanding stock options would subject
Mr. Popielec to the imposition of tax
and/or
penalties under Section 409A of the Internal Revenue Code
(the Code), the vesting
and/or
payment of such stock options and other equity shall be delayed
to the extent necessary to avoid the imposition of such tax
and/or
penalties. The Employment Agreement also provides for the
continuation of certain
34
benefits in the event Mr. Popielecs employment is
terminated for disability (as defined in the Employment
Agreement) or by his death. Mr. Popielec has also executed
an Employee Confidentiality Non-Disclosure No-Compete,
Non-Disparagement and Assignment Agreement in our standard form.
Mr. Kavazanjian
On April 27, 2007, we entered into a new employment
agreement with Mr. Kavazanjian, which superseded
his existing employment agreement. Annually, our
Compensation and Management Committee reviewed
Mr. Kavazanjians salary and made such adjustments as
it deemed appropriate in accordance with our executive
compensation guidelines. The agreement automatically extended
for successive one-year terms, unless either of the parties
provided advance written notice of such partys desire not
to renew the agreement. Such written notice was required to be
provided at least 90 days prior to the scheduled expiration
date of the then current term of the agreement.
In December 2008, Mr. Kavazanjians employment
agreement was amended to bring it into compliance with
Section 409A of the Code. In July 2009,
Mr. Kavazanjians employment agreement was amended and
restated to cap the severance benefits upon a specified
change-in-control
event at no more than three times Mr. Kavazanjians
average annual compensation for the previous five years to the
extent necessary not to incur the excise tax under
Section 4999 of the Code and not limit our tax deduction
under Section 280G of the Code (the Tax
Limitations). In the event a severance benefit owed to
Mr. Kavazanjian exceeds the Tax Limitations, then we will
determine which severance benefits are reduced so that such
severance benefits are not subject to the Tax Limitations.
Mr. Kavazanjians employment agreement was also
amended to, among other things: (i) clarify that restricted
stock awards and stock appreciation rights will be accelerated
along with other equity arrangements (to the same extent
described above) in the event of an (a) involuntary
termination without business reasons or a constructive
termination, (b) change in control or (c) termination
upon death, as such terms are defined in his employment
agreement; (ii) reflect our paid time off policy; and
(iii) increase to 90 days the period of time
Mr. Kavazanjian can exercise vested stock options to
coincide with the period of time set forth in the Restated LTIP.
On May 24, 2010, we entered into an addendum to our
employment agreement with Mr. Kavazanjian to supplement
certain provisions of Mr. Kavazanjians employment
agreement to reflect, among other things, that
Mr. Kavazanjian may retire. The addendum gave either
Mr. Kavazanjian or us the right to terminate
Mr. Kavazanjians employment agreement by giving the
other party written notice 60 days prior to the effective
date of such termination (an Early Termination) and
set forth Mr. Kavazanjians entitlements in the event
of an Early Termination. Pursuant to the terms of the addendum,
Mr. Kavazanjian notified us of his decision to retire
effective February 7, 2011. He ceased being our President
and Chief Executive Officer on December 30, 2010 when
Mr. Popielec assumed those positions. Upon his retirement,
Mr. Kavazanjian became entitled to: (i) the
continuation of his salary for a period of 12 months,
(ii) the cash value of any unused paid time off consistent
with our paid time off policy, (iii) all of his equity
awards which will remain exercisable through their original
expiration dates, and (iv) the continuation of health
benefits for him, his spouse and dependent children for a period
of 12 months. Mr. Kavazanjian will also make himself
available to act in a consulting capacity, at no additional cost
to us, for up to 10 hours per month, as requested by us,
through February 7, 2012. We will reimburse
Mr. Kavazanjian for all reasonable expenses he incurs as a
result of his consultation.
Mr. Comerford
On April 27, 2007, we entered into an employment agreement
with Mr. Comerford. Annually, our Compensation and
Management Committee reviews Mr. Comerfords salary
and makes such adjustments as it deems appropriate in accordance
with our executive compensation guidelines. The agreement
automatically extends for successive one-year terms, unless
either of the parties provides advance written notice of such
partys desire not to renew the agreement. Such written
notice must be provided at least 90 days prior to the
scheduled expiration date of the then current term of the
agreement.
If we terminate Mr. Comerfords employment agreement
without Business Reasons (as defined in the
employment agreement) or because Mr. Comerford experiences
a Disability (as defined in the employment
agreement), or if a Constructive Termination (as
defined in the employment agreement) occurs, then
Mr. Comerford will be entitled to the following benefits:
(1) salary and the cash value of any accrued vacation
(consistent with our vacation policies then effect) through the
termination date of his employment plus continued salary for an
additional 18 months; (2) an amount equal to the
average of the bonuses paid to him during the two preceding
fiscal years or, if no bonuses were paid during such period, an
amount equal to his then current annual target bonus; and
35
(3) acceleration of vesting of all outstanding stock
options, and other equity arrangements subject to vesting and
held by him, provided that the acceleration shall not cover more
than two years from the termination date of his employment (and
in this regard, all such options and other exercisable rights
held by Mr. Comerford shall remain exercisable for one year
following such termination date). In such circumstances,
Mr. Comerford would also be entitled to continued health
benefits at his cost for a period of 18 months.
If we terminate Mr. Comerfords employment agreement
within 18 months of the date of a Change in
Control (as defined in the employment agreement), then
Mr. Comerford will receive the same benefits as discussed
above except that all of his outstanding stock options and
equity arrangements will accelerate, even if the remaining
vesting period is in excess of two years. If
Mr. Comerfords employment agreement is terminated
because he experiences a Disability (as defined in
the employment agreement) then Mr. Comerford will be
entitled to the same benefits as described above except that he
will only receive an amount equal to his then current annual
target bonus, not the average of the bonuses paid to him during
the two preceding fiscal years.
If Mr. Comerfords employment agreement is terminated
because of his death, his representatives will be entitled to
(1) an amount equal to his annual target bonus for the
fiscal year in which he died (plus any unpaid bonus from the
prior fiscal year end); and (2) the acceleration of vesting
of all outstanding stock options, and other equity arrangements
subject to vesting and held by him, provided that the
acceleration shall not cover more than two years from the
termination date of his employment (and in this regard, all such
options and other exercisable rights held by
Mr. Comerfords representatives shall remain
exercisable for one year following such termination date).
In December 2008, Mr. Comerfords employment agreement
was amended to bring it into compliance with Section 409A
of the Code. In July 2009, Mr. Comerfords employment
agreement was amended and restated in the same manner as
Mr. Kavazanjians employment agreement.
Other
Executive Officers
We do not have employment agreements with Messrs. Fain or
Hanna, and did not have employment agreements with
Messrs. Evans or Cirin.
Special
Short-Term Severance and Change in Control Benefit
Messrs. Fain and Hanna are currently covered by a
short-term severance and
change-in-control
benefit that was put in place by the Board of Directors to
alleviate any concerns that key management employees might have
with their future employment opportunities with us as a result
of the retirement of John Kavazanjian, our former President and
Chief Executive Officer and the search for a new President and
Chief Executive Officer. This special package of benefits was
initially put in place for a period of one (1) year. This
benefit is not intended to be a permanent benefit
and will be reviewed by the Compensation and Management
Committee on an annual basis. If the decision were made to
terminate the benefit, the employee would be notified in writing
with a thirty (30) day notice of the intent not to renew.
If no notice is provided, the benefit will renew for an
additional year.
Under the terms of the special short-term severance and change
in control benefit for Messrs. Fain and Hanna, each is
entitled to certain severance benefits if we terminate their
employment without cause. Mr. Fain and Mr. Hanna are
entitled to these benefits for a period of 12 and 9 months,
respectively. The severance benefits include accrued
compensation and benefits through the date of termination, as
well as: (1) salary continuation through the period
specified above, paid in accordance with the normal payroll
cycle; (2) continuation of medical and dental benefits
through the period specified above, provided the executive pays
the employee portion of such premiums; and (3) the ability
to exercise vested stock options through the period specified
above.
In addition, if we terminate Mr. Fain or
Mr. Hannas employment within 12 months of the
date of a Change in Control, without cause, then the terminated
executive shall be entitled to receive certain change in control
severance benefits. Mr. Fain and Mr. Hanna are
entitled to these benefits for a period of 12 and 9 months,
respectively. The change in control severance benefits include
accrued compensation and benefits through the date of
termination, as well as: (1) salary continuation through
the period specified above, paid in a lump-sum payment;
(2) continuation of medical and dental benefits through the
period specified above, including a company contribution equal
to the difference between the COBRA premium and the amount the
executive was required to pay immediately prior to such
separation from service; and (3) the ability to exercise
vested stock options through the period specified above.
36
POTENTIAL
PAYMENTS UPON TERMINATION AND/OR A CHANGE IN CONTROL
The table below outlines certain potential payments and benefits
payable by us to those of our Named Executive Officers who were
employed by us during 2010 in the event of various scenarios
involving either a termination
and/or
change in control. The amounts disclosed assume the Named
Executive Officers termination under the various scenarios
occurred on December 31, 2010. The value of the stock
awards is based on the closing price of our Common Stock as
reported on the NASDAQ Global Market on December 31, 2010,
which was $6.61.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accelerated
|
|
|
|
|
|
|
|
|
|
|
Salary
|
|
Bonus
|
|
Restricted
|
|
Accelerated
|
|
Health Care
|
|
Gross-Up
|
|
|
|
|
Continuation
|
|
Payment
|
|
Stock Awards
|
|
Stock Options
|
|
Continuation
|
|
Payment
|
|
Total
|
Triggering Event
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
Michael D. Popielec (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary Termination without Business Reasons or
Constructive Termination
|
|
$
|
675,000
|
|
|
|
|
|
|
|
|
|
|
|
2,375
|
|
|
|
11,734
|
|
|
|
|
|
|
|
689,109
|
|
Involuntary Termination without Business Reasons or
Constructive Termination within 12 months of the date of a
Change in Control
|
|
|
675,000
|
|
|
|
|
|
|
|
|
|
|
|
9,500
|
|
|
|
23,469
|
|
|
|
|
|
|
|
707,969
|
|
Change in Control
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,500
|
|
|
|
|
|
|
|
|
|
|
|
9,500
|
|
Disability
|
|
|
450,000
|
|
|
|
|
|
|
|
|
|
|
|
2,375
|
|
|
|
11,734
|
|
|
|
|
|
|
|
464,109
|
|
Death
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,375
|
|
|
|
|
|
|
|
|
|
|
|
2,375
|
|
John D. Kavazanjian (1)(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary Termination without Business Reasons or
Constructive Termination
|
|
|
840,000
|
|
|
|
270,000
|
|
|
|
27,610
|
|
|
|
74,721
|
|
|
|
|
|
|
|
|
|
|
|
1,212,331
|
|
Involuntary Termination without Business Reasons or
Constructive Termination within 18 months of the date of a
Change in Control
|
|
|
840,000
|
|
|
|
270,000
|
|
|
|
27,610
|
|
|
|
90,920
|
|
|
|
|
|
|
|
|
|
|
|
1,228,530
|
|
Change in Control
|
|
|
|
|
|
|
|
|
|
|
27,610
|
|
|
|
90,920
|
|
|
|
|
|
|
|
|
|
|
|
118,530
|
|
Disability
|
|
|
840,000
|
|
|
|
270,000
|
|
|
|
27,610
|
|
|
|
74,721
|
|
|
|
|
|
|
|
|
|
|
|
1,212,331
|
|
Death
|
|
|
|
|
|
|
270,000
|
|
|
|
27,610
|
|
|
|
74,721
|
|
|
|
|
|
|
|
|
|
|
|
372,331
|
|
Philip A. Fain (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary Termination without Cause
|
|
|
240,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
240,000
|
|
Involuntary Termination without Cause within 12 months
of the date of a Change in Control
|
|
|
240,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,734
|
|
|
|
251,734
|
|
Change in Control
|
|
|
|
|
|
|
|
|
|
|
12,718
|
|
|
|
59,400
|
|
|
|
|
|
|
|
|
|
|
|
72,118
|
|
Peter F. Comerford (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary Termination without Business Reasons or
Constructive Termination
|
|
|
315,000
|
|
|
|
63,000
|
|
|
|
7,892
|
|
|
|
43,224
|
|
|
|
|
|
|
|
|
|
|
|
429,116
|
|
Involuntary Termination without Business Reasons or
Constructive Termination within 18 months of the date of a
Change in Control
|
|
|
315,000
|
|
|
|
63,000
|
|
|
|
7,892
|
|
|
|
43,224
|
|
|
|
|
|
|
|
|
|
|
|
429,116
|
|
Change in Control
|
|
|
|
|
|
|
|
|
|
|
7,892
|
|
|
|
43,224
|
|
|
|
|
|
|
|
|
|
|
|
51,116
|
|
Disability
|
|
|
315,000
|
|
|
|
63,000
|
|
|
|
7,892
|
|
|
|
43,224
|
|
|
|
|
|
|
|
|
|
|
|
429,116
|
|
Death
|
|
|
|
|
|
|
63,000
|
|
|
|
7,892
|
|
|
|
43,224
|
|
|
|
|
|
|
|
|
|
|
|
114,116
|
|
Patrick R. Hanna, Jr. (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary Termination without Cause
|
|
|
142,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
142,500
|
|
Involuntary Termination without Cause within 12 months
of the date of a Change in Control
|
|
|
142,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,801
|
|
|
|
151,301
|
|
Change in Control
|
|
|
|
|
|
|
|
|
|
|
6,841
|
|
|
|
21,612
|
|
|
|
|
|
|
|
|
|
|
|
28,453
|
|
James E. Evans (4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Resignation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Julius M. Cirin (5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Death
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37
|
|
|
(1) |
|
All amounts appearing in this table for Messrs. Popielec,
Kavazanjian and Comerford are made pursuant to their employment
agreements with us. The employment agreements are summarized
above under the heading Employment Arrangements.
With respect to the acceleration of restricted stock awards and
stock options, the acquisition of 51% of our outstanding shares
of Common Stock by any one person or group will be deemed a
Change in Control pursuant to the employment
agreements. |
|
(2) |
|
Mr. Kavazanjian retired effective February 7, 2011. |
|
(3) |
|
All amounts appearing in this table for Messrs. Fain and
Hanna are made under the short-term severance and
change-in-control
benefit summarized above and the award agreements under our
Restated LTIP. With respect to the acceleration of restricted
stock awards and stock options, the acquisition of 30% of our
outstanding shares of Common Stock by any one person or group
will be deemed a Change in Control pursuant to award
agreements under our Restated LTIP. |
|
(4) |
|
Mr. Evans resigned on April 30, 2010. |
|
(5) |
|
Mr. Cirin died on December 30, 2010. |
PROPOSAL 4
APPROVAL
OF AMENDMENT TO OUR AMENDED AND
RESTATED
2004 LONG-TERM INCENTIVE PLAN
On June 10, 2004, our shareholders approved the Ultralife
Batteries, Inc. 2004 Long-Term Incentive Plan (the
LTIP). Our Board of Directors approved certain
amendments to the LTIP on July 26, 2004 and restated the
LTIP to reflect those amendments (the Restated
LTIP). The Restated LTIP was subsequently amended with
shareholder approval on June 8, 2006 to increase from
750,000 to 1,500,000 the number of shares of our Common Stock
authorized to be issued pursuant to the Restated LTIP and was
amended again with shareholder approval on June 5, 2008 to
increase from 1,500,000 to 2,000,000 the number of shares of our
Common Stock authorized to be issued pursuant to the Restated
LTIP.
We believe that long-term incentive awards are invaluable tools
for the recruitment, retention and motivation of employees,
directors and consultants who can contribute materially to our
success. We have used stock options for such purposes since
1992, and other forms of equity-based compensation since 2004,
and we continue to believe that stock options and other forms of
equity-based compensation are an appropriate vehicle to
incentivize and reward our employees, directors and consultants.
As of April 12, 2011, there are outstanding options to
acquire up to 1,873,277 shares of our Common Stock. Of the
2,000,000 shares originally reserved for issuance pursuant
to the Restated LTIP, only 187,946 shares remain available
for future issuance pursuant to new grants or awards as of
April 12, 2011. Our Board of Directors believes that it is
important to have additional shares available to provide
adequate flexibility to meet future needs.
On December 6, 2010, we entered into an Employment
Agreement with Michael D. Popielec pursuant to which we retained
him as our President and Chief Executive Officer effective
December 30, 2010. Pursuant to the terms of that Employment
Agreement, Mr. Popielec received the following options to
purchase shares of our Common Stock:
(a) 50,000 shares on December 30, 2010 with an
exercise price determined on that date in accordance with our
Restated LTIP, with equal vesting on each of December 30,
2011, December 30, 2012, December 30, 2013 and
December 30, 2014;
(b) 250,000 shares on December 30, 2010 with an
exercise price determined on that date in accordance with our
Restated LTIP with equal vesting on each of December 30,
2011, December 30, 2012, December 30, 2013 and
December 30, 2014;
(c) 200,000 shares on December 30, 2010 with an
exercise price of $10 per share with vesting to begin on the
date our Common Stock first reaches a closing price of $10 for
15 trading days in a 30
trading-day
period, with such vesting in equal amounts over the four
anniversary dates of that date;
38
(d) 200,000 shares on December 30, 2010 with an
exercise price of $15 per share with vesting to begin on the
date our Common Stock first reaches a closing price of $15 for
15 trading days in a 30
trading-day
period, with such vesting in equal amounts over the four
anniversary dates of that date; and
(e) 50,000 shares on January 3, 2011 with an
exercise price determined on that date in accordance with our
Restated LTIP with equal vesting on each of December 30,
2011, December 30, 2012, December 30, 2013 and
December 30, 2014.
All options described in (a), (b) and (e) above
terminate on December 30, 2017. All options described in
(c) and (d) above terminate as of the later of
December 30, 2017 and five years after the initial date
vesting commences, but in no event later than December 30,
2020. The options described at (b), (c) and (d) above
are conditional and are subject to shareholder approval to
increase the number of shares available under our Restated LTIP
to accommodate those options and to also increase the current
limitation on maximum options issuable to an employee in a given
year. If such approval is not obtained, these options shall be
null and void.
In order to provide adequate flexibility to meet future needs
and to accommodate the conditional options granted to our new
President and Chief Executive Officer, Michael D. Popielec,
pursuant to the terms of his employment agreement, on
April 20, 2011, the Board of Directors approved an
amendment to the Restated LTIP to increase from 2,000,000 to
2,900,000 the number of shares of our Common Stock authorized to
be issued pursuant to the Restated LTIP and to provide an
exception to the 50,000 share annual limitation provision
to accommodate inducement grants in an amount not to exceed
700,000 shares per grant. The complete text of that
amendment is attached as Appendix A to this proxy statement.
The description of the Restated LTIP (as amended) set forth
below is a summary, does not purport to be complete and is
qualified in its entirety by reference to the provisions of the
Restated LTIP itself. The complete text of the Restated LTIP (as
amended) is attached as Appendix B to this proxy statement.
Unless otherwise defined in this summary, capitalized terms used
in this summary have the meanings given such terms in the
Restated LTIP.
The following table provides certain important information
concerning our existing equity compensation plans as of
April 12, 2011:
Equity
Compensation Plan Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
Remaining Available for
|
|
|
|
|
|
|
Future Issuance Under
|
|
|
|
|
Weighted-Average
|
|
Equity Compensation
|
|
|
Number of Securities to be
|
|
Exercise Price of
|
|
Plans, Excluding
|
|
|
Used Upon Exercise of
|
|
Outstanding Options
|
|
Securities Reflected in
|
Plan Category
|
|
Outstanding Options (a)
|
|
(b)
|
|
Column (a) (c)
|
|
Equity compensation plans approved by security holders
|
|
|
1,776,812
|
|
|
$
|
9.21
|
|
|
|
187,946
|
|
Equity compensation plans not approved by security holders
|
|
|
98,000
|
(1)
|
|
$
|
12.85
|
|
|
|
0
|
|
Total
|
|
|
1,874,812
|
|
|
$
|
9.40
|
|
|
|
187,946
|
|
|
|
|
(1) |
|
On December 19, 2005, we granted our former President and
Chief Executive Officer, John D. Kavazanjian, an option to
purchase 48,000 shares of Common Stock at $12.96 per share
outside of any of our equity-based compensation plans, subject
to shareholder approval. Shareholder approval was obtained on
June 8, 2006. The stock option is fully vested and expires
on June 8, 2013. On March 7, 2008, in connection with
his becoming employed by us, we granted our Chief Financial
Officer and Treasurer, Philip A. Fain, an option to purchase
50,000 shares of Common Stock at $12.74 per share outside
of any of our equity-based compensation plans. The option vests
in annual increments of 16,667 shares over a three-year
period which commenced March 7, 2009. The option expires on
March 7, 2015. |
39
Summary
of Restated LTIP (as amended)
Purpose. Like our previous option
plans, the purpose of our Restated LTIP is to provide our
employees, directors and consultants who are in a position to
contribute to our long-term success, with Common Stock and
options to acquire Common Stock, to increase their interest in
our companys welfare and to aid in attracting and
retaining employees, directors and consultants of outstanding
ability.
Term. The LTIP was adopted by our Board
of Directors on April 27, 2004 and became effective on
June 10, 2004 when it was approved by our shareholders. The
Restated LTIP was adopted by our Board of Directors on
July 26, 2004 after the Annual Meeting of Shareholders.
Awards may not be granted under the Restated LTIP after
June 9, 2014, but awards granted before then may extend
beyond that date. Our Restated LTIP was subsequently amended
with shareholder approval on June 8, 2006 and June 5,
2008 so that now our Restated LTIP authorizes the issuance of
2,000,000 shares of our Common Stock.
Administration. The Restated LTIP is
administered by our Compensation and Management Committee, or
such other committee as may be designated by our Board of
Directors (the Committee); provided, however, that
the Committee shall consist of not less than two directors who
are non-employee directors, within the meaning of
Rule 16b-3
under the Exchange Act.
The Committee may allocate all or any portion of its
responsibilities and powers under the Restated LTIP to any one
or more of its members, our President and Chief Executive
Officer or other senior members of management as the Committee
deems appropriate; however, only the Committee may select and
grant awards to participants who are subject to Section 16
of the Exchange Act.
The Committee has broad authority in its administration of the
Restated LTIP, including, but not limited to, the authority to
interpret the plan; to establish rules and regulations for the
operation and administration of the plan; to select the persons
to receive awards; to determine the type, size, terms,
conditions, limitations, and restrictions of awards, including,
without limitation, terms regarding vesting, exercisability,
assignability, expiration and the effect of certain events, such
as a change of control in our company or the participants
death, disability, retirement or termination as a result of
breach of agreement; and to take all other action it deems
necessary or advisable to administer the Restated LTIP.
Notwithstanding the Committees broad authority to
administer the Restated LTIP and the awards issued under the
Restated LTIP, the exercise price of any stock option or stock
appreciation right granted pursuant to the Restated LTIP may not
be subsequently repriced without shareholder
approval. The term reprice means: (1) the
reduction, directly or indirectly, in the per-share exercise
price of an outstanding stock option or stock appreciation right
by amendment, cancellation or substitution; (2) the
cancellation of a stock option or stock appreciation right when
its exercise price exceeds the fair market value of the
underlying Common Stock in exchange for another stock option,
stock appreciation right or other equity security (unless the
cancellation and exchange occurs in connection with a merger,
acquisition, or similar transaction); or (3) the taking of
any other action that is treated as a repricing under United
States generally accepted accounting principles or by the rules
or regulations of any stock exchange on which our securities are
traded. The term reprice shall not include
adjustments made to awards by the Committee upon the occurrence
of certain events (as described under Adjustments Upon
Certain Events below).
To facilitate the granting of awards to participants who are
employed or retained outside of the United States, the Committee
will be authorized to modify and amend the terms and conditions
of an award to accommodate differences in local law, policy or
custom.
Eligibility. All of our employees,
directors and consultants are eligible to participate in the
Restated LTIP; provided, however, only employees are eligible to
receive incentive stock options. Participants in the Restated
LTIP will be selected by the Committee from those eligible
persons who are in a position to have a material impact on the
results of operations of our company and our subsidiaries.
Participants may be selected and awards may be made at any time
during the ten-year period following the effective date of the
Restated LTIP. As of December 31, 2010, four executive
officers, approximately 1,165 other officers and employees and
seven non-employee directors were eligible to participate in the
Restated LTIP.
40
The selection of those persons within a particular class who
will receive awards is entirely within the discretion of the
Committee. The Committee has not yet determined how many persons
are likely to participate in the Restated LTIP. The Committee
intends, however, to grant most of the Restated LTIPs
awards to those persons who are in a position to have a
significant direct impact on our growth, profitability and
success, which would include the participants in our current
equity compensation plans.
Shares Available. A total of
187,946 shares of Common Stock remain available for grant
of awards under the Restated LTIP. In addition, any shares
remaining available for issuance under our prior 2000 Option
Plan, or shares which become available upon the lapse,
expiration, termination or cancellation of outstanding stock
options under the 2000 Option Plan or Restated LTIP, will be
available for grant of awards under the Restated LTIP. However,
of the total number of shares of Common Stock available for
awards under the Restated LTIP, no more than 200,000 shares
of Common Stock may be used for awards other than stock options
and stock appreciation rights. (The Restated LTIP authorizes the
Committee to make equitable adjustments to the authorized number
and class of securities to be issued under the Restated LTIP
upon the occurrence of certain events, as described under
Adjustments Upon Certain Events below.) If our
shareholders approve the proposed amendment to our Restated
LTIP, we will have a total of 1,087,946 shares of Common
Stock available for award grants, 650,000 of which will be
reserved for the options granted to Mr. Popielec which were
subject to shareholder approval of the amendment to our Restated
LTIP. That will leave 437,946 shares available for future
award grants.
Types of Awards. Awards under the
Restated LTIP may be in the form of stock options, stock
appreciation rights, restricted stock, unrestricted stock and
other stock-based awards, or any combination thereof. All awards
granted to participants under the Restated LTIP shall be
evidenced by an award agreement which specifies the type of
award granted pursuant to the Restated LTIP, the number of
shares of Common Stock underlying the award and all of the terms
governing the award, including, without limitation, terms
regarding the vesting, exercisability and expiration of the
award. The Committee has exclusive power and authority,
consistent with the provisions of the Restated LTIP, to
establish the terms and conditions of any award and to waive any
such terms or conditions.
Award Limits. The maximum number of
shares with respect to which awards may be paid or granted
during each calendar year to any given participant may not
exceed 50,000 shares of Common Stock. (The Restated LTIP
authorizes the Committee to make equitable adjustments to the
number of shares with respect to which awards may be paid or
granted during each calendar year to any given participant under
the Restated LTIP upon the occurrence of certain events, as
described under Adjustments Upon Certain Events
below.) If the proposed amendment to our Restated LTIP is
approved, inducement grants to new executives and key employees
not to exceed 700,000 shares will not be subject to the
50,000 share annual limitation.
Stock Options and Stock Appreciation
Rights. The Committee may grant awards under
the Restated LTIP in the form of stock options to purchase
shares of Common Stock, which stock options may be non-qualified
stock options or incentive stock options for federal income tax
purposes. Any stock option granted in the form of an incentive
stock option must satisfy the requirements of Section 422A
of the Code. Stock options shall be vested and exercisable at
such times and upon such terms and conditions as may be
determined by the Committee, but in no event shall a stock
option be exercisable more than ten years (five years for
incentive stock options issued to certain Control Persons) after
the date it is granted. The exercise price per share of Common
Stock for any stock option awarded shall not be less than
100 percent (110 percent for incentive stock options
issued to certain Control Persons) of the fair market value of a
share of Common Stock on the day the stock option is granted,
except for stock options granted in assumption or replacement of
outstanding awards in connection with specified corporate
transactions.
A stock option may be exercised by paying the exercise price in
cash or its equivalent, or, to the extent permitted by the
Committee, shares of Common Stock, a combination of cash and
shares of Common Stock or through the delivery of irrevocable
instruments to a broker to sell the shares of Common Stock
obtained upon the exercise of the stock option and to deliver to
us an amount equal to the exercise price.
The Committee may grant stock appreciation rights independent of
(Freestanding SARs) or in conjunction with
(Tandem SARs) a stock option. The exercise price of
a stock appreciation right shall be an amount determined by the
Committee, but in no event shall such amount be less than the
fair market value of the Common Stock on the date the stock
appreciation right is granted. Each Freestanding SAR shall
entitle the participant upon
41
exercise to an amount equal to (i) the excess of
(A) the fair market value on the exercise date of one share
of Common Stock over (B) the exercise price, times
(ii) the number of shares of Common Stock as to which the
stock appreciation right is exercised. Each Tandem SAR shall
entitle the participant to surrender the related stock option
and to receive an amount equal to (i) the excess of
(A) the fair market value on the exercise date of one share
of Common Stock over (B) the exercise price per share of
Common Stock, times (ii) the number of shares of Common
Stock covered by the related stock option which is surrendered.
Payment of a stock appreciation right may be made by us in
shares of Common Stock or in cash or partly in shares of Common
Stock and partly in cash, as determined by the Committee.
Stock-Based Awards. The Committee, in
its sole discretion, may grant stock awards (shares of
restricted stock or unrestricted stock) and other awards that
are valued in whole or in part by reference to, or are otherwise
based on the fair market value of, the Common Stock. Such
stock-based awards shall be in such form, and dependent on such
conditions, as the Committee shall determine, including, without
limitation, the right to receive, or vest with respect to, one
or more shares of Common Stock (or the equivalent cash value of
such shares of Common Stock) upon the completion of a specified
period of service, the occurrence of an event
and/or the
attainment of performance objectives. The restricted period
specified in respect of any stock award shall not be less than
three years, except that the Committee may (i) provide for
the restricted period to terminate at any time after one year
upon the attainment of performance-based objectives, and
(ii) grant stock awards of up to 30,000 shares of
Common Stock without regard to this limitation. Furthermore, the
Committee may not terminate the restrictions applicable to
outstanding stock awards except in connection with a Change in
Control. The Committee may grant an unrestricted stock award
only if the Committee determines that such stock award is made
in lieu of all or a portion of salary or cash bonus of
comparable value.
Withholding. We will be entitled to
deduct from any payment to a participant under the Restated LTIP
the amount of all applicable income and employment taxes
required by law to be withheld with respect to such payment or
may require the participant to pay to us such tax prior to and
as a condition of the making of such payment. Subject to certain
limitations, the Committee may allow a participant to pay the
amount of taxes required by law to be withheld from an award by
withholding shares of Common Stock to be paid under such award
or by permitting the participant to deliver to us shares of
Common Stock having a fair market value equal to the amount of
such taxes.
Adjustments Upon Certain Events. In the
event of any reclassification, recapitalization, merger,
consolidation, reorganization, issuance of warrants, rights or
debentures, stock dividend, stock split or reverse stock split,
cash dividend, property dividend, combination or exchange of
shares, repurchase of shares or any other change in corporate
structure which in the judgment of the Committee materially
affects the value of the Common Stock, the Committee shall
determine, in its sole discretion, the substitutions or
adjustments to the maximum number of shares available for the
grant or issuance of awards under the Restated LTIP, the maximum
award payable under the Restated LTIP, the number and class of
shares and the exercise price per share set forth in any award
theretofore granted, or any other affected terms of an award or
the Restated LTIP as the Committee deems equitable or
appropriate.
Effect of Certain Events. The Committee
will have the authority to promulgate rules and regulations to
determine the treatment of a participants award in the
event of the participants death, disability or
termination. In addition, the Committee shall have the right to
extend the period for exercise of any stock option or stock
appreciation right, provided such extension does not exceed the
term for such stock option or stock appreciation right.
Unless otherwise decided by the Committee and provided in an
award agreement, upon a participants death or disability
prior to the complete exercise of the stock options or stock
appreciation rights granted to him or her under the Restated
LTIP, any such remaining stock options or stock appreciation
rights may be exercised within one year after the date of the
participants death or disability and prior to the
expiration of the term thereof, to the extent exercisable on the
date of the participants death or disability.
Unless otherwise decided by the Committee and provided in an
award agreement, upon a participants termination for any
reason other than death or disability prior to the complete
exercise of the stock options or stock appreciation rights
granted to him or her under the Restated LTIP, any such
remaining stock options or stock
42
appreciation rights may be exercised within three months after
the date of the participants termination and prior to the
expiration of the term thereof, to the extent exercisable on the
date of the participants termination.
Amendment and Termination. The Board of
Directors may, at any time, alter, amend, suspend, discontinue
or terminate the Restated LTIP; provided, however, that no such
action shall adversely affect the rights of participants to
awards previously granted hereunder and, provided further,
however, that any shareholder approval necessary or desirable in
order to comply with tax, securities, or other applicable laws
or regulations, including, but not limited to, the listing
requirements of the stock exchanges on which our securities are
listed, shall be obtained in the manner required therein. In
addition, the Board of Directors may, at any time and for any
reason, with or without prior notice, amend the Restated LTIP in
any manner, but may not without shareholder approval, adopt any
amendment which would: (1) increase the number of shares
available under the Restated LTIP; (2) expand the types of
awards available; (3) expand the class of persons eligible
to participate; (4) extend the term of the Restated LTIP;
(5) be a material amendment to the Restated LTIP,
including, but not limited to, a change in the method of
determining the exercise price of options issued under the
Restated LTIP; (6) allow for repricing of options or SARs;
or (vii) terminate restrictions applicable to awards
(except in connection with a grantees death, disability or
termination of employment or connection with a change in
control).
New Plan
Benefits
Because the benefits conveyed under the amendment to the
Restated LTIP will largely be at the discretion of the Committee
(other than those options automatically granted at the end of
each calendar quarter to executive officers and non-employee
directors), it is not possible to determine what benefits
participants will receive under the amended LTIP. If the
Restated LTIP as proposed to be amended had been in effect in
2010, the stock options received in 2010 by the Named Executive
Officers, all current executive officers as a group, all current
directors who are not executive officers as a group, and all
employees who are not executive officers, would have been the
same as the stock options actually received by such persons for
2010 under the Restated LTIP, as set forth in the following
table:
|
|
|
|
|
|
|
Name and Position
|
|
Dollar Value ($)
|
|
Number of Units
|
|
Michael D. Popielec
President and Chief Executive Officer
|
|
|
|
|
650,000
|
|
Philip A. Fain
Chief Financial Officer and Treasurer
|
|
|
|
|
0
|
|
Peter F. Comerford
Vice President of Administration, Secretary and General Counsel
|
|
|
|
|
0
|
|
Patrick R. Hanna, Jr.
Vice President, Corporate Compliance Officer
|
|
|
|
|
0
|
|
All Executive Officers as a Group
|
|
|
|
|
650,000
|
|
All Non-Employee Directors as a Group
|
|
|
|
|
0
|
|
All Other Employees as a Group
|
|
|
|
|
0
|
|
43
The material terms of the 650,000 stock options granted to
Mr. Popielec, which are conditioned on shareholder approval
of the amendment to our Restated LTIP, are as follows:
|
|
|
|
|
|
|
|
|
Number of
|
|
Exercise
|
|
|
Shares
|
|
Price
|
|
Vesting Schedule
|
|
|
250,000
|
|
|
$
|
6.4218
|
|
|
Twenty five percent of the shares will vest on each of the four
anniversaries of the date of grant.
|
|
200,000
|
|
|
$
|
10.00
|
|
|
Vesting begins on the date the stock first reaches a closing
price equal to the exercise price for 15 trading days in a 30
trading-day period, with such vesting in equal amounts over the
four anniversary dates of that date.
|
|
200,000
|
|
|
$
|
15.00
|
|
|
Vesting begins on the date the stock first reaches a closing
price equal to the exercise price for 15 trading days in a 30
trading-day period, with such vesting in equal amounts over the
four anniversary dates of that date.
|
Securities
Act Registration
We intend to register the additional shares of Common Stock
issuable and purchasable under the Restated LTIP pursuant to a
Registration Statement on
Form S-8
as soon as practicable, subject to the shareholders
approval of the amendment to the Restated LTIP at the Meeting.
Tax
Status of Restated LTIP Awards
Introduction. The following discussion
of the United States federal income tax consequences of awards
under the Restated LTIP, as proposed, is based on present
federal tax laws and regulations and does not purport to be a
complete description of the federal income tax laws.
Participants may also be subject to certain foreign, state and
local taxes which are not described below.
Incentive Stock Options. Pursuant to
the requirements of Section 422A of the Code, only
employees are eligible to receive incentive stock options. If a
stock option is an incentive stock option, no income is realized
by the employee upon grant or exercise of the incentive stock
option, and no deduction is available to us at such times. If
the Common Stock purchased upon the exercise of an incentive
stock option is held by the employee for at least two years from
the date of the grant of such incentive stock option and for at
least one year after exercise, any resulting gain is taxed at
long-term capital gains rates. If the Common Stock purchased
pursuant to the incentive stock option is disposed of before the
expiration of that period, any gain on the disposition, up to
the difference between the fair market value of the Common Stock
at the time of exercise and the exercise price of the incentive
stock option, is taxed at ordinary rates as compensation paid to
the employee, and we are entitled to a deduction for an
equivalent amount. Any amount realized by the employee in excess
of the fair market value of the Common Stock at the time of
exercise is taxed at capital gains rates.
Non-Qualified Options. If a stock
option is a non-qualified option, no income is realized by the
participant at the time of grant of the non-qualified stock
option, and no deduction is available to us at such time. At the
time of exercise (other than by delivery of shares of Common
Stock to us), ordinary income is realized by the participant in
an amount equal to the difference between the exercise price and
the fair market value of the shares on the date of exercise, and
we receive an income tax deduction for the same amount. If a
non-qualified stock option is exercised by delivering shares of
Common Stock to us, the number of shares received by the
participant equal to the number of shares so delivered are
received tax-free and have a tax basis and holding period equal
to the shares so delivered. The fair market value of the
additional shares received by the participant are taxable to the
participant as ordinary income, and the participants tax
basis in such shares is their fair market value on the date of
exercise. Upon disposition, any appreciation or depreciation of
the Common Stock after the date of exercise may be treated as
capital gain or loss depending on how long the shares have been
held.
Stock Appreciation Rights. No income is
realized by a participant at the time a stock appreciation right
is granted, and no deduction is available to us at such time.
When the stock appreciation right is exercised, ordinary income
is realized in the amount of the cash or the fair market value
at such time of the shares of Common Stock received by the
participant, and we are entitled to a deduction of equivalent
value.
44
Unrestricted Stock and Unrestricted Stock-Based
Awards. Upon the grant of an award of shares
of unrestricted stock or another stock-based award which is not
restricted, a participant realizes taxable income equal to the
cash and fair market value at such time of the shares of Common
Stock received by the participant under such award (less the
purchase price, if any), and we are entitled to a corresponding
tax deduction at that time.
Restricted Stock and Restricted Stock-Based
Awards. Upon the grant of an award of shares
of restricted stock or another stock-based award which is
restricted, no income is realized by a participant (unless a
participant timely makes an election under Section 83(b) of
the Code to accelerate the recognition of the income to the date
of grant), and we are not allowed a deduction at that time; when
the award vests and is no longer subject to a substantial risk
of forfeiture for income tax purposes, the participant realizes
taxable ordinary income in an amount equal to the cash and the
fair market value at the time of vesting of the shares of Common
Stock received by the participant under such award (less the
purchase price therefor, if any), and we are entitled to a
corresponding deduction at such time. If a participant makes an
election, as permitted under Section 83(b) of the Code,
within 30 days after the date of the transfer by us to the
participant of the shares of restricted stock or other
restricted stock-based award, then the participant recognizes
taxable ordinary income in an amount equal to the cash and the
fair market value at the time of grant of the shares of Common
Stock to be received by the participant under such award (less
the purchase price therefor, if any), and we are entitled to a
corresponding deduction at such time.
Stock
Price
The closing price of our Common Stock reported on the NASDAQ
Global Market on April 12, 2011, was $4.59 per share.
Required
Vote and Board of Directors Recommendation
We believe that our best interests will be served by the
approval of Proposal 4. Amending the Restated LTIP will
enable us to be in a position to grant stock options and other
new forms of long-term incentive awards to employees, directors
and consultants who can contribute materially to our success.
Approval of Proposal 4 requires the affirmative vote of a
majority of shares of the Common Stock represented at the
Meeting, provided that a majority of the outstanding shares of
the Common Stock votes on the proposal.
The Board of Directors recommends a vote FOR the proposal
to approve the amendment to the Restated LTIP, and, unless
otherwise indicated therein, the shares represented by the
enclosed properly executed proxy will be voted FOR such
proposal.
PROPOSAL 5
RATIFY
THE SELECTION OF
OUR
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The firm of BDO USA, LLP, independent registered public
accountants, served as our independent registered public
accounting firm in connection with the audit of our financial
statements for 2009 and 2010.
Our Audit and Finance Committee has selected BDO USA, LLP as our
independent registered public accounting firm for 2011. This
selection will be presented to our shareholders for their
ratification at the Meeting. Our Board of Directors recommends a
vote in favor of the proposal to ratify this selection, and the
persons named in the enclosed proxy (unless otherwise instructed
therein) will vote such proxies FOR this proposal. If the
shareholders do not ratify this selection, the Audit and Finance
Committee will seek to identify and address the reason or
reasons why the shareholders did not ratify the committees
selection.
We have been advised by BDO USA, LLP that a representative will
be present at the Meeting and will be available to respond to
appropriate questions. In addition, we intend to give such
representative an opportunity to make any statements if he or
she should so desire.
45
Principal
Accountant Fees and Services
Aggregate fees for professional services rendered for us by BDO
USA, LLP for 2009 and 2010 were:
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2010
|
|
|
Audit Fees
|
|
$
|
530,734
|
|
|
$
|
462,703
|
|
Audit-Related Fees
|
|
|
0
|
|
|
|
0
|
|
Tax Fees
|
|
|
9,250
|
|
|
|
10,608
|
|
All Other Fees
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
539,984
|
|
|
$
|
473,311
|
|
|
|
|
|
|
|
|
|
|
Audit
Fees
Audit fees for 2009 and 2010, respectively, were for
professional services rendered for the audits of our
consolidated financial statements, audits of internal controls
over financial reporting pursuant to Section 404 of the
Sarbanes-Oxley Act of 2002, consents, income tax provision
procedures and assistance with review of documents filed with
the SEC.
Audit-Related
Fees
There were no audit-related fees for 2009 and 2010.
Tax
Fees
Tax fees for 2009 and 2010 were for services related to tax
compliance, including the preparation of tax returns and claims
for refund, and tax planning and tax advice.
All
Other Fees
There were no other fees for 2009 and 2010.
Our Audit and Finance Committee has not adopted pre-approval
policies and procedures for audit and non-audit services. The
engagement of BDO USA, LLP for tax services during 2009 and 2010
was limited to circumstances where those services were
considered integral to the audit services that it provided or
where there was another compelling rationale for using BDO USA,
LLP. Although no pre-approval policy was in effect, all audit,
audit-related and permitted non-audit services for which BDO
USA, LLP was engaged were pre-approved by our Audit and Finance
Committee in compliance with applicable SEC requirements.
REPORT OF
THE AUDIT AND FINANCE COMMITTEE
The duties and responsibilities of the Audit and Finance
Committee are set forth in our Audit and Finance Committee
Charter, a copy of which is available on our website at
http://investor.ultralifecorp.com
under the subheading Corporate Governance. Among
other things, the Audit and Finance Committee reviews the
adequacy of our systems of internal controls regarding financial
reporting, disclosure controls and procedures and preparing our
consolidated financial statements. In addition, the Audit and
Finance Committee recommends to our Board of Directors that our
audited financial statements be included in our Annual Report on
Form 10-K,
approves our quarterly filings on
Form 10-Q
and selects the independent registered public accounting firm to
audit our books and records.
The Audit and Finance Committee has:
|
|
|
|
|
Reviewed and discussed our audited financial statements for 2010
with our management and with BDO USA, LLP, our independent
registered public accounting firm for 2010;
|
|
|
|
Discussed with BDO USA, LLP, our independent registered public
accounting firm, the matters required to be discussed by
statement on Auditing Standards No. 61, as amended (AICPA,
Professional Standards, Vol. 1. AU
section 380), as adopted by the Public Company Accounting
Oversight Board in Rule 3200T; and
|
46
|
|
|
|
|
Received from BDO USA, LLP the written disclosures and the
letter from BDO USA, LLP required by applicable requirements of
the Public Company Accounting Oversight Board regarding the
independent registered public accounting firms
communications with the Audit and Finance Committee concerning
independence, and has discussed with BDO USA, LLP their
independence.
|
The Audit and Finance Committee met with our independent
accountants with and without management present and discussed
with them the results of their examinations, their evaluations
of our internal control over financial reporting, our disclosure
controls and procedures and the quality of our financial
reporting. Based on the review and discussions referred to
above, the Audit and Finance Committee concluded that BDO USA,
LLP is independent and recommended to the Board of Directors
that the audited financial statements be included in our Annual
Report on
Form 10-K
for the year ended December 31, 2010 for filing with the
SEC.
Thomas L. Saeli, Chair
Patricia C. Barron
Robert W. Shaw II
OTHER
MATTERS
Our Board of Directors does not intend to present, and has not
been informed that any other person intends to present, any
matters for action at the Meeting other than those specifically
referred to in this proxy statement. If any other matters
properly come before the Meeting, it is intended that the
holders of the proxies will act in respect thereof in accordance
with their best judgment.
EXECUTIVE
OFFICERS
The names of, and certain information with respect to, our
executive officers who are not director nominees are presented
below.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Present Principal Occupation and Employment History
|
|
Peter F. Comerford
|
|
|
53
|
|
|
Mr. Comerford was named Vice President of Administration and
General Counsel on July 1, 1999 and was elected Corporate
Secretary in December 2000. He joined us in May 1997 as Senior
Corporate Counsel and was appointed Director of Administration
and General Counsel in December of that year. Prior to joining
us, Mr. Comerford was a practicing attorney for approximately
fourteen years having worked primarily in municipal law
departments including the City of Niagara Falls, New York where
he served as the Corporation Counsel. Mr. Comerford has a B.A.
from the State University of New York at Buffalo, an MBA from
Canisius College and a J.D. from the University of
San Diego School of Law.
|
47
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Present Principal Occupation and Employment History
|
|
Philip A. Fain
|
|
|
56
|
|
|
Mr. Fain was named Chief Financial Officer in November 2009 and
Treasurer in December 2009. He previously served as Vice
President of Business Development, having joined us in February
2008. Prior to joining us, he was Managing Partner of CXO on the
GO, LLC, a management-consulting firm, which he co-founded in
November 2003 and which we retained in connection with our
acquisition activity. Prior to founding CXO on the GO, LLC. Mr.
Fain served as Vice President of Finance RayBan
Sunoptics for Luxottica, SpA. Prior to the acquisition of Bausch
& Lombs global eyewear business by Luxottica, Mr.
Fain served as Bausch & Lombs Senior Vice President
Finance Global Eyewear from 1997 to 1999 and as Vice
President and Controller for the US Sunglass business from 1993
to 1996. From 1983 to 1993, Mr. Fain served in various positions
with Bausch & Lomb including executive positions in
corporate accounting, finance and audit. Mr. Fain began his
career as a CPA and consultant with Arthur Andersen & Co.
in 1977. He received his B.A. in Economics from the University
of Rochester and an MBA from the William E. Simon Graduate
School of Business Administration of the University of Rochester.
|
Patrick R. Hanna, Jr.
|
|
|
62
|
|
|
Mr. Hanna was named Vice President, Corporate Compliance Officer
in May 2009. He was previously appointed Vice President of
Corporate Strategy and Business Integration in February 2006,
having served as our Vice President of Corporate Strategy since
December 2001. He joined us in February 2000 as Director of
Strategic Planning after a 23 year career with Xerox
Corporation. Mr. Hanna served in many capacities in the areas of
strategic and business planning development, most recently as
the Strategic Planning Manager of the Xerox Internet and
Software Services organization. Mr. Hanna has a B.S. in
electrical engineering from Howard University and an MBA from
the William E. Simon Graduate School of Business Administration
of the University of Rochester.
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
The table below shows certain information regarding the
beneficial ownership of shares of our Common Stock as of
April 12, 2011 by each person known by us to beneficially
own more than five percent of the outstanding shares of our
Common Stock, with percentages based on 17,289,114 shares
issued and outstanding.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
Percent of Class
|
Name and Address of Beneficial Owner
|
|
Beneficially Owned
|
|
Beneficially Owned
|
|
Grace Brothers, Ltd.(1)
1560 Sherman Avenue, Suite 900
Evanston, IL 60201
|
|
|
4,518,616
|
|
|
|
26.1
|
%
|
|
|
|
(1) |
|
This information as to the beneficial ownership of shares of our
Common Stock is based on the Schedule 13D/A (Amendment
No. 5) dated March 2, 2007 filed with the SEC by
Grace Brothers, Ltd., an Illinois limited partnership, Bradford
T. Whitmore (Whitmore) and Spurgeon Corporation
(Spurgeon), its general partners, that reports
beneficial ownership of 4,419,542 shares of our Common
Stock, and on a March 15, 2007 Form 4
Statement of Changes in Beneficial Ownership, filed with the SEC
by Grace Brothers, Ltd. that reports the acquisition of an
additional 99,074 shares of our Common Stock. Grace
Brothers, Ltd., Whitmore and Spurgeon share voting and
dispositive power with respect to all 4,518,616 shares. The
amount reported in the table excludes 595,170 shares of our
Common Stock held by Whitmore, who has sole voting and
dispositive power with respect to such shares. |
48
SECURITY
OWNERSHIP OF MANAGEMENT
The table below shows certain information regarding the
beneficial ownership of shares of our Common Stock as of
April 12, 2011 by (1) each of our directors,
(2) each of our Named Executive Officers (as defined on
page 16), and (3) all of our directors and executive
officers as a group.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
Percent of Class
|
Name of Beneficial Owner (1)
|
|
Beneficially Owned (1)
|
|
Beneficially Owned (2)
|
|
Steven M. Anderson
|
|
|
7,332
|
|
|
|
*
|
|
Patricia C. Barron (3)
|
|
|
126,150
|
|
|
|
*
|
|
James A. Croce
|
|
|
5,190
|
|
|
|
*
|
|
Michael D. Popielec
|
|
|
0
|
|
|
|
0
|
%
|
Thomas L. Saeli
|
|
|
8,332
|
|
|
|
*
|
|
Robert W. Shaw II
|
|
|
6,605
|
|
|
|
*
|
|
Ranjit C. Singh (4)
|
|
|
93,678
|
|
|
|
*
|
|
Bradford T. Whitmore(5)
|
|
|
5,113,786
|
|
|
|
29.6
|
%
|
Peter F. Comerford (6)
|
|
|
102,500
|
|
|
|
*
|
|
Philip A. Fain (7)
|
|
|
107,604
|
|
|
|
*
|
|
Patrick R. Hanna, Jr. (8)
|
|
|
61,370
|
|
|
|
*
|
|
Julius M. Cirin (9)
|
|
|
57,020
|
|
|
|
*
|
|
James E. Evans (10)
|
|
|
6,016
|
|
|
|
*
|
|
John D. Kavazanjian (11)
|
|
|
345,338
|
|
|
|
2.0
|
%
|
All directors and executive officers as a group
(14 persons) (12)
|
|
|
6,040,921
|
|
|
|
33.9
|
%
|
|
|
|
* |
|
Less than 1% |
|
(1) |
|
Except as otherwise indicated, the shareholders named in this
table have sole voting and investment power with respect to the
shares of our Common Stock beneficially owned by them. The
information provided in this table is based upon information
provided to us by such shareholders. The table reports
beneficial ownership for our directors and executive officers in
accordance with
Rule 13d-3
under the Exchange Act. This means all our securities over which
directors and executive officers directly or indirectly have or
share voting or investment power are listed as beneficially
owned. The amounts also include shares that may be acquired by
exercise of stock options prior to June 11, 2011, which
shares are referred to in the footnotes to this table as
shares subject to options that may be exercised,
and, for executive officers, shares of restricted stock that are
subject to vesting. |
|
(2) |
|
Based on 17,289,114 shares issued and outstanding. |
|
(3) |
|
The amount shown includes (i) 1,200 shares held
jointly by Ms. Barron and her husband;
(ii) 10,000 shares held in the Patricia C. Barron
Profit Sharing Plan; and (iii) 24,000 shares subject
to options that may be exercised by Ms. Barron. |
|
(4) |
|
The amount shown includes 45,000 shares subject to options
that may be exercised by Mr. Singh. |
|
(5) |
|
The amount shown includes 4,518,616 shares beneficially
owned by Grace Brothers, Ltd., an Illinois limited partnership,
which shares are held in a securities margin account.
Mr. Whitmore is a general partner of Grace Brothers, Ltd.
See Security Ownership of Certain Beneficial Owners
on page 48 for more information about Grace Brothers, Ltd. |
|
(6) |
|
The amount shown includes (i) 68,159 shares subject to
options that may be exercised by Mr. Comerford; and
(ii) 397 shares of restricted stock that are subject
to time vesting. |
|
(7) |
|
The amount shown includes 76,318 shares subject to options
that may be exercised by Mr. Fain; and
(ii) 662 shares of restricted stock subject to time
vesting. |
|
(8) |
|
The amount shown includes 45,216 shares subject to options
that may be exercised by Mr. Hanna; and
(ii) 317 shares of restricted stock subject to time
vesting. |
49
|
|
|
(9) |
|
Mr. Cirin went out on disability in June 2010 and died on
December 30, 2010. The amount shown includes
48,108 shares subject to options that may be exercised by
Mr. Cirins estate. |
|
(10) |
|
Mr. Evans retired from our company effective
April 30, 2010. This information as to the beneficial
ownership of shares of our Common Stock is based on the last
Form 4 Statement of Changes in Beneficial
Ownership, filed with the SEC on March 3, 2010 by
Mr. Evans. |
|
(11) |
|
Mr. Kavazanjian retired from our company effective
February 7, 2011. The amount shown includes
(i) 1,800 shares held by Mr. Kavazanjians
wife; and (ii) 228,911 shares subject to options that
may be exercised by Mr. Kavazanjian. |
|
(12) |
|
The amount shown includes (i) 535,712 shares subject
to options that may be exercised by directors and executive
officers; and (ii) 1,376 shares of restricted stock
subject to time vesting. |
SECTION 16(a)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires our directors,
executive officers and persons who own more than 10% of our
Common Stock to file with the SEC initial reports of beneficial
ownership and reports of changes in beneficial ownership of our
Common Stock and our other equity securities. To our knowledge,
based solely on the written representations of our directors and
executive officers and the copies of such reports filed with the
SEC during 2010, all Section 16(a) filings applicable to
our officers, directors and more than 10% beneficial owners were
filed in a timely manner except for Mr. Saelis
initial report on Form 3 which was inadvertently filed late.
SUBMISSION
OF SHAREHOLDER PROPOSALS
Under
Rule 14a-8
of the Exchange Act, shareholder proposals intended for
inclusion in the proxy statement for our 2012 Annual Meeting of
Shareholders must be submitted in writing to us to our Corporate
Secretary at 2000 Technology Parkway, Newark, New York 14513,
and must be received by December 29, 2011.
Any shareholder proposal submitted for consideration at our 2011
Annual Meeting of Shareholders but not submitted for
inclusion in the proxy statement for that meeting that is
received by us after March 13, 2012 will not be considered
filed on a timely basis with us under
Rule 14a-4(c)(1)
of the Exchange Act. For such proposals that are not timely
filed, we retain discretion to vote proxies we receive. For such
proposals that are timely filed, we retain discretion to vote
proxies we receive provided that we include in our proxy
statement advice on the nature of the proposal and how we intend
to exercise our voting discretion and the proponent of
any such proposal does not issue its own proxy statement.
Our Annual Report on
Form 10-K
for the year ended December 31, 2010, as filed with the
SEC, is included in the 2010 Annual Report to Shareholders which
accompanies this proxy statement.
By Order of the Board of Directors
Bradford T. Whitmore
Chair of the Board of Directors
April 28, 2011
50
Appendix A
Amendment
No. 4
To The
Ultralife Corporation
Amended And Restated 2004 Long-Term Incentive Plan
WHEREAS, Ultralife Corporation (the Company)
maintains the Ultralife Corporation Amended and Restated 2004
Long-Term Incentive Plan (as last amended effective as of
June 5, 2008) (the Plan);
WHEREAS, pursuant to Section 12(i) of the Plan, the
Company has reserved the right to amend the Plan;
WHEREAS, the Company desires to amend the Plan in certain
respects;
WHEREAS, on April 20, 2011, subject to shareholder
approval, the Board of Directors of the Company approved this
amendment; and
WHEREAS, pursuant to Section 12(i) of the Plan,
approval by the Companys shareholders is required with
respect to this amendment.
NOW, THEREFORE, the Plan is hereby amended as follows:
1. The first sentence of Section 4(a) of the Plan is
hereby amended to read as follows:
(a) In General. The maximum number of
shares of Stock which shall be available for the grant or
issuance of Awards under the Plan (including ISOs) during its
term shall not exceed 2,900,000 (plus any shares of Stock which
are or become available under Section 2 hereof, which
shares shall also be available for the grant or issuance of
Awards under the Plan); provided, however, that no more than
200,000 shares of Stock may be used for Awards other than
Options or SARs.
2. Section 4(b) of the Plan is hereby amended to read
as follows:
(b) Maximum Awards Payable. Subject to
Section 4(c) hereof, and notwithstanding any provision
contained in the Plan to the contrary, the maximum Award payable
(or granted, if applicable) to any one Grantee under the Plan
for a calendar year is 50,000 shares of Stock; provided,
however, that the 50,000 share limitation shall not apply
to inducement grants to Grantees who are new executives or key
employees that do not exceed 700,000 shares of Stock.
3. This amendment shall be effective upon approval of the
shareholders of the Company at the 2011 Annual Meeting of
Shareholders on June 7, 2011. If this amendment is not so
approved at such meeting, then the amendment shall be null and
void.
4. Except as hereinabove provided, the Plan is hereby
ratified, confirmed and approved in all respects.
A-1
Appendix B
ULTRALIFE
CORPORATION
AMENDED
AND RESTATED
2004
LONG-TERM INCENTIVE PLAN
Original
Plan Effective June 10, 2004
As Amended by the Board on July 26, 2004
As Further Amended by Company Shareholders on June 8,
2006
As further Amended by the Board on September 7, 2007
As Further Amended by Company Shareholders on June 5, 2008
Section 1. Purpose.
The Plan authorizes the Committee to provide Employees,
Directors and Consultants of the Corporation and its
Subsidiaries, who are in a position to contribute to the
long-term success of the Corporation, with Stock and options to
acquire Stock, in accordance with the terms specified herein.
The Corporation believes that this incentive program will cause
those persons to increase their interest in the
Corporations welfare and aid in attracting and retaining
Employees, Directors and Consultants of outstanding ability.
Section 2. Successor
Plan.
This Plan shall serve as the successor to the Ultralife
Batteries, Inc. Amended and Restated 2000 Stock Option Plan (the
Predecessor Plan), and no further stock options
shall be made under the Predecessor Plan from and after the
effective date of the Plan. All outstanding stock options under
the Predecessor Plan immediately prior to the effective date of
the Plan are hereby incorporated into the Plan and shall
accordingly be treated as outstanding stock options under the
Plan; provided, however, each such stock option shall continue
to be governed solely by the terms and conditions of the
instrument evidencing such stock option and interpreted under
the terms of the Predecessor Plan, and, except as otherwise
expressly provided herein, no provision of the Plan shall affect
or otherwise modify the rights or obligations of holders of such
incorporated stock options with respect to their acquisition of
Stock, or otherwise modify the rights or the obligations of the
holders of such stock options. Any Stock reserved for issuance
under the Predecessor Plan in excess of the number of shares as
to which stock options have been granted thereunder, plus any
such shares as to which stock options granted under the
Predecessor Plan may lapse, expire, terminate or be cancelled,
shall be deemed available for issuance or reissuance under
Section 4(a) hereof.
Section 3. Definitions.
Unless the context clearly indicates otherwise, the following
terms, when used in the Plan, shall have the meanings set forth
in this Section 3:
(a) Award shall mean any Option, SAR,
Stock Award or other incentive award granted under the Plan,
whether singly, in combination, or in tandem, to a Grantee by
the Committee pursuant to such terms, conditions, restrictions
and/or
limitations, if any, as the Committee may establish by the Award
Agreement or otherwise.
(b) Award Agreement shall mean the
document establishing the terms, conditions, restrictions and
limitations of an Award in addition to those established by the
Plan and by the Committees exercise of its administrative
powers.
(c) Board shall mean the Board of
Directors of the Corporation.
(d) CEO shall mean the Chief Executive
Officer of the Corporation.
(e) Change in Control shall mean the
occurrence of any of the following: (i) any
person (as such term is used in Sections 13(d)
and 14(d) of the Exchange Act) is or becomes a beneficial
owner (as defined in
Rule 13d-3
under the Exchange Act), directly or indirectly, of securities
of the Corporation representing 30% or more of the voting power
of the then outstanding securities of the Corporation;
(ii) during any period of two consecutive calendar years
there is a change of 25% or more in the composition of the Board
in office at the
B-1
beginning of the period except for changes approved by at least
two-thirds of the Directors then in office who were Directors at
the beginning of the period; (iii) the stockholders of the
Corporation approve an agreement providing for (A) the
merger or consolidation of the Corporation with another
corporation where the stockholders of such corporation,
immediately after the merger or consolidation, own shares
entitling such stockholders to 50% or more of all votes (without
consideration of the rights of any class of stock to elect
Directors by separate class vote) to which all stockholders of
the corporation issuing cash or securities in the merger or
consolidation would be entitled in the election of directors or
where the members of the board of directors of such corporation,
immediately after the merger or consolidation, constitute a
majority of the board of directors of the corporation issuing
cash or securities in the merger or consolidation, or
(B) the sale or other disposition of all or substantially
all the assets of the Corporation, or a liquidation, dissolution
or statutory exchange of the Corporation; or (iv) any
person has commenced, or announced an intention to commence, a
tender offer or exchange offer for 30% or more of the voting
power of the then-outstanding securities of the Corporation.
(f) Code shall mean the Internal Revenue
Code of 1986 as it may be amended from time to time.
(g) Committee shall mean the
Compensation and Management Committee of the Board, or such
other Board committee as may be designated by the Board to
administer the Plan; provided that the Committee shall consist
of not less than two Directors who are Non-Employee
Directors, as that term is defined and interpreted
pursuant to
Rule 16b-3
under the Exchange Act. The Committee shall be appointed by and
serve at the pleasure of the Board.
(h) Consultant shall mean any
consultant, advisor or independent contractor retained by the
Corporation or its Subsidiaries.
(i) Control Person shall mean any person
who, as of the date of grant of an Option, owns (within the
meaning of Section 422A(b)(6) of the Code) stock possessing
more than 10% of the total combined voting power or value of all
classes of stock of the Corporation or of any Parent or
Subsidiary.
(j) Corporation shall mean Ultralife
Corporation, a Delaware corporation.
(k) Director shall mean any member of
the Board.
(l) Disability shall mean permanent and
total disability as defined by Section 22(e)(3) of the Code.
(m) Employee shall mean any person
employed by the Corporation or its Subsidiaries on a full or
part-time basis, including Directors who are otherwise employed
by the Corporation or its Subsidiaries.
(n) Exchange Act shall mean the
Securities Exchange Act of 1934 as it may be amended from time
to time, including the rules thereunder and any successor
provisions and the rules thereto.
(o) Fair Market Value shall mean for any
day (i) if the Corporation is a registrant under
Section 12 of the Exchange Act, the volume weighted average
price (VWAP) of the Stock in the
over-the-counter
market, as determined in accordance with the trading rules of
the National Association of Securities Dealers Automated
Quotation System or, if the Stock is listed or admitted to
trading on any national securities exchange, the VWAP as
determined in accordance with the trading rules on such exchange
or, (ii) if the Corporation is not a registrant under
Section 12 of the Exchange Act, the price of the Stock will
be determined by the Board on the date of grant but will not be
less than the par value of such Stock.
(p) Grantee shall mean an Employee,
Director or Consultant granted an Award under the Plan.
(q) Immediate Family Member shall mean
the transferor and his or her spouse, children or grandchildren,
whether natural, step or adopted children or grandchildren.
(r) ISO shall mean an Option granted
pursuant to the Plan to purchase shares of Stock and intended to
qualify as an incentive stock option under Section 422 of
the Code, as now or hereafter constituted.
(s) NQSO shall mean an Option granted
pursuant to the Plan to purchase shares of the Stock that is not
an ISO.
B-2
(t) Non-Employee Director shall mean a
non-employee director within the meaning of
Rule 16b-3
under the Exchange Act.
(u) Options shall refer collectively to
NQSOs and ISOs subject to the Plan.
(v) Parent shall mean any parent (as
defined in Section 425 of the Code) of the Corporation.
(w) Plan shall mean this 2004 Long-Term
Incentive Plan as set forth herein and as amended from time to
time.
(x) SAR shall mean a stock appreciation
right granted pursuant to Section 8 hereof; a stock
appreciation right shall entitle the Grantee to receive a
payment equal to the appreciation in a stated number of shares
of Stock from the exercise price for that stock appreciation
right to the Fair Market Value of the stated number of shares of
Stock on the date of exercise.
(y) Securities Act shall mean the
Securities Act of 1933 as it may be amended from time to time,
including the rules thereunder and any successor provisions and
the rules thereto.
(z) Stock shall mean shares of the
Common Stock, par value $.10 per share, of the Corporation.
(aa) Stock Award shall mean an award of
shares of Stock or restricted shares of Stock granted pursuant
to Section 9 hereof.
(bb) Subsidiary shall mean any
subsidiary (as defined in Section 425 of the Code) of the
Corporation.
Section 4. Shares
of Stock Subject to the Plan.
(a) In General. The maximum number of
shares of Stock which shall be available for the grant or
issuance of Awards under the Plan (including ISOs) during its
term shall not exceed 2,000,000 (plus any shares of Stock which
are or become available under Section 2 hereof, which
shares shall also be available for the grant or issuance of
Awards under the Plan); provided, however, that no more than
200,000 shares of Stock may be used for Awards other than
Options or SARs. Such amounts shall be subject to adjustment as
provided in Section 4(c) hereof. Any shares of Stock
related to Awards which terminate by expiration, forfeiture,
cancellation or otherwise without the issuance of such shares,
are settled in cash in lieu of Stock, or are exchanged with the
Committees permission for Awards not involving Stock,
shall be available again for grant under the Plan. Moreover, if
the exercise price of any Award granted under the Plan or the
tax withholding requirements with respect to any Award granted
under the Plan are satisfied by tendering shares of Stock to the
Corporation (by either actual delivery or by attestation), only
the number of shares of Stock issued net of the shares of Stock
tendered will be deemed delivered for purposes of determining
the maximum number of shares of Stock available for delivery
under the Plan. The shares of Stock available for issuance under
the Plan may be authorized and unissued shares or treasury
shares, including shares purchased in open market or private
transactions. For the purpose of computing the total number of
shares of Stock granted under the Plan, where one or more types
of Awards, both of which are payable in shares of Stock, are
granted in tandem with each other, such that the exercise of one
type of Award with respect to a number of shares cancels an
equal number of shares of the other, the number of shares
granted under both Awards shall be deemed to be equivalent to
the number of shares under one of the Awards.
(b) Maximum Awards Payable. Subject to
Section 4(c) hereof, and notwithstanding any provision
contained in the Plan to the contrary, the maximum Award payable
(or granted, if applicable) to any one Grantee under the Plan
for a calendar year is 50,000 shares of Stock.
(c) Adjustment Upon Changes in
Capitalization. In the event of any
reclassification, recapitalization, merger, consolidation,
reorganization, issuance of warrants, rights or debentures,
stock dividend, stock split or reverse stock split, cash
dividend, property dividend, combination or exchange of shares,
repurchase of shares or any other change in corporate structure
which in the judgment of the Committee materially affects the
value of shares, then the Committee may determine the
substitutions or adjustments to the maximum number of shares
available for the grant or issuance of Awards under the Plan
pursuant to Section 4(a) hereof, the maximum Award payable
under Section 4(b) hereof, the number and class of shares
and the exercise price per share set forth in any Award
theretofore granted, or any other affected terms of an Award or
the Plan as the Committee, in its sole discretion and without
liability to any person, deems equitable or appropriate;
provided, however, that no such
B-3
adjustments shall be made to any ISO without the Grantees
consent, if such adjustment would cause such ISO to fail to
qualify as such.
Section 5. Administration
of the Plan.
(a) In General. The Committee shall have
total and exclusive responsibility to control, operate, manage
and administer the Plan in accordance with its terms. The
Committee may act only by a majority of its members. Any
determination of the Committee may be made, without a meeting,
by a writing or writings signed by all of the members of the
Committee. The decisions of the Committee and its actions with
respect to the Plan shall be final, binding and conclusive upon
all persons having or claiming to have any right or interest in
or under the Plan.
(b) Authority. The Committee shall have
all the authority that may be necessary or helpful to enable it
to discharge its responsibilities with respect to the Plan.
Without limiting the generality of the preceding sentence, the
Committee shall have the exclusive right to:
(i) determine eligibility for participation in the Plan;
(ii) select the Grantees and determine the type of Awards
to be made to Grantees, the number of shares of Stock subject to
Awards and the terms, conditions, restrictions and limitations
of the Awards, including, but not by way of limitation,
restrictions on the transferability of Awards and conditions
with respect to continued employment or performance criteria;
(iii) interpret the Plan or any Award Agreement;
(iv) construe any ambiguous provision, correct any default,
supply any omission, and reconcile any inconsistency of the Plan
or an Award Agreement;
(v) issue administrative guidelines as an aid to administer
the Plan and make changes in such guidelines as it from time to
time deems proper;
(vi) promulgate regulations for carrying out the Plan and
make changes in such regulations as it from time to time deems
proper;
(vii) to the extent permitted under the Plan, grant waivers
of Plan terms, conditions, restrictions, and limitations;
(viii) promulgate rules and regulations regarding treatment
of Awards of a Grantee under the Plan in the event of such
Grantees death, disability, retirement, termination from
the Corporation or breach of agreement by the Grantee, or in the
event of a Change in Control of the Corporation;
(ix) to the extent permitted under the Plan, accelerate the
vesting, exercise, or payment of an Award when such action or
actions would be in the best interest of the Corporation;
(x) subject to Section 5(d) hereof, grant Awards in
replacement of Awards previously granted under the Plan or any
other executive compensation plan of the Corporation;
(xi) determine the terms and provisions of any Award
Agreements entered into hereunder, including, a provision in an
Award Agreement that requires, upon the occurrence of a Change
in Control specified in Section 3(e)(iii) hereof, the
cancellation for cash of outstanding Awards or the issuance of
comparable replacement Awards granted by the successor entity in
such event;
(xii) take any and all other action it deems necessary or
advisable for the proper operation or administration of the
Plan; and
(xiii) make all other determinations it deems necessary or
advisable for the administration of the Plan, including factual
determinations.
(c) Delegation. The Committee may
allocate all or any portion of its responsibilities and powers
under the Plan to any one or more of its members, the CEO or
other senior members of management as the Committee deems
appropriate and may delegate all or any part of its
responsibilities and powers to any such person or persons,
provided that any such allocation or delegation be in writing;
provided, however, that only the Committee, or other
B-4
committee consisting of two or more Non-Employee Directors may
select and grant Awards to Grantees who are subject to
Section 16 of the Exchange Act. The Committee may revoke
any such allocation or delegation at any time for any reason
with or without prior notice.
(d) Repricing. Except for adjustments
pursuant to Section 4(c) hereof, the Committee shall not
reprice any Options or SARs unless such action is approved by
the stockholders of the Corporation. For purposes of the Plan,
the term reprice shall mean: (i) the reduction,
directly or indirectly, in the per-share exercise price of an
outstanding Option or SAR by amendment, cancellation or
substitution; (ii) any action that is treated as a
repricing under United States generally accepted accounting
principles; (iii) canceling an Option or SAR when its
exercise price exceeds the fair market value of the underlying
Stock in exchange for another Option, SAR or other equity
security (unless the cancellation and exchange occurs in
connection with a merger, acquisition, or similar transaction);
and (iv) any other action that is treated as a repricing by
the rules or regulations of any stock exchange on which the
securities of the Corporation are traded. Any amendment or
repeal of this provision shall require the affirmative vote of a
majority of shares of voting capital stock present at a
stockholders meeting in person or by proxy and entitled to vote
thereon.
Section 6. Awards.
(a) Eligibility. Subject to
Section 5 hereof, all Employees, Directors and Consultants
are eligible to participate in the Plan; provided, however, only
Employees are eligible to receive ISOs. The Committee shall
determine and designate from time to time those Employees,
Directors and Consultants who are to be granted Awards, the
nature of each Award granted and the number of shares of Stock
subject to each such Award.
(b) In General. Awards may, at the
Committees sole discretion, be paid in the form of Options
pursuant to Section 7 hereof, SARs pursuant to
Section 8 hereof, Stock Awards pursuant to Section 9
hereof, or a combination thereof. Each Award shall be subject to
the terms, conditions, restrictions and limitations of the Plan
and the Award Agreement for such Award. Awards under a
particular Section of the Plan need not be uniform and Awards
under two or more Sections may be combined into a single Award
Agreement. Any combination of Awards may be granted at one time
and on more than one occasion to the same Grantee.
(c) Foreign Jurisdictions. With respect
to Grantees who reside or work outside of the United States, the
Committee may, in its sole and absolute discretion, amend the
terms of the Plan or Awards with respect to such Grantees in
order to conform such terms with the provisions of local law and
practice or otherwise as deemed necessary or desirable by the
Committee.
Section 7. Stock
Options.
(a) In General. Awards may be granted in
the form of Options. Options granted under the Plan may be of
two types: ISOs and NQSOs. The Committee shall have the
authority and discretion to grant to an eligible Employee either
ISOs, NQSOs, or both, but shall clearly designate the nature of
each Option at the time of grant. Consultants and Directors
shall only receive NQSOs.
(b) Terms of Options. An Option shall be
exercisable in accordance with such terms and conditions and at
such times and during such periods as may be determined by the
Committee. In addition to any such terms and conditions, the
following terms and conditions shall apply to all Options
granted under the Plan:
(i) The exercise price per share of Stock subject to an
Option shall be not less than 100% of the Fair Market Value of a
share of the Stock on the date such Option is granted, except
for Options granted in assumption of or substitution for
outstanding awards previously granted by the Corporation or its
affiliates or an entity that the Corporation acquires or with
which the Corporation combines, in any case in a transaction
contemplated by Section 4(c); provided, however, that the
exercise price for any ISO granted to a Control Person shall not
be less than 110% of such Fair Market Value.
(ii) The term of each Option shall be determined by the
Committee, provided that no Option shall be exercisable more
than ten years from the date such Option is granted, and
provided further that no ISO granted to a Control Person shall
be exercisable more than five years from the date of Option
grant.
B-5
(iii) Notwithstanding any other provisions hereof, the
aggregate Fair Market Value (determined at the time the ISO is
granted) of the Stock with respect to which ISOs are exercisable
for the first time by any Employee during any calendar year
under all plans of the Corporation and any Parent or Subsidiary
corporation shall not exceed $100,000.
(c) Exercise of Options. Except as
provided in Section 11 hereof, no Option granted to an
Employee or Consultant shall be exercised unless at the time of
such exercise the Grantee is then an Employee or Consultant.
Upon exercise, the exercise price of an Option may be paid in
cash, or, to the extent permitted by the Committee, by
tendering, by either actual delivery of shares or by
attestation, shares of Stock, a combination of the foregoing, or
such other consideration as the Committee may deem appropriate.
The Committee shall establish appropriate methods for accepting
Stock, whether restricted or unrestricted, and may impose such
conditions as it deems appropriate on the use of such Stock to
exercise an Option. Options awarded under the Plan may also be
exercised by way of a broker-assisted stock option exercise
program, if any, provided such program is available at the time
of the Grantees exercise. Notwithstanding the foregoing or
the provision of any Award Agreement, a Grantee may not pay the
exercise price of an Option using shares of Stock if, in the
opinion of counsel to the Corporation, (i) the Grantee is,
or within the six months preceding such exercise was, subject to
reporting under Section 16(a) of the Exchange Act,
(ii) there is a substantial likelihood that the use of such
form of payment or the timing of such form of payment would
subject the Grantee to a substantial risk of liability under
Section 16 of the Exchange Act, or (iii) there is a
substantial likelihood that the use of such form of payment
would result in accounting treatment to the Corporation under
generally accepted accounting principles that the Committee
reasonably determines is adverse to the Corporation.
Section 8. Stock
Appreciation Rights.
(a) In General. Awards may be granted in
the form of SARs. SARs granted under the Plan may be of two
types: an SAR granted in tandem with all or a portion of a
related Option under the Plan (Tandem SARs) or
granted separately (Freestanding SARs). A Tandem SAR
may be granted either at the time of the grant of the related
Option or at any time thereafter during the term of the Option.
(b) Tandem SARs. A Tandem SAR shall be
exercisable to the extent, and only to the extent, that the
related Option is exercisable, and the exercise
price of such a SAR (the base from which the value of the
SAR is measured at its exercise) shall be the exercise price
under the related Option. However, at no time shall a Tandem SAR
be issued if the exercise price of its related Option is less
than the Fair Market Value of the Stock, as determined by the
Committee, on the date that the Tandem SAR is granted. If a
related Option is exercised as to some or all of the shares
covered by the Award, the related Tandem SAR, if any, shall be
canceled automatically to the extent of the number of shares
covered by the Option exercise. Upon exercise of a Tandem SAR as
to some or all of the shares covered by the Award, the related
Option shall be canceled automatically to the extent of the
number of shares covered by such exercise. All Tandem SARs shall
expire not later than ten years from the date of the grant of
the SAR.
(c) Freestanding SARs. Freestanding SARs
shall be exercisable or automatically mature in accordance with
such terms and conditions and at such times and during such
periods as may be determined by the Committee. The exercise
price of a Freestanding SAR shall be defined in the Award
Agreement for that SAR and shall be not less than 100% of the
Fair Market Value of a share of Stock on the date of the grant
of the Freestanding SAR. All Freestanding SARs shall expire not
later than ten years from the date of grant of the SAR.
(d) Exercise of SARs. Except as provided
in Section 11 hereof, no SAR granted to an Employee or
Consultant shall be exercised unless at the time of such
exercise the Grantee is then an Employee or Consultant. The
Committee may provide that an SAR shall be deemed to be
exercised at the close of business on the scheduled expiration
date of such SAR if at such time the SAR by its terms remains
exercisable and, if so exercised, would result in a payment to
the holder of such SAR. Unless otherwise provided in an Award
Agreement, an SAR may be paid in cash, shares of Stock or any
combination thereof, as determined by the Committee, in its sole
and absolute discretion, at the time that the SAR is exercised.
B-6
Section 9. Stock
Awards
(a) In General. Awards may be granted in
the form of Stock Awards. Stock Awards shall be awarded in such
numbers and at such times during the term of the Plan as the
Committee shall determine.
(b) Restrictions. The Committee may
condition, restrict or limit the grant of a Stock Award on the
achievement of enumerated performance objectives or, with
respect to Stock Awards issued to an Employee or a Consultant,
on such Employees or Consultants continued
employment or service to the Corporation through a specified
period of time. The restricted period specified in respect of
any Stock Award shall not be less than three years, except that
the Committee may (i) provide for the restricted period to
terminate at any time after one year upon the attainment of
performance-based objectives, and (ii) grant Stock Awards
of up to 30,000 shares of Stock without regard to this
limitation. Furthermore, the Committee may not terminate the
restrictions applicable to outstanding Stock Awards except in
connection with a Change in Control. The Committee may grant an
unrestricted Stock Award only if the Committee determines that
such Stock Award is made in lieu of all or a portion of salary
or cash bonus of comparable value.
(c) Rights as Stockholders. During the
period in which any shares of Stock received pursuant to a Stock
Award are subject to any restrictions, the Committee may, in its
sole and absolute discretion, deny the Grantee to whom such
shares have been awarded all or any of the rights of a
stockholder with respect to such shares, including, but not by
way of limitation, limiting the right to vote such shares or the
right to receive dividends on such shares.
Section 10. Payment
of Awards.
(a) In General. Absent a Plan or Award
Agreement provision to the contrary, payment of Awards may, at
the discretion of the Committee, be made in cash, Stock, a
combination of cash and Stock, or any other form of property as
the Committee shall determine. In addition, payment of Awards
may include such terms, conditions, restrictions
and/or
limitations, if any, as the Committee deems appropriate,
including, in the case of Awards paid in the form of Stock,
restrictions on transfer and forfeiture provisions; provided,
however, such terms, conditions, restrictions
and/or
limitations are not inconsistent with the Plan.
(b) Withholding. The Corporation shall be
entitled to deduct from any payment under the Plan, regardless
of the form of such payment, the amount of all applicable income
and employment taxes required by law to be withheld with respect
to such payment or may require the Grantee to pay to the
Corporation such tax prior to and as a condition of the making
of such payment. In accordance with any applicable
administrative guidelines it establishes, the Committee may
allow a Grantee to pay the amount of taxes required by law to be
withheld from an Award by withholding from any payment of shares
of Stock due as a result of such Award, or by permitting the
Grantee to deliver to the Corporation, shares of Stock having a
Fair Market Value equal to the minimum amount of such required
withholding taxes. Notwithstanding the foregoing or the
provision of any Award Agreement, a Grantee may not pay the
amount of taxes required by law to be withheld using shares of
Stock if, in the opinion of counsel to the Corporation,
(i) the Grantee is, or within the six months preceding such
exercise was, subject to reporting under Section 16(a) of
the Exchange Act, (ii) there is a substantial likelihood
that the use of such form of payment or the timing of such form
of payment would subject the Grantee to a substantial risk of
liability under Section 16 of the Exchange Act, or
(iii) there is a substantial likelihood that the use of
such form of payment would result in accounting treatment to the
Corporation under generally accepted accounting principles that
the Committee reasonably determines is adverse to the
Corporation.
Section 11. Effect
of Termination of Relationship with the Corporation.
(a) Committee Rules. The Committee shall
have the authority to promulgate rules and regulations to
determine the treatment of a Grantees Awards under the
Plan in the event of such Grantees death, Disability, and
termination. In addition, notwithstanding the provisions of this
Section 11, the terms of an Award Agreement or the rules
and regulations promulgated by the Committee and in effect from
time to time, the Committee shall have the right to extend the
period for exercise of any Option or SAR, provided such
extension does not exceed the term of such Option or SAR.
(b) Death. Unless otherwise decided by
the Committee and provided in an Award Agreement, upon a
Grantees death prior to the complete exercise of the
Options or SARs granted to him or her under the Plan, any
B-7
remaining Options or SARs may be exercised in whole or in part
within one year after the date of the Grantees death and
then only:
(i) by the beneficiary designated by the Grantee in a
writing submitted to the Corporation prior to the Grantees
death, or in the absence of same, by the Grantees estate
or by or on behalf of such person or persons to whom the
Grantees rights pass under his or her will or the laws of
descent and distribution,
(ii) to the extent that the Grantee would have been
entitled to exercise the Option or SAR at the date of his or her
death and subject to all of the conditions on exercise imposed
by the Plan and the Award Agreement, and
(iii) prior to the expiration of the term of the Option or
SAR.
(c) Disability. Unless otherwise decided
by the Committee and provided in an Award Agreement, upon a
Grantees Disability prior to the complete exercise of the
Options or SARs granted to him or her under the Plan, any
remaining Options or SARs may be exercised in whole or in part
within one year after the date of the Grantees Disability
and then only:
(i) by the Grantee or his or her legal representative,
(ii) to the extent that the Grantee would have been
entitled to exercise the Option or SAR on the date of his or her
Disability, subject to all of the conditions on exercise imposed
by the Plan and the Award Agreement, and
(iii) prior to the expiration of the term of the Option or
SAR.
(d) Other Termination. Unless otherwise
decided by the Committee and provided in an Award Agreement, the
termination of a Grantees employment, consulting
relationship or term of directorship with the Corporation for a
reason other than the Grantees death or Disability and
prior to the complete exercise of the Options or SARs granted to
him or her under the Plan, any remaining Options or SARs may be
exercised in whole or in part within three months after the date
of the Grantees termination and then only:
(i) by the Grantee or his or her legal representative,
(ii) to the extent that the Grantee would have been
entitled to exercise the Option or SAR on the date of his or her
termination, subject to all of the conditions on exercise
imposed by the Plan and the Award Agreement, and
(iii) prior to the expiration of the term of the Option or
SAR.
(e) Treatment of Intra-Corporation
Transfers. In the case of an Employee or
Consultant, the transfer between the Corporation and any
Subsidiary shall not be deemed to be a termination of employment
or consulting relationship, and a change from the status of an
Employee to a Consultant or from a Consultant to an Employee
shall not be deemed to be a termination of employment or
consulting relationship.
Section 12. General
Provisions.
(a) Award Agreement. Each Award grant
shall be evidenced by a written Award Agreement containing such
terms and conditions, not inconsistent with the Plan, as the
Committee shall approve. The terms and provisions of Award
Agreements may vary among Grantees and among different Awards
granted to the same Grantee. Any Stock Award granted under the
Plan may be evidenced in such manner as the Committee deems
appropriate, including, without limitation, book-entry
registration or issuance of a stock certificate or certificates,
with such restrictive legends
and/or stop
transfer instructions as the Committee deems appropriate.
(b) No Right to Further Awards or Continued
Service. The grant of an Award in any year shall
not give the Grantee any right to similar grants in future years
or any right to continue such Grantees employment or
consultant relationship with the Corporation or its
Subsidiaries. All Grantees shall remain subject to discharge to
the same extent as if the Plan were not in effect.
(c) No Right, Title, or Interest in Corporation
Assets. No Grantee shall have any rights as a
stockholder as a result of participation in the Plan until the
date of issuance of a stock certificate in his or her name, and,
in the case of restricted shares of Stock, such rights are
granted to the Grantee under the Plan. To the extent any person
acquires a
B-8
right to receive payments from the Corporation under the Plan,
such rights shall be no greater than the rights of an unsecured
creditor of the Corporation and the Grantee shall not have any
rights in or against any specific assets of the Corporation. All
of the Awards granted under the Plan shall be unfunded and the
Corporation shall not be required to establish any fund or make
any other segregation of assets to assure the payment of any
Award.
(d) Nonassignability.
(i) Except as otherwise determined by the Committee or as
otherwise provided in Section 12(d)(ii) hereof, no Award or
other right under the Plan shall be subject to anticipation,
sale, assignment, pledge, encumbrance, or charge except by will
or the laws of descent and distribution, and an Award shall be
exercisable during the Grantees lifetime only by the
Grantee.
(ii) The Committee shall have the discretionary authority
to grant NQSOs or amend outstanding NQSOs to provide that they
be transferable, subject to such terms and conditions as the
Committee shall establish. In addition to any such terms and
conditions, the following terms and conditions shall apply to
all transfers of NQSOs:
(A) Except as otherwise permitted by the Committee, in its
sole and absolute discretion, only Directors and corporate
officers of the Corporation shall be permitted to transfer their
NQSOs, and such individuals must be a Director or a corporate
officer on the date of transfer.
(B) Transfers shall only be permitted to: (1) the
transferors Immediate Family Members; (2) a trust or
trusts for the exclusive benefit of the transferors
Immediate Family Members; or (3) a family partnership or
family limited partnership in which each partner is, at the time
of transfer and all time subsequent thereto, either an Immediate
Family Member or a trust for the exclusive benefit of one or
more Immediate Family Members.
(C) All transfers shall be made for no consideration.
(D) Once a NQSO is transferred, any subsequent transfer of
such transferred NQSO shall, notwithstanding
Section 12(d)(i) hereof to the contrary, be permitted;
provided, however, such subsequent transfer complies with all of
the terms and conditions of this Section 12(d)(ii), with
the exception of Section 12(d)(ii)(A) hereof.
(E) In order for a transfer to be effective, the
Committees designated transfer agent must be used to
effectuate the transfer. The costs of such transfer agent shall
be borne solely by the transferor.
(F) In order for a transfer in accordance with
Section 12(d)(ii) to be effective, the transferor must
agree in writing prior to the transfer on a form provided by the
Corporation to pay any and all payroll and withholding taxes due
upon exercise of the transferred NQSO. In addition, prior to the
exercise of the transferred NQSO by the transferee, arrangements
must be made by the Grantee with the Corporation for the payment
of any and all payroll and withholding taxes.
(G) Upon transfer, a NQSO continues to be governed by and
subject to the terms and conditions of the Plan. A transferee of
a NQSO is entitled to the same rights as the Grantee to whom
such NQSO was originally granted, as if no transfer had taken
place. Accordingly, the rights of the transferee are subject to
the terms and conditions of the original grant of the NQSO,
including provisions relating to expiration date,
exercisability, exercise price and forfeiture.
(H) The Corporation shall be under no obligation to provide
a transferee with any notice regarding the transferred NQSO held
by the transferee upon forfeiture or any other circumstance.
(e) Regulatory Approvals and
Listings. Notwithstanding any other provision of
the Plan or Award Agreements made pursuant thereto, the
Corporation shall not be required to issue or deliver any
certificate or certificates for shares of Stock under the Plan
prior to fulfillment of all of the following conditions:
(i) The listing, or approval for listing upon notice of
issuance, of such shares on any securities exchange on which the
Stock may then be traded;
B-9
(ii) Any registration or other qualification of such shares
under any state or federal law or regulation, or other
qualification which the Board shall, in its absolute discretion
and upon the advice of counsel, deem necessary or advisable;
(iii) The obtaining of any other consent approval or permit
from any state or federal government agency which the Board
shall, in its absolute discretion and upon the advice of
counsel, determine to be necessary or advisable; and
(iv) The execution by the Grantee (or the Grantees
legal representative) of such written representation that the
Committee may in its sole discretion deem necessary or advisable
to the effect that the shares then being purchased are being
purchased for investment with no present intention of reselling
or otherwise disposing of such shares in any manner which may
result in a violation of the Securities Act and the placement
upon certificates for such shares of an appropriate legend in
connection therewith.
(f) In the case of a grant of an Option to any Employee or
Consultant of a Subsidiary, the Corporation may, if the
Committee so directs, issue or transfer the shares covered by
the Option to the Subsidiary, for such lawful consideration as
the Committee may specify, upon the condition or understanding
that the Subsidiary will transfer the shares to the Employee or
Consultant in accordance with the terms of the Plan and the
Award Agreement relating to such Option.
(g) Governing Law. The Plan shall be
governed by and construed in accordance with the laws of the
State of New York, except as superseded by applicable federal
law, without giving effect to its conflicts of law provisions.
(h) No Guarantee of Tax Consequences. No
person connected with the Plan in any capacity, including, but
not limited to, the Corporation and its directors, officers,
agents and employees, makes any representation, commitment, or
guarantee that any tax treatment, including, but not limited to,
federal, state and local income, estate and gift tax treatment,
will be applicable with respect to the tax treatment of any
Award, or that such tax treatment will apply to or be available
to a Grantee on account of participation in the Plan.
(i) Amendment or Termination. The Board
may, at any time and for any reason, with or without prior
notice, suspend, discontinue or terminate the Plan; provided,
however, that no such action shall adversely affect the rights
of Grantees to Awards previously granted hereunder. In addition,
the Board may, at any time and for any reason, with or without
prior notice, amend the Plan in any manner, but may not without
stockholder approval, adopt any amendment which would:
(i) increase the number of shares available under the Plan;
(ii) expand the types of Awards available under the Plan;
(iii) expand the class of persons eligible to participate
in the Plan; (iv) extend the term of the Plan; (v) be
a material amendment to the Plan, including, but not limited to,
a change in the method of determining the exercise price of
Options issued under the Plan; (vi) allow for repricing of
Options or SARs issued under the Plan; (vii) terminate
restrictions applicable to Awards (except in connection with a
Grantees death, Disability or termination of employment or
in connection with a Change in Control); or (viii) require
the vote of the stockholders if such approval is necessary or
desirable in order to comply with tax, securities, or other
applicable laws or regulations, including, but not limited to,
the listing requirements of the stock exchanges on which the
securities of Corporation are listed.
(j) Duration of Plan. The Plan was
approved by the Board on April 27, 2004, and became
effective on June 10, 2004, upon the approval by the
stockholders of the Corporation at the 2004 Annual Meeting of
the Stockholders. Awards may not be granted under the Plan after
June 9, 2014, but Awards theretofore granted may extend
beyond that date.
* * * * *
B-10
ULTRALIFE CORPORATION
2000 Technology Parkway
Newark, NY 14513
VOTE
BY INTERNET - www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the meeting date. Have your proxy card in hand when you access the web site and follow the instructions
to obtain your records and to create an electronic voting instruction form.
ELECTRONIC
DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs incurred
by our company in mailing proxy materials, you can consent
to receiving all future proxy statements, proxy cards and
annual reports electronically via e-mail or the Internet.
To sign up for electronic delivery, please follow the instructions
above to vote using the Internet and, when prompted, indicate that
you agree to receive or access proxy materials electronically in future years.
VOTE
BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until
11:59 P.M. Eastern Time the day before the meeting date.
Have your proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have
provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way,
Edgewood, NY 11717.
|
|
|
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
|
|
|
|
|
|
|
|
KEEP THIS PORTION FOR YOUR RECORDS |
|
|
|
|
|
DETACH AND RETURN THIS PORTION ONLY |
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends you vote FOR the
following:
|
|
For All |
|
Withhold All |
|
For All Except |
|
To withhold authority to vote for any individual
nominee(s), mark For All
Except and write the number(s) of the nominee(s) on the line below. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o |
|
|
|
o |
|
|
|
o |
|
|
|
|
|
|
1. |
|
Election of Directors Nominees |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01
|
|
Steven M. Anderson |
|
02 |
|
Patricia C. Barron |
|
03 |
|
James A. Croce |
|
04 |
|
Michael D. Popielec |
|
05 |
|
Thomas L. Saeli |
06
|
|
Robert W. Shaw II |
|
07 |
|
Ranjit C. Singh |
|
08 |
|
Bradford T. Whitmore |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends you vote FOR
the following proposal: |
|
For |
|
Against |
|
Abstain |
|
|
|
|
|
For |
|
Against |
|
Abstain |
|
|
|
|
|
|
|
|
|
|
|
2. |
|
To approve an advisory resolution on executive
compensation.
|
|
o |
|
o |
|
o |
|
5. |
|
To ratify the selection of BDO USA, LLP as our
independent registered public accounting firm
for the fiscal year ending December 31, 2011.
|
|
o |
|
o |
|
o |
The Board of Directors recommends you
vote 3 YEARS on the following proposal: |
|
1 year |
|
2 years |
|
3 years |
|
Abstain |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3. |
|
To conduct an advisory vote on the
frequency of future advisory votes on
executive compensation.
|
|
o |
|
o |
|
o |
|
o |
|
NOTE: The proxies are authorized to vote in their
discretion upon such other business as may properly
come before the meeting and any adjournments
thereof.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends you vote FOR
proposals 4. and 5. |
|
For |
|
Against |
|
Abstain |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
To approve an amendment to our Amended and
Restated 2004 Long-Term Incentive Plan,
including an increase in the number of
authorized shares under the plan and an
amendment to the annual limitation set forth in
the plan. |
|
|
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Please sign exactly as your name(s) appear(s) hereon. When signing as
attorney, executor, administrator, or other fiduciary, please give full
title as such. Joint owners should each sign personally. All holders must
sign. If a corporation or partnership, please sign in full corporate or
partnership name, by authorized officer.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature [PLEASE SIGN WITHIN BOX]
|
|
Date |
|
Signature (Joint Owners) |
|
Date |
|
|
Important Notice
Regarding the Availability of Proxy Materials for the Annual Meeting:
The Annual Report, Notice & Proxy Statement is/are available at www.proxyvote.com.
ULTRALIFE CORPORATION
2011 Annual Meeting of Shareholders
June 7, 2011
This proxy is solicited on behalf of the Board of Directors.
The undersigned hereby appoints Philip A. Fain and Peter F. Comerford, and each of them, as proxy for the
undersigned, with full power of substitution, to vote all shares of the Common Stock of Ultralife Corporation
owned by the undersigned at the Annual Meeting of Shareholders to be held on June 7, 2011 at 10:30 A.M., local
time, at our corporate offices, which are located at 2000 Technology Parkway, Newark, New York 14513, and at
any adjournments of such meeting, on the matters listed in this proxy and described in the notice of annual
meeting and proxy statement and upon such other business as may properly come before such meeting and any
adjournments thereof.
This proxy is solicited on behalf of the Board of Directors of the Company and each matter to be voted
on at the Annual Meeting has been proposed by the Board of Directors of the Company. This proxy will
be voted as specified by the undersigned. This proxy revokes any prior proxy given by the undersigned.
Unless authority to vote for one or more of the nominees is specifically withheld according to the
instructions, a signed proxy will be voted FOR the election of the eight named nominees for director,
FOR the advisory resolution on executive compensation, for the proposal to conduct an advisory vote on
the frequency of future advisory votes on executive compensation every 3 years, FOR the amendment
to our Amended and Restated 2004 Long-Term Incentive Plan, and FOR the ratification of the selection of
BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December
31, 2011. The undersigned acknowledges receipt with this proxy of a copy of the notice of annual
meeting and proxy statement dated April 28, 2011, describing more fully the proposals set forth in this
proxy.
(continued and to be signed on the reverse side)